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ABSTRACT 
 
JAMES ALLEN GREEN: Organization and Function of Molecular Domains in Myelinated 
Neurons  
(Under the direction of Manzoor A. Bhat) 
 
Myelinated neurons are organized into distinct molecular domains that are essential 
for electrical conduction. These domains include the axon initial segment, nodes of Ranvier, 
paranodes, juxtaparanodes, and internode. The paranode acts as a molecular fence, 
maintaining separation of the sodium channel-enriched nodes from the potassium channel-
enriched juxtaparanodes via axo-glial septate junctions. In demyelinating diseases like 
multiple sclerosis and Guillain-Barré, the clustering and segregation of such domains and 
structures are disrupted, resulting in altered neuronal function.  
Whirlin (Whrn) is a PDZ-containing cytoskeletal protein whose role is to cluster and 
segregate transmembrane proteins in both the ear and eye. We examined Whrn knockout 
(Whrn
-/-
) mice and how the loss of Whirlin protein affected myelinated axonal domain 
organization. Our studies confirmed loss of the major 110kDa Whrn isoform in Whrn
-/-
 
dorsal root ganglia, spinal cord, and eye tissue lysates. Curiously, the expression levels of 
nodal, paranodal, and juxtaparanodal markers in spinal cord lysates were similar between 
wild-type and Whrn
-/-
 mice. Also, conduction velocities in isolated Whrn
-/-
 sciatic nerves 
were similar to wild-type. We detected and quantified a ‘spring-like’ paranodal compaction 
phenotype in four to eight week-old Whrn
-/-
 sciatic nerves. The paranodal compaction 
phenotype, juxtaparanodal and associated cytoskeletal disruption were observed in Whrn
-/-
 
mutant sciatic nerves and spinal cord fibers from two week-old to one year-old mice. Light 
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and transmission electron microscopic analyses of Whrn
-/-
 mice revealed cellular swellings in 
cerebellar Purkinje axons filled with mitochondria and vesicles. Such Purkinje axon findings 
were similar to the Caspr, another paranodal protein, knockout mouse cerebellar phenotype. 
Additional higher magnification, electron micrograph images of the paranodal, 
juxtaparanodal and internodal region in Whrn
-/-
 mice reveal abnormal accumulation of 
mitochondria and vesicles. Taken together, our studies revealed Whirlin plays an important 
role in paranodal and juxtaparanodal organization, maintaining cytoskeletal organization, and 
preventing accumulation of mitochondria and vesicles. In addition to these core findings, 
results are included from a study characterizing fluorescent imaging of 
myelination/demyelination in the cuprizone mouse model, as well an investigation of the 
localization and function of PDZD7 in the inner ear, a protein structurally similar to Whirlin.   
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CHAPTER 1 
 
INTRODUCTION: ORGANIZATION AND FUNCTION OF MOLECULAR DOMAINS 
IN MYELINATED NEURONS 
 
 
1.1 The axon initial segment (AIS) 
 The axon initial segment (AIS) is the most proximal section of the outgoing axon 
from the neuron cell body and just distal to the axon hillock (Hedstrom and Rasband 2006). 
Like all the molecular domains of the myelinated axon, this region has a broad collection of 
transmembrane proteins necessary for protein interactions and/or ion channels as well as 
cytoskeletal elements to anchor protein complexes to their recognized region. Functionally, 
the AIS is an electrical gatekeeper, the decision point as to whether or not to initiate an action 
potential. The AIS performs this function by summing all excitatory and inhibitory inputs 
until a critical firing threshold is reached and the action potential initiated.  
Several ion channels cluster at the AIS and contribute to the final summation 
including sodium (Na
+
, Nav1.6, Nav1.2) channels, promoting membrane depolarization and 
subsequent firing, as well as potassium (K
+
, KCNQ2/3, Kv1.1/1.2) channels, regulating 
action potential frequency and modulating excitability (Pan, Kao et al. 2006, Johnston, 
Griffin et al. 2008, Kole, Ilschner et al. 2008). Sodium and potassium channels are 
heteromeric protein complexes containing a pore-forming α-subunit that regulates ion flow 
and one or more transmembrane-spanning β-subunits that mediate both extracellular and  
2 
 
  
 
 
Figure 1.1. Molecular domains in myelinated axons  
A-D. Labeled schematics and images describing the molecular domains and regions in 
myelinated axons. A. Simplified schematic of mouse cerebellar Purkinje neuron. Shown is 
Purkinje cell body (blue), axon initial segment (AIS in green), unmyelinated axonal region 
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(grey), first paranode (red), and remaining myelin-wrapped juxtaparanode and internode 
(grey). B. Transmission electron micrograph through a 3 month-old mouse cerebellar 
Purkinje neuron with color matched overlay from schematic in A. Note this slice fails to 
show the unmyelinated segment of the axon (middle pseudo-colored grey segment) either 
above or below the imaged plane. AIS region is peusdo-colored in green and paranode in red. 
Note the distinctive electron dense layers of myelin wrapped around the axon past the first 
paranode. C. Immunostaining of a 4 month-old mouse sciatic nerve fiber immunostained 
against potassium channels (Kv1.2) to label the juxtaparanode (red), Contactin-associated 
protein (Caspr) to label the paranode (blue), and the 186kDa isoform of Neurofascin to label 
the node (green). D. Transmission electron micrograph showing a longitudinal section from a 
3 month-old myelinated mouse spinal cord neuron. The image is pseudo-colored to match the 
colored regions from immunostaining in C. Juxtaparanode is pseudo-colored in red, paranode 
in blue and node in green. Note the distinctive electron dense layers of myelin around the 
juxtaparanodal and paranodal regions that are absent from the nodal region. 
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Figure 1.2. Molecular organization of myelinated axon domains  
A-D. Labeled diagrams showing the known proteins responsible for formation and 
stabilization of the various molecular domains myelinated axons. A. Molecular components 
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at the axon initial segment (Punkinje neuron example), including ion channels (Kv1.x in dark 
yellow, Nav1.x in pink, KCNQ2 in light yellow, GABA-R in dark blue), cell adhesion 
molecules (Caspr2 in orange, Tag1 in violet, NF186 in light purple, NrCAM in green) and 
cytoskeletal scaffolding proteins (PSD93 in blue-green, IV-spectrin in green, AnkG in 
cyan). B. Molecular components at the node of Ranvier, including ion channels (Nav1.x in 
pink, KCNQ2 in light yellow), cell adhesion molecules (Gliomedin in cyan, NF186 in light 
purple, NrCAM in green) and cytoskeletal scaffolding proteins (EBP50 in orange, IV-
spectrin in green, AnkG in cyan). Note microvilli are unique structures found on myelinating 
Schwann cells in the peripheral nervous system and thus EBP50 and Gliomedin only found 
there and not in the central nervous system. C. Molecular components at the paranode, 
including cell adhesion molecules (Caspr in dark orange, Cont in brown, NF155 in yellow) 
and cytoskeletal scaffolding proteins (II-spectrin in pale green,II-spectrin in dark green, 
4.1B in green). The protein complex of Caspr, Cont, and NF155 make up the axo-glial 
septate junctions critical to paranodal barrier function. D. Molecular components at the 
juxtaparanode, including ion channels (Kv1.x in dark yellow), cell adhesion molecules 
(Caspr2 in orange, Tag1 in violet) and cytoskeletal scaffolding proteins (PSD95 in blue, 
PSD93 in blue-green, 4.1B in grey). 
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intracellular interactions (Isom 2002, Yu and Catterall 2003). Also present at the AIS are 
numerous cell adhesion molecules (CAMs). Many of these CAMs belong to the L1 
subfamily of immunoglobulin (Ig) which include neurofascin186 (NF186, 186kDa isoform 
of Neurofascin), contactin-associated protein-2 (Caspr2), neuron-related cell adhesion 
molecule (NrCAM), and transiently expressed axonal surface glycoprotein-1 (Tag1) (Dodd, 
Morton et al. 1988, Volkmer, Hassel et al. 1992, Davis, Lambert et al. 1996, Grumet 1997, 
Brummendorf, Kenwrick et al. 1998, Hedstrom, Xu et al. 2007). As mentioned previously, 
several adaptor and scaffolding proteins are responsible for anchoring these membrane-
bound surface proteins to the AIS’s underlying actin/spectrin cytoskeleton (Zhou, Lambert et 
al. 1998, Boiko, Vakulenko et al. 2007). Such adaptors and scaffolding proteins include IV-
spectrin (b4spec), ankyrinG (AnkG), and postsynaptic density protein 93 (PSD-93) (Jenkins 
and Bennett 2001, Kole, Ilschner et al. 2008).  
AnkyrinG (AnkG) is the initial intrinsic ‘AIS master regulator’ (Bennett and Baines 
2001). Historically, the ankyrin class of proteins is known for stabilizing groups of plasma 
membrane-bound proteins to specific cellular regions for interactions between cells and 
efficient signaling (Bennett and Baines 2001). Independent in vitro and in vivo studies have 
confirmed this decisive role for AnkG in AIS organization (Zhou, Lambert et al. 1998, 
Hedstrom, Xu et al. 2007, Hedstrom, Ogawa et al. 2008). Using shRNA in a targeted 
knockdown of AnkG, cultured hippocampal neurons failed to cluster any other AIS-
associated proteins at the AIS relative to untreated cell lines (Hedstrom, Ogawa et al. 2008). 
This in vivo study also demonstrated that targeted knockdown of other AIS components such 
as NrCAM, Neurofascin (Nfasc), and IV-spectrin failed to disrupt the accumulation of other 
AIS-associated protein enrichment. Taken a step further, it was found that knockdown of 
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AnkG in mature hippocampal neurons where the mature AIS had already clustered proteins 
like sodium channels and cytoskeletal elements led to destabilization of such proteins 
(Hedstrom, Ogawa et al. 2008). Using an in vitro mouse model, it was shown that genetic 
ablation of AnkG in the cerebellum resulted in a lack of clustering of Nfasc and sodium 
channels at the Purkinje AIS (Zhou, Lambert et al. 1998). Once such effects regarding AnkG 
on the AIS were independently verified, reports shifted to the exact molecular mechanism as 
to how AnkG stabilizes this region. If AnkG is the initial AIS molecule, what cellular signals 
get AnkG to the AIS and recruit other protein partners? One series of in vivo experiments 
suggested that phosphorylated inhibitor of kappa B alpha (B) acts as a cofactor in 
trafficking AnkG to the AIS (Schultz, Konig et al. 2006, Sanchez-Ponce, Tapia et al. 2008, 
Rasband 2010), but lack the scientific support of in vitro results. Once at the AIS, AnkG, 
through an unphosphorylated tyrosine on a conserved motif, binds NrCAM and NF186 at the 
AIS (Davis, Lambert et al. 1996, Garver, Ren et al. 1997, Zhang and Bennett 1998, Lustig, 
Zanazzi et al. 2001). Without this AnkG interaction, protein accumulation and stabilization 
with Na
+
 channels fails to occur at the AIS in numerous studies (Zhou, Lambert et al. 1998, 
Hedstrom, Xu et al. 2007, Zonta, Desmazieres et al. 2011, Buttermore, Piochon et al. 2012). 
Taken together, these results strongly suggest AnkG represents the master organizer and 
regulator of the AIS.  
The AIS acts as a molecular filter in neurons, separating and distinguishing often 
hundreds of dendritic projections from the singular and unique axonal projection. There 
remains great mystery as to the molecular mechanisms by which this AIS region selectively 
separates proteins and molecules destined for the axonal projection from the dendritic or 
somatic cell regions. Concomitant with this observation is the belief the dendritic fate is in 
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fact the default fate for any neuronal projection. Axonal identity and specialization is the 
ultimate consequence of AIS formation and associated AnkG intrinsic regulation. This 
diffusion barrier role in the AIS was first discovered when some membrane proteins were 
found to diffuse more slowly through the AIS than other proteins (Winckler, Forscher et al. 
1999). Moreover, disruption of the filamentous actin cytoskeleton nullified this differential 
mobility, thereby suggesting AIS barrier function required the interaction of the cytoskeleton 
with membrane proteins. Such AIS barrier activity restricts both cytoplasmic and membrane-
bound proteins from simply diffusing into the axon. More recent studies have taken 
advantage of fluorescent reporters to show that tagged, unsaturated phospholipids halt their 
diffusion across the AIS within the same developmental window of AIS protein clustering 
and maturation of associated protein complexes (Nakada, Ritchie et al. 2003). In support of 
this finding, another study found large-molecular weight dextrans would not diffuse into the 
axon once the AIS was formed in contrast to smaller-molecular weight dextrans used (Song, 
Wang et al. 2009). Likewise, large dextrans could diffuse into the axon once AIS barrier 
function was compromised with disruption of the filamentous actin cytoskeleton. In addition 
to molecular size, the AIS permits entry of specific molecules depending on their cargo or 
associated proteins. In this study, the authors found kinesin motor proteins carrying axonal 
component cargos were permitted entry while dendritic component cargos were blocked 
from entering the axon through the AIS (Song, Wang et al. 2009). Taken together, these 
studies reveal the AIS is critical for establishing and maintaining axonal identity in addition 
to initiating action potential propagation.  
Regulation of neuronal activity requires the AIS to have plastic, transitional, and 
static states. Contributing to all states, genetically encoded information determines AIS 
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tuning frequency, size, and location which differ greatly between cellular subtypes, brain 
nuclei, and cortical regions (Konishi 2003, Kuba, Ishii et al. 2006, Lorincz and Nusser 2008, 
Fried, Lasker et al. 2009, Grubb, Shu et al. 2011). Depending on the requirement of the 
individual neuron within the circuit, a range of plasticity can be observed. While much of the 
AIS research has been relatively recent, direct evidence of AIS plasticity comes from two 
independent studies. The authors of one such study found an increase in AIS length of 
auditory brainstem neurons following auditory deprivation of birds (Kuba, Oichi et al. 2010). 
In the second highly technical study, ion flux could be directly monitored through live 
imaging of the associated AIS (Grubb and Burrone 2010, Grubb, Shu et al. 2011). The in 
vitro study found spatial shifting in AIS position distally along the axon as it was exposed to 
long-term increased excitatory activity (Grubb and Burrone 2010). The positional shift in the 
AIS required prolonged two-day stimulation as well as recruitment of voltage-gated calcium 
channel activity. Such results suggest AIS function responds to environmental and circuitry 
cues to control firing rate in a plastic fashion through alterations in cellular organization, 
movement of channels up or down the AIS region, and recruitment of non-standard ionic 
channels. However, it should be noted the extent of plasticity in older animals has not been 
demonstrated. So while studies in certain neurons of younger animals display remarkable 
AIS plasticity, reports also suggest molecules such as AnkG and NF186 in mice promote the 
long-term stabilization and rigidity of the AIS (Zonta, Desmazieres et al. 2011). Examining 
the transitional periods of AIS function, recent data shows maturation of the AIS depends on 
NF186 expression (Buttermore, Piochon et al. 2012). A transitional developmental switch 
from Nav1.2 to Nav1.6 within the AIS is critical to AIS function in adult myelinated neurons 
(Boiko, Van Wart et al. 2003). However, the mature voltage-gated sodium channel isoform 
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(Nav1.6) does not enrich at the Purkinje AIS segment of NF186 deficient Purkinje neurons 
compared to wild-type Purkinje neurons (Buttermore, Piochon et al. 2012), suggesting 
differing mechanisms between primary formation through AnkG and secondary maturation 
through NF186 of the AIS. Supporting this hypothesis, electrophysiological measurements of 
Purkinje cells lacking an intact AIS demonstrated an inducible action potential firing was 
possible, but the resulting waveform of that action potential was altered (Zonta, Desmazieres 
et al. 2011, Buttermore, Piochon et al. 2012). Notably, the loss of the AIS disrupted the 
spontaneous firing of the Purkinje cell (Zonta, Desmazieres et al. 2011, Buttermore, Piochon 
et al. 2012). Together, it is highly likely the cellular mechanisms responsible for neuronal 
AIS plasticity overlap with mechanisms for AIS maturation. 
Finally, the AIS can be further subdivided using sodium channel isoform localization 
with Nav1.2 channels segregated to the proximal AIS and Nav1.6 channels restricted to the 
distal AIS (Hu, Tian et al. 2009, Buttermore, Piochon et al. 2012). Interestingly, the distal 
AIS and associated Nav1.2 channels are activated at a lower electrophysiological threshold 
relative to proximal AIS and its Nav1.6 channels (Hu, Tian et al. 2009). In order to explain 
this finding, it was suggested by the authors that proximal AIS sodium channels are 
responsible for back-propagation of the action potential while the distal AIS sodium channels 
and higher-voltage threshold regulate the axonal action potential initiation. Bifurcation of 
AIS organization and function vis-à-vis sodium channel isoforms highlights the precise 
relationship between molecular form and function in regulating axonal activity. Such 
molecular trends are well preserved in the subsequently discussed domains of the myelinated 
axon.  
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1.2 The node of Ranvier (node) 
 The nodes of Ranvier (nodes) are ~1m long, unmyelinated molecular domains 
enriched with voltage-gated sodium channels and necessary for saltatory action potential 
propagation (Waxman and Ritchie 1993, Salzer 2003, Hedstrom and Rasband 2006, Rasband 
2006, Thaxton and Bhat 2009). Unlike one AIS per neuron, numerous nodes are distributed 
at regular intervals along the axonal projection. In conjunction with the insulating properties 
of myelin, the nodal configuration and associated sodium channel enrichment allows the 
action potential to leap or ‘saltare’ down the axon at a faster velocity than unmyelinated 
axons. Spacing and assembly of nodes is coordinated with cues from myelinating glia, 
allowing for decreased membrane capacitance and increased membrane resistance (Court, 
Sherman et al. 2004, Susuki and Rasband 2008, Thaxton, Pillai et al. 2011). For example, 
spacing between nodes and the diameter of axons in the avian brainstem are regulated so 
interaural time differences are detectable (Jeffress 1948, Rasband 2010, Seidl, Rubel et al. 
2010). Of note, a significant number of protein complexes are conserved between the AIS 
and node including Nav1.2, Nav1.6, KCNQ2/3, IV-spectrin, AnkG, NrCAM, and NF186 
(Volkmer, Hassel et al. 1992, Berghs, Aggujaro et al. 2000, Boiko, Rasband et al. 2001, 
Komada and Soriano 2002, Salzer 2003). AnkG interacts with CAMs, Nav1.6, and indirectly 
to the underlying cytoskeleton through IV-spectrin at the node (Bennett and Lambert 1999). 
Like the AIS, a developmental switch in sodium channel isoform expression from Nav1.2 
(immature nodes) to Nav1.6 (mature nodes) takes place (Boiko, Rasband et al. 2001, Kaplan, 
Cho et al. 2001). Unlike the AIS, the mechanism of node formation is different, and therefore 
numerous studies have sought to identify the exact mechanisms responsible.  
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 In contrast to AIS intrinsic formation which depends on AnkG localization prior to 
CAM and sodium channel clustering, external signals aid the development of the node 
(Pedraza, Huang et al. 2001, Eshed, Feinberg et al. 2005). Notably, different mechanisms of 
node formation are thought to occur whether in the CNS versus PNS due to the different glial 
cells types that contribution to myelination. Schwann cells, the myelinating glia in the PNS, 
have microvilli protrusions that extend out toward the unmyelinated nodal gap. These 
microvilli in turn secrete proteins as part of the extracellular matrix (ECM) (Eshed, Feinberg 
et al. 2005, Eshed, Feinberg et al. 2007). The nodal ECM becomes a developmental partner 
in node formation with various glycoprotein constituents necessary for stabilizing Schwann 
cell microvilli at the node (Saito, Moore et al. 2003, Melendez-Vasquez, Carey et al. 2005). 
Several independent studies have identified an initial formative event for the node is the 
binding of gliomedin on the Schwann cell microvilli to the axonal NF186 (Lambert, Davis et 
al. 1997, Eshed, Feinberg et al. 2005, Schafer, Custer et al. 2006). This interaction between 
gliomedin and NF186 stabilizes and recruits subsequent nodal proteins, and when gliomedin 
expression was knocked-down, it resulted in a disruption to clustering of NF186 and sodium 
channels (Dzhashiashvili, Zhang et al. 2007) Surprisingly, ectopic gliomedin clusters were 
observed along the internodes of co-cultured Scwhann cell-myelinated dorsal root ganglion 
(DRG) neurons when only the extracellular domain of NF186 was added to the media 
(Eshed, Feinberg et al. 2005). Such findings suggest that the extracellular domain of NF186 
was critical to node formation, and thus greater research effort has been spent on determining 
the involvement and role of NF186 in myelinated neurons.  
 The 186kDa isoform of Neurofascin (NF186) has a significant role in node formation. 
Looking first at NF186’s protein domains, the extracellular domain contains six 
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immunoglobulin domains, three fibronectin type III repeats, and a mucin domain (Thaxton 
and Bhat 2009). The intracellular region of NF186 contains an FIGQY motif (Garver, Ren et 
al. 1997) which interacts and recruits AnkG to the nodal domain. Sodium channels are 
typically found bound to NF186 through the cytoskeletal protein AnkG, but the -subunit of 
sodium channels can also independently bind to NF186 (Malhotra, Kazen-Gillespie et al. 
2000, Lemaillet, Walker et al. 2003, Brechet, Fache et al. 2008, Rasband 2008). In vitro 
knockdown studies of NF186 in Schwann cell-DRG co-cultures have confirmed that loss of 
NF186 disrupts sodium channel enrichment at the node in the PNS (Dzhashiashvili, Zhang et 
al. 2007). However, this knockdown of NF186 was unable to rescue nodal formation after 
adding a different NF186 construct deficient in the intracellular domain responsible for 
binding AnkG, further reinforcing the recruitment role of NF186 for AnkG and sodium 
channels (Dzhashiashvili, Zhang et al. 2007).By demonstrating the external and intracellular 
domains of NF186 were required for nodal protein clustering, it reinforces the hypothesis that 
at least some glial involvement is necessary for nodal organization in the PNS. These PNS 
studies, however, have limited insight into the formation and stabilization of CNS nodes.  
The importance of other cell types in facilitating the organization of CNS nodes 
remains elusive. Some analogous structures can be proposed as with perinodal astrocytes in 
the CNS and the Schwann cell microvilli in the PNS. EM data reveals that perinodal 
astrocytes fill the space adjacent to CNS nodes and thus thought to interact with nodal 
proteins as a similar manner to PNS microvilli (Hildebrand, Remahl et al. 1993). To date 
however, no CNS signaling equivalent of gliomedin has been found. Some candidate proteins 
have been put forward as gliomedin equivalents including Brevican, an ECM protein critical 
to organizing the CNS nodal ECM (Bekku, Rauch et al. 2009). Reports of Brevican ablation 
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in mice however did not demonstrate significant deficits in nodal organization (Brakebusch, 
Seidenbecher et al. 2002) which could suggest CNS nodal organization may require 
interaction of Brevican in conjunction with other yet unidentified molecules. Some of these 
proteins could come from the oligodendrocyte protein secretion prior to myelination, which 
has been linked to nodal protein clustering (Kaplan, Cho et al. 2001). Clearly, this lack of 
knowledge as to the signaling components necessary for CNS node formation suggests more 
research is needed. Once nodes are formed, numerous studies have demonstrated several 
neuronally-derived proteins for organization and stabilization of the node. For example, 
deficits in IV-spectrin showed vesicle-filled membrane protrusions in the nodal area of the 
axon (Yang, Lacas-Gervais et al. 2004). This suggests cytoskeletal organization at the node is 
linked to proper IV-spectrin function. Also, loss of IV-spectrin resulted in disrupted 
axonal conduction and significant drops in the expression level of AnkG and sodium 
channels at the node, suggesting it is vital for stabilizing the nodal complex (Komada and 
Soriano 2002, Lacas-Gervais, Guo et al. 2004).  
Some controversial and conflicting reports have been found concerning the role of 
Neurofascin in CNS nodal domain development. To begin, Neurofascin null mice have 
disruption of both CNS and PNS nodes, but die at post-natal day six before the nervous 
system starts most of its myelination (Sherman, Tait et al. 2005). Such mice lack both 
dominant isoforms in the nervous system, the 186kDa (NF186) isoform and 155kDa (NF155) 
isoform. NF155 is produced by the myelinating glia and localized to the paranodal region 
(see section 1.4). NF186 is expressed by neurons, transported and localized to the AIS and 
node. Given the significant involvement of Neurofascin in several neuronal domains, 
disrupted organization of AIS and nodes and paranodes results in early lethality at post-natal 
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day six. To overcome this technical problem, re-expression of transgenic NF186 in 
Neurofascin null mice revealed AnkG and Nav1.6 localized to nodes and was independent of 
paranode formation (Zonta, Tait et al. 2008). Controversially, the same group also found re-
expression of transgenic NF155 in Neurofascin null mice rescued CNS nodal components 
(Zonta, Tait et al. 2008). Such results suggested paranodal formation was linked in a 
dependent manner with nodal formation in the CNS. These results challenge the findings 
where nodal clustering and organization were unaffected in paranodal mutant mice like 
Caspr, Contactin, and NF155 null mice (Bhat, Rios et al. 2001, Boyle, Berglund et al. 2001, 
Pillai, Thaxton et al. 2009). Additionally, scanning electron microscopy (SEM) of freeze-
fracture samples show early differentiation events still take place in the node prior to 
paranodal axo-glial septate junction (AGSJ) formation (Tao-Cheng and Rosenbluth 1983). 
Recent in vitro work in co-cultures of Schwann cell and DRGs have contributed further to 
the scientific debate. In such co-cultures from wild-type and Neurofascin null mice which 
lack in vivo environmental cues, sodium channel clustering at mature nodes appears 
dependent on paranodes and independent of NF186 (Feinberg, Eshed-Eisenbach et al. 2010). 
Loss of paranodal AGSJs appear to result in destabilization of sodium channels, furthering 
the hypothesis of linked paranodal-dependent nodal stabilization (Ishibashi, Dupree et al. 
2002, Poliak and Peles 2003, Rios, Rubin et al. 2003, Rosenbluth, Dupree et al. 2003). In 
order to definitely resolve these conflicting reports concerning Neurofascin and qualifying 
nodal-paranodal regional independence, in vivo studies need to be performed in which 
paranodes remain intact while node-organizing proteins are altered. 
Recent lab work utilizing an in vivo conditional neuronal knockout of Neurofascin 
has provided the most definite results as to nodal organization and nodal-paranodal regional 
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independence (Thaxton, Pillai et al. 2011). It was found in this study that loss of NF186 
disrupted clustering of the node but left paranodal and juxtaparanodal regions unaffected. 
Additionally, it presented a unified story for NF186 nodal organization in both the PNS and 
CNS tissues, independent of paranodal influence on either. Just as the literature suggested the 
semi-permeable barrier function of the AIS, the node seemed to act as barrier to the 
neighboring paranodal domains in normal mice. Paranodal myelin loops typically never 
occupy the ECM spare around the nodal axolemma. However, transmission electron 
microscopy of the neuronal knockout of Neurofascin revealed that paranodal loops had 
encroached from both sides and overlapped each other, thereby covering the nodal gap 
(Thaxton, Pillai et al. 2011). Also highlighted in the study was the differences in supposed 
mechanistic paths of AIS and node formation with relation to NF186 as nodal loss of NF186 
resulted in failed clustering of AnkG, NrCAM, and either gliomedin or ezrin binding protein 
(EBP50) in the PNS (Thaxton, Pillai et al. 2011). Such findings correlate with previous 
results that demonstrate NF186 can localize to nodes independently of interaction or 
stabilization by AnkG and that NF186’s arrival at the possible node occurs before any other 
known nodal molecules (Lambert, Davis et al. 1997, Lustig, Zanazzi et al. 2001, Koticha, 
Maurel et al. 2006, Dzhashiashvili, Zhang et al. 2007, Thaxton, Pillai et al. 2011). An 
independent study also revealed that the fibronectin type-III domain within NF186 was 
necessary for interaction with PNS-specific gliomedin and subsequent clustering at the node 
(Labasque, Devaux et al. 2011). Further reports suggested NF186 as the master organizer of 
the node by demonstrating NF186 can directly interact with the -subunit of sodium channels 
as a secondary non-AnkG mediated means of clustering them at nodes (Ratcliffe, 
Westenbroek et al. 2001).  
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While significant evidence exists for NF186’s role in node formation, the subsequent 
steps of nodal organization remain elusive. Some of the mechanistic puzzle has begun to take 
shape with recent scientific work. One study used an in vitro co-culture system, but this time 
transected the axons in order to remove the soma and its contribution to nodal organization 
prior to induced myelination (Zhang, Bekku et al. 2012). Such a design allowed researchers 
to isolate whether components were diffusely localized in the axonal membrane already or 
had to be translocated from the neuronal soma prior to clustering at the node. The authors 
found CAMs were already expressed on the axolemma and only needed to be ensnared by 
induced Schwann cells and associated ligands for nodal accumulation. In contrast, nodal 
molecules such as sodium channels and cytoskeletal components required production and/or 
transport from the soma to the targeted node (Zhang, Bekku et al. 2012). Curiously, it was 
also found in the study that recycling of mature nodal components was only possible if the 
soma remained attached to the axon. Taken together, such data suggests the formative nodal 
molecule NF186 interacts with the myelinating glia and/or extracellular environment to 
become clustered, signal and recruit other nodal components regardless of axonal trafficking.  
 
1.3 The paranode  
 The paranode is the myelinated axonal region where the terminal myelin loops form 
axo-glial septate junctions (AGSJs) with the axolemma. The region separates the node from 
the juxtaparanode (JXP), acting as a rigid membrane molecular barrier to diffusion between 
nodal and juxtaparanodal complexes (Salzer 2003, Thaxton and Bhat 2009). The paranode 
was first conceptualized as a fence, blocking ion channels in the JXP from mixing with ion 
channels in frog brain nodes (Rosenbluth 1976). As myelinating glia wrap around the 
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axolemma, the glial cytoplasm becomes concentrated at the outer edges, forming loops which 
attach to the axolemma through AGSJs. Similar to invertebrate septate junctions that form 
between the ensheathing glial cells of axon bundles (Banerjee, Sousa et al. 2006), AGSJs 
represent electron-dense structures that form a ladder-like formation along the axolemma and 
glial paranodal loops (Schnapp, Peracchia et al. 1976). Three proteins are necessary to form 
AGSJs including neuronally-derived contactin (Cont) and contactin-associated protein 
(Caspr) which extend across the ECM to bind glially-derived, 155kDa isoform of 
Neurofascin (NF155) (Menegoz, Gaspar et al. 1997, Peles, Nativ et al. 1997, Rios, 
Melendez-Vasquez et al. 2000, Tait, Gunn-Moore et al. 2000, Charles, Tait et al. 2002, 
Einheber, Bhat et al. 2006). The loss in any of these three components (Cont, Caspr, or 
NF155) results in disruption of AGSJs and subsequently paranodal organization (Bhat, Rios 
et al. 2001, Boyle, Berglund et al. 2001, Pillai, Thaxton et al. 2009). Significant research has 
examined the various domains of each protein. Beginning with Cont, this protein is anchored 
externally to the axolemma via a glycosylphophatidylinositol-group (GPI). Cont binds 
together with Caspr in cis configuration extracellularly via their immunoglobulin domains 
(Tait, Gunn-Moore et al. 2000). The c-terminus of Caspr contains a 4.1/ezrin/radixin/moesin 
(FERM) binding domain and SH3 domain. It’s through Caspr’s c-terminal domains that 
AGSJs communicate and cross-link with axonal proteins (Bhat 2003). Within the paranodal 
axon, several cytoskeletal proteins accumulate including II- and II-spectrin, protein 4.1B 
and the adaptor protein AnkB (Ohara, Yamakawa et al. 2000, Garcia-Fresco, Sousa et al. 
2006, Ogawa, Schafer et al. 2006, Thaxton and Bhat 2009). Specifically, protein 4.1B with 
its FERM domain interacts with Caspr and its FERM binding domain (Menegoz, Gaspar et 
al. 1997, Peles, Nativ et al. 1997, Poliak, Gollan et al. 1999, Gollan, Sabanay et al. 2002, 
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Denisenko-Nehrbass, Oguievetskaia et al. 2003). Additionally, Caspr complexes with 4.1B, 
spectrin and actin to likely anchor the membrane-bound AGSJs to the axonal cytoskeleton 
(Garcia-Fresco, Sousa et al. 2006, Buttermore, Dupree et al. 2011). Unlike the nodal or JXP 
regions where ion channels cluster, the paranode has no such clustering of any channels. 
Instead, the paranodal region forms and subsequently accumulates proteins necessary to 
fulfill its primary role as molecular barrier between node and JXP.  
 Formation and stabilization of the paranode requires both neuronal and glial 
components; therefore the paranode is devoid of intrinsic or independent formation 
mechanisms like the AIS or node respectively. However, a great deal of scientific research 
has examined the timing and tracking of each component to its final paranodal destination. 
An in vitro study demonstrated Caspr must complex with Cont prior to being trafficked from 
the endoplasmic reticulum to the outer plasma membrane (Faivre-Sarrailh, Banerjee et al. 
2004). Ablation of Caspr or even just Caspr’s c-terminus leads to loss of Cont from the 
paranode (Bhat, Rios et al. 2001, Gollan, Sabanay et al. 2002). Additionally, the absence of 
Caspr leads to ectopic localization of Cont to CNS nodes (Rios, Melendez-Vasquez et al. 
2000). Such findings suggest the interdependence of Caspr and Cont for stable paranodal 
localization, but the third partner of AGSJs, glially-derived NF155, also contributes to this 
stabilization in vivo. When glial-specific ablation of Neurofascin results in loss of NF155 
(Pillai, Thaxton et al. 2009), AGSJs and paranodal organization are significantly disrupted, 
suggesting Caspr and Cont can’t stabilize paranodes in the absence of NF155. While the tri-
protein complex of Caspr, Cont, and NF155 are the minimal requirement for paranodal glial-
axonal interaction, more evidence is emerging that additional cytoskeletal components help 
recruit the AGSJs to the paranodal membrane and/or act to stabilize such membrane 
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complexes. One cytoskeletal protein of importance is 4.1B. Paranodal mutants show 
diffusion of 4.1B along the axon rather than enrichment at the paranode, suggesting 
paranodal interactions between 4.1B with Caspr (Gollan, Sabanay et al. 2002). Likewise, 
recent studies demonstrate that paranodal proteins Caspr and Cont traffic and localize to the 
paranode but lack stability in the absence of protein 4.1B (Buttermore, Dupree et al. 2011, 
Cifuentes-Diaz, Chareyre et al. 2011). Similarly, electron microscopy revealed that the loss 
of 4.1B triggers a destabilization of AGSJs, pulling away of AGSJs from paranodal loops and 
axolemma, and ultimately broken paranodes (Buttermore, Dupree et al. 2011). Such data 
correlate to earlier findings that the paranodal axonal cytoskeleton is maintained as a 
complex between Caspr and proteins 4.1B, II-spectrin, II-spectrin, and actin (Gollan, 
Sabanay et al. 2002, Denisenko-Nehrbass, Oguievetskaia et al. 2003, Garcia-Fresco, Sousa et 
al. 2006, Ogawa, Schafer et al. 2006), suggesting AGSJ formation is possible without 
cytoskeletal interaction but that their long-term stabilization is diminished. Finally, the 
cytoskeletal influence from the glial side through NF155 remains a mystery.  
 A separate line of investigation suggests paranodal organization depends not only on 
paranodal proteins but also the glial membrane lipid composition of such cells (Simons and 
Trotter 2007). The composition of myelin is predominately lipids, making up approximately 
70-85% of the dry weight, followed by proteins (Morell, Toews et al. 1994). Of the lipids 
involved in myelination, nearly one-third are gylcosphingolipids, galactosylceramide (GalC), 
and its sulfated derivative, sulfatide (Coetzee, Fujita et al. 1996). In particular, it was 
hypothesized that lipid rafts utilize the enzyme ceramide galactosyltransferase (CGT) to 
assist in the organization of the AGSJs at the paranode during myelination. CGT helps 
synthesize the myelin lipids galactocerebroside and sulfatide (Coetzee, Fujita et al. 1996, 
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Dupree, Girault et al. 1999, Dupree and Popko 1999, Marcus, Dupree et al. 2002, Marcus, 
Honigbaum et al. 2006). Loss of CGT resulted in AGSJ disruption and breakdown in 
segregation of nodal sodium channels from juxtaparanodal potassium channels (Dupree, 
Girault et al. 1999, Marcus, Dupree et al. 2002). After subcellular fractionation studies of 
glial NF155 (Schafer, Bansal et al. 2004), the evidence supporting the lipid raft hypothesis 
was strengthened by showing lipid rafts form in the paranodal loops to help organize glial 
paranodal components. While lipids make up a majority of the myelin sheath, protein 
constituents are also critical to its formation and maintenance. Vital proteins for proper ASGJ 
formation include NF155, ceramide galactosyltransferase (CGT), proteolipid protein (PLP), 
myelin-basic protein (MBP), myelin-associated glycoprotein (MAG), 2’,3’-cyclic nucleotide 
3’-phosphodiesterase and Nkx6-2 (Rosenbluth 1981, Trapp, Andrews et al. 1989, Coetzee, 
Fujita et al. 1996, Klugmann, Schwab et al. 1997, Honke, Hirahara et al. 2002, Lappe-Siefke, 
Goebbels et al. 2003, Southwood, He et al. 2004, Rasband, Tayler et al. 2005, Garcia-Fresco, 
Sousa et al. 2006). In summary, the paranode is a complex, interdependent structure whose 
formation and maintenance require glial and neuronal, protein and lipid interaction.  
 Returning to paranodal function, loss in the three critical AGSJ components NF155, 
Caspr, or Cont results in subsequent dissolution of these structures (Bhat, Rios et al. 2001, 
Boyle, Berglund et al. 2001, Pillai, Thaxton et al. 2009). Once ASGJs are lost, the distance 
between glial paranodal loop membrane and the axolemma widens. This loss of AGSJs have 
fundamental consequences on axonal conductance and survival as mice with ablation of 
Caspr have severe problems with conduction velocity, waveform and amplitude and 
subsequently fail to live for more than a month (Bhat, Rios et al. 2001). While this molecular 
disconnection occurs, other adhesive complexes and extracellular support like the basal 
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lamina in the PNS helps maintain the overall myelin structure (Poliak and Peles 2003). 
Behavioral outcomes likely relate to the loss in paranodal barrier function and diffusion of 
potassium channels away from the JXP, as seen in other paranodal mutants (Dupree, Girault 
et al. 1999, Bhat, Rios et al. 2001, Garcia-Fresco, Sousa et al. 2006, Pillai, Thaxton et al. 
2009). Additional to its barrier role between nodal and juxtaparanodal regions, paranodal 
complexes act as an intracellular organizer of the axonal cytoskeleton. Electron microscopic 
examination of Caspr and NF155 paranodal mutants shows the presence of swellings and 
accumulations along the axon (Garcia-Fresco, Sousa et al. 2006, Pillai, Thaxton et al. 2009). 
Such swellings reveal tangles and knots of axonal cytoskeletal elements rather than normal 
parallel arrays. Also, organelle accumulation was a dominant feature within these 
cytoskeletal tangles and a sign of disrupted axonal transport that eventually led to axon 
degeneration (Garcia-Fresco, Sousa et al. 2006). These results suggested the axonal 
cytoskeleton was highly sensitive to disruption in paranodal organization and stability (Sousa 
and Bhat 2007). Measurements of phosphorylated neurofilaments in NF155 mutants showed 
increased levels in swellings, a secondary indication of cytoskeletal and domain 
disorganization (Pillai, Thaxton et al. 2009). Of significance, the appearance of cytoskeletal 
abnormalities and swellings are found prior to the degeneration in axonal neuropathies, 
hinting of a conserved mechanism in neuronal pathology and ultimate destruction (Rodriguez 
and Scheithauer 1994, Lappe-Siefke, Goebbels et al. 2003, Fabrizi, Cavallaro et al. 2007). 
For example, accumulation of organelles in Purkinje cells has been a historical hallmark of 
axonal degeneration since the 1970’s (Palay and Palay 1974). In summary, a significant body 
of scientific evidence demonstrates the relationships between the axonal cytoskeleton and 
axo-glial septate junctions (AGSJs) responsible for anchoring the glial myelin loops to the 
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axolemma. Ultimately, the formation and stabilization of paranodal proteins, lipids, and 
scaffolding proteins at AGSJs are necessary for axonal stability and health. 
 
1.4 The juxtaparanode (JXP) 
 The juxtaparanode is the axonal domain located between the paranode and internode. 
In normal myelinated neurons, this region’s molecular signature is an enrichment of 
potassium channels, in particular delayed rectifier potassium channels Kv1.1 and Kv1.2 
(Wang, Kunkel et al. 1993, Rhodes, Strassle et al. 1997). Myelin compaction is required for 
potassium channel enrichment and stabilization at JXP (Baba, Akita et al. 1999). A 
subsequent report found these potassium channels form a complex with the axonal, 
transmembrane cellular adhesion molecule Caspr2 at the JXP (Poliak, Gollan et al. 1999). 
Curiously, the GPI-anchored CAM transient axonal glycoprotein (Tag1) is localized to both 
glial and axonal membranes at the JXP, joined in a complex with Caspr2 on the axonal 
membrane (Traka, Dupree et al. 2002, Poliak, Salomon et al. 2003, Traka, Goutebroze et al. 
2003). Within the JXP, loss of Caspr2 or Tag1 each resulted in disrupted potassium channel 
clustering (Poliak, Salomon et al. 2003). Unlike the AIS, nodal, or paranodal domains, some 
studies have shown independence between these membrane complexes and the axonal 
cytoskeleton. Several post-synaptic density scaffolding proteins, including PSD93 and 
PSD95, localized to the JXP (Baba, Akita et al. 1999, Horresh, Poliak et al. 2008). Ablation 
of PSD93 and PSD95 did however not disrupt potassium channel localization at the JXP nor 
did ablation disrupt Caspr2 interaction with potassium channels (Rasband, Park et al. 2002, 
Horresh, Poliak et al. 2008). Notably, this contrasts with PSD proteins role at the AIS. 
PSD93, but not Tag1 or Caspr2, are required for potassium channel clustering at the AIS 
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(Ogawa, Horresh et al. 2008). The internal c-terminus of Caspr2 like Caspr contains a FERM 
binding domain that mediates its binding to protein 4.1B (Menegoz, Gaspar et al. 1997, 
Peles, Nativ et al. 1997, Poliak, Gollan et al. 1999, Gollan, Sabanay et al. 2002, Denisenko-
Nehrbass, Oguievetskaia et al. 2003). To better characterize this interaction and determine its 
significance, GST-fusion proteins of Caspr2’s c-terminus were generated with subsequent 
mutations both in the PDZ-binding motif as well as in the 4.1-binding domain. The study 
found only Caspr2 mutations lacking its 4.1-binding domain failed to bind with membrane 
associated guanylate kinases, suggesting those interactions between Caspr2 and 4.1 may be 
of greater significance for JXP organization (Horresh, Bar et al. 2010). As expected, protein 
4.1B is enriched at the paranode and JXP, and subsequent loss of 4.1B results in diffusion of 
potassium channels, Caspr2, and PSD95 from the JXP (Horresh, Bar et al. 2010, Buttermore, 
Dupree et al. 2011, Cifuentes-Diaz, Chareyre et al. 2011). Finally, a report shows 4.1B is 
required for clustering of JXP components but not necessary for interaction between Caspr2 
and potassium channels (Buttermore, Dupree et al. 2011). 
 Given the hallmark clustering of potassium channels at the juxtaparanode, groups 
have attempted to determine whether the JXP has a role in action potential propagation 
and/or modulation. As a reminder, paranodal disruption results in a net movement of 
potassium channels out of the JXP to bordering the node (Bhat, Rios et al. 2001, Boyle, 
Berglund et al. 2001, Garcia-Fresco, Sousa et al. 2006, Pillai, Thaxton et al. 2009). Such 
findings suggest a sorting mechanism at the paranodal-juxtaparanodal axolemma, separating 
the potassium channels and JXP CAMs from the CAMs at the paranode in order to anchor 
them properly with the underlying cytoskeleton (Poliak and Peles 2003). Typically, delayed 
rectifier potassium channels repolarize the membrane potential back to resting potential after 
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depolarization by sodium channels (Benatar 2000). This however is only one function. 
Potassium channels also can push the membrane potential back further into hyperpolarized 
state. Such a hyperpolarized state prevents back propagation of action potentials (Purves, 
Augustine et al. 2004). Importantly, the abnormal localization of potassium channels does 
not disrupt conduction velocity of action potentials but rather makes neurons more 
hyperexcitable (Cifuentes-Diaz, Chareyre et al. 2011). After in vivo analysis of 4.1B null 
mice revealed potassium channels were mislocalized, spontaneous and evoked repetitive 
activity was also found in mutants, characteristic of hyperactivity, compared to control axons 
(Cifuentes-Diaz, Chareyre et al. 2011). Such findings agree with previous literature which 
demonstrates potassium channels modulate neuronal activity as well as display 
hyperexcitability when disrupted as in the case of disorders such as epilepsy (Sutherland, 
Williams et al. 1999, Lopantsev, Tempel et al. 2003). In summary, studies characterizing the 
importance of the juxtaparanodal domain and potassium channel function underscore their 
necessity for neuronal activity and firing patterns. Disruptions to these domains can result in 
devastating physiological consequences. 
 
1.5 The internode 
 The internode is the longest and largest myelinated domain flanked by distant 
juxtaparanodes and surrounded by compact, tightly wrapped myelin. Like the other domains, 
this area also contains axon-glial interactions while maintaining a tight apposition between 
the axolemma and adaxonal myelin loop of only twelve nanometers (Maurel, Einheber et al. 
2007). Of interest, the links joining myelin and axon within the internode were disrupted by 
proteases. Such a result suggests transmembrane proteins stabilize this interaction (Yu and 
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Bunge 1975, Maurel, Einheber et al. 2007). Spread along the internode of mature 
myelinating glial cells are spiraling cytosplasmic channels known as Schmidt-Lanterman 
incisures (SLIs). At SLIs, links form between the adaxonal membrane (glial membrane that 
contacts the axon) and the abaxonal membrane (glial membrane that contacts the ECM) 
(Poliak and Peles 2003). The exact role for these SLIs has yet to be determined, but it has 
been proposed these channels transport materials across the myelin to provide maintenance 
of the myelin sheath (Ghabriel and Allt 1981, Arroyo, Xu et al. 2001). Significant cellular 
communication is required between axon and myelinating glia in order for these internodal 
structures to maintain proper compaction and organization.  
 In addition to interaction between axon and myelinating glia, mechanisms within both 
sense cellular signals from the axon for proper myelination. During development and 
myelination of the axon, the axonal diameter must be estimated by the myelinating glial cell 
so that the proper number of myelin wraps and thickness is achieved (Smith, Blakemore et al. 
1982). Investigators of this process have found a conserved ratio of axon diameter to myelin 
thickness known as the g ratio. Curiously, the g ratio is determined differently by Schwann 
cells and oligodendrocytes, suggesting the cellular context between the PNS and CNS 
matters. In the PNS but not CNS of mice with altered levels of phosphorylated 
neurofilaments, myelin thickness was disrupted (Elder, Friedrich et al. 2001). It was 
interpreted that phosphorylated neurofilaments help organize the axon cytoskeleton within 
the internode. Further investigations have shown that altered expression in Neuregulin 1 
(Nrg1) interferes with the g ratio in myelinating nerve fibers, suggesting a molecular 
interaction between Nrg1 and its partner glial protein tyrosine kinase receptor ErbB2 
(Michailov, Sereda et al. 2004, Sousa and Bhat 2007). Such data highlight that CAMs and 
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their binding partners are critical to axo-glial interactions at the internode and subsequent 
downstream effects on myelin compaction and thickness.  
 Here we discuss proteins localized to the internode and/or Schmidt-Lanterman 
incisures (SLIs) that could potentially influence their organization and stabilization. The 
cellular adhesion molecule myelin associated glycoprotein (MAG) is found along the 
internode and SLIs (Trapp and Quarles 1984, Trapp, Quarles et al. 1984, Trapp 1990). Given 
the propensity of myelinated axonal domains to utilize proteins with immunoglobulin 
domains (Ig superfamily) like Caspr and Caspr2, a similar protein like MAG could play a 
role in axo-glial interactions within the internode (Lai, Brow et al. 1987, Salzer, Holmes et al. 
1987). Reports demonstrate that MAG mutant mice have typical overall myelination and 
organization, but small differences along the internodal space were observed between the 
axon and myelin (Li, Tropak et al. 1994, Montag, Giese et al. 1994) Another protein 
localized to the myelin-axon interface at the internode include several transmembrane nectin 
cell adhesion (Necl) proteins, Necl1 and Necl4 (Sakisaka and Takai 2004, Maurel, Einheber 
et al. 2007). In the PNS, Necl1 and Necl2 are expressed along the axon while Necl4 and 
Necl2 are expressed within Schwann cells (Maurel, Einheber et al. 2007). Based on binding 
analyses and immunohistochemical data, Necl4 and Necl1 interact along the internode to 
help maintain a stable interaction (Maurel, Einheber et al. 2007). Like other CAMs involved 
in axo-glial interactions, both Necl1 and Necl4 belong to the Ig superfamily with additional 
binding domains for PDZ binding motifs and 4.1 proteins (Takai, Irie et al. 2003, Ogita and 
Takai 2006). In addition, Necl2 has been shown to interact with a truncated form of protein 
4.1B and even function in both hetero- and homophilic orientations (Biederer, Cao et al. 
2002, Biederer, Sara et al. 2002, Masuda, Yageta et al. 2002, Yageta, Kuramochi et al. 2002, 
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Shingai, Ikeda et al. 2003). Necl proteins seem particularly abundant in their interactions as 
SLIs within the internode also reveal homophilic and heterophilic interactions (Maurel, 
Einheber et al. 2007). Expanding the protein players at the internodal region, a recent report 
found protein 4.1G is a novel component of internode organization (Ivanovic, Horresh et al. 
2012). Expression of 4.1G was found in Schwann cells and colocalized with Necl4 (Horresh, 
Bar et al. 2010, Ivanovic, Horresh et al. 2012). However, in 4.1G null sciatic nerve fibers, 
Necl4 failed to properly cluster at the SLIs (Ivanovic, Horresh et al. 2012). Further 
investigation revealed paranodal proteins appeared broken into segments near the paranodal 
and JXP components in the absence of 4.1G. Proteins, like Kv1.2 channels, were ectopically 
accumulated by the broken paranodal segments and no longer properly distributed along the 
inner mesaxon. In summary, these studies demonstrate the conserved and unique molecules 
and mechanisms responsible for formation and stabilization of not only the internodal region 
but also the juxtaparanodal, paranodal, nodal and axon initial segment regions within the 
myelinated neuron.  
 
1.6 Myelination and evolutionary model systems 
 As organisms evolved in their cellular complexity so too did their specialization and 
function in their nervous system. The electrical insulation by glial cells of axons evolved 
independently several times in Annelids, Arthropods, and chrodates which highlights the 
evolutionary advantage and importance of more efficient neuronal transmission (Hartline 
2008, Roots 2008). Curiously, the molecular signals responsible for clustering of ion 
channels at axonal domains appeared to evolve prior to myelination (Hartline 2008). As an 
example, the amino acid motif in the sodium channel subunits which granted them capacity 
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to link to the actin-spectrin cytoskeleton through AnkG evolved in early chordates (Garrido, 
Giraud et al. 2003, Lemaillet, Walker et al. 2003, Hill, Nishino et al. 2008, Rasband 2008). 
Therefore, sodium channels clustered at the AIS likely before the node had evolved. 
Furthermore, potassium channels that localize to the AIS and node also contained this 
conserved AnkG motif (Pan, Kao et al. 2006, Rasband 2008). Since potassium channels are 
necessary for saltatory conduction, the potassium channel motif and myelination were likely 
concurrent in their evolutionary process (Hill, Nishino et al. 2008). Invertebrates lack nodes 
in their nervous system but do contain structures similar to vertebrate AIS. Consequentially, 
the invertebrate site of action potential initiation can occur at a variable distance from the 
soma as one neurite extension can split into both dendritic and axonal specializations 
(Meyrand, Weimann et al. 1992, Rolls, Satoh et al. 2007, Maniar, Kaplan et al. 2012). In C. 
elegans, axonal domains are analogous to the vertebrate AIS. For example, AnkG clusters 
with microtubule-stabilizing protein UNC-33 in vertebrates or protein collapsing response 
mediator protein-2 (CRMP-2) in C. elegans (Maniar, Kaplan et al. 2012). In vertebrates, the 
CRMP-2 protein takes on the additional role for axon specification (Maniar, Kaplan et al. 
2012). Therefore, molecules and mechanisms responsible for sodium channel clustering (in 
the AIS) and axonal organization have evolutionary conservation.  
 While we’ve focused on the conserved motifs and regions in neurons like the AIS and 
node, protein complexes like the AGSJs were also conserved during evolution (Banerjee, 
Sousa et al. 2006). Septate junctions are regularly found in the epithelia and nervous system 
of invertebrates (Banerjee, Sousa et al. 2006) but only found at vertebrate AGSJs. 
Surprisingly, the three main components of the AGSJs are highly conserved in invertebrates 
like Drosophila. In this case, the orthologs of vertebrate Caspr/Cont/NF155 are Drosophila 
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NeurexinIV/Cont/Neuregulin respectively (Faivre-Sarrailh, Banerjee et al. 2004, Banerjee, 
Sousa et al. 2006). Even molecular interactions are shared between these orthologs. For 
example, Neurexin IV, like Caspr, contains a 4.1-binding sequence in its c-terminus 
(Baumgartner, Littleton et al. 1996, Bellen, Lu et al. 1998, Bhat 2003, Bhat 2004, Banerjee, 
Sousa et al. 2006). Likewise, the Drosophila 4.1 family ortholog Coracle colocalizes with 
Neurexin IV at septate junctions (Fehon, Dawson et al. 1994). Comparison of the 
ablation/mutation studies in both invertebrates and vertebrates suggest an evolutionarily 
conserved mechanism whereby junctions are stabilized through interaction with 4.1 proteins 
to the underlying cytoskeleton (Fehon, Dawson et al. 1994, Baumgartner, Littleton et al. 
1996, Lamb, Ward et al. 1998, Ward, Lamb et al. 1998, Horresh, Bar et al. 2010, Buttermore, 
Dupree et al. 2011). Understanding the conserved functions of septate junctions and ion 
channel clustering across evolution is not just an academic exercise in the theory of domain 
organization. How such domains are maintained for neuronal function is vital to applying 
such studies to human disease and therapies. Therefore, the more we know regarding domain 
organization and maintenance of the axon initial segment, node, paranode, juxtaparanode and 
internode, the greater likelihood we have to successfully treat and prevent such disorders that 
target these domains. Secondarily, any insight into how the membrane and cytoskeletal 
barrier function within the AIS, node and paranode is maintained could help in therapies to 
selectively restore ion channel localization in damaged or demyelinated fibers. Contributions 
from this knowledge could also lead to prevention of axonal degeneration and death that 
often follow such neuropathies. In summary, this scientific work provides understanding into 
neurons’ development and maintenance of domain segregation throughout the life of the 
neuron and their ability to communicate in complex networks.  
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1.7 Neuropathies, myelinopathies and related domain pathology 
 Neuropathies are functional disturbances to neurons, often first identified in 
peripheral nerves and typically manifest by numbness, tingling, pain, and/or weakness. 
Neuropathies can be subdivided into acquired (diabetic, ischemic, sarcoid, toxic, etc.) or 
hereditary (sensory and autonomic, sensory radicular, progressive hypertrophic). Unlike most 
cells in the body with relatively short life spans and regenerative capacity, post-mitotic 
neurons must survive and adapt to insults for decades with their limited regenerative 
capacity. A great deal of mystery still remains between the human reports of such 
neuropathic symptoms and the cellular and molecular pathology that cause them.  
Myelinopathies are any disease which negatively impacts myelin including 
hypomyelination, dysmyelination, leukodystrophies, myelinolytic disease, spongiform 
myelinopathies, and encephalomyelinopathies. Given the extensive dependence of the human 
nervous system on myelinated fibers to carry electrical impulses, a constellation of symptoms 
can arise from the various myelinopathies depending on the etiology and area of the lesions. 
Some of the most common human myelinopathies include multiple sclerosis (MS) and 
Charcot-Marie Tooth (CMT) disease which result in progressive demyelination of nerves and 
ultimately axonal degeneration and demise. Variable etiologies have been ascribed to the 
development of MS and CMT disease, both autoimmune and genetic predisposition. Yet to 
both diseases, the dissolution of axonal domain organization in myelinated neurons is a 
progressive indicator as to the disorders’ development (Lubetzki, Williams et al. 2005, 
Oguievetskaia, Cifuentes-Diaz et al. 2005, Berger, Niemann et al. 2006, Shy 2006, Nave, 
Sereda et al. 2007, Trapp and Nave 2008). The remaining section will examine the role of 
each domain and implications in human disease or injury. 
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The AIS region has had significant investigation concerning injury and genetic 
disease, but in vitro culture data have not always agreed with in vivo genetic models. A 
recent report found AIS as a target of ischemic injury (Schafer, Jha et al. 2009). During 
stroke, the protease calpain degrades AnkG and IV-spectrin, critical cytoskeletal scaffolds 
in the AIS, resulting in loss of neuronal polarity. Given that this damage was independent 
from axonal degeneration, it suggests the AIS represents a vulnerable myelinated domain 
region during ischemic events. Dysfunction of the AIS has also been identified in diseased 
brain states. In one such study, pyramidal neurons in the hippocampus of Angelman 
Syndrome mice were found to have elongated AIS regions with altered membrane properties 
(Kaphzan, Buffington et al. 2011). Due to increased sodium/potassium channel pumps, 
investigations found initial resting potential of neurons in the Angelman Syndrome mice was 
more hyperpolarized. Further investigation found action potential amplitude and maximal 
rise rate were greater in Angelman Syndrome mice. These results were due to increased 
Nav1.6 and AnkG within at the hippocampal AIS but not somatosensory cortex. Overall, 
these alterations resulted in decreased neuronal excitability (Kaphzan, Buffington et al. 
2011). Proper neuronal function depends on the balance of ion channel expression at the AIS, 
and further insight into the mechanisms of AIS formation and maintenance will be the 
cornerstone of therapy for AIS dysfunction and injury. But how does this apply to human 
disease? Research into schizophrenic patients has found a decrease in GABA release at the 
synapses between the cortical pyramidal AIS and chandelier neurons (Lewis, Hashimoto et 
al. 2005, Rasband 2010). This decrease in GABA transmission does not describe the 
mechanisms responsible, but another study correlated the GABA decrease with a decrease in 
AnkG in the superficial cortical layers of the schizophrenic patients (Cruz, Weaver et al. 
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2009). As a reminder, a decrease in AnkG disrupts localization of other AIS components like 
Neurofascin. Likewise, Neurofascin disruption alters GABA receptor clustering as well as 
targeting of GABAergic synapses to the AIS (Ango, di Cristo et al. 2004, Burkarth, Kriebel 
et al. 2007, Cruz, Weaver et al. 2009, Buttermore, Piochon et al. 2012). Alterations in AIS 
stability likely play a role in disrupting neuronal activity homeostasis found in patients 
affected with schizophrenia. While imbalances in excitatory and inhibitory transmission 
within the brain are the hallmark of psychiatric disorders like autism and schizophrenia, 
significant literature has expanded such imbalances to other disorders such as epilepsy and 
seizures. Within the epilepsy field of research, one identified cause for epilepsy is sodium 
channel mutations. For example, the authors of one study reported 1-subunit NaV channel 
mutations resulted in altered subcellular localization of these channels and hyper-excitable 
neurons (Meadows, Malhotra et al. 2002). In addition, another study using an animal model 
for epilepsy discovered that at the AIS AnkG and Nav1.6 levels were increased (Chen, Chen 
et al. 2009). Therefore, a common means of seizure activity seems to involve an increase in 
sodium channel activity at the AIS. With each study, the fact is reiterated that a balance of 
ion channel function is required within the axon, particularly the AIS, for proper neuronal 
function. In summary, the study of the AIS represents an axonal region rich in discovery for 
potential therapies related to ion channel localization and stabilization.  
 Similar to the ion channel literature in the AIS, the node also has considerable 
associations to human disease and injury. Mouse studies have clearly delineated that nodal 
function is vital for action potential propagation and neuronal communication. Disrupted 
nodal organization in early mouse development negatively affects their neurological and 
overall health, eventually succumbing to early death (Thaxton, Pillai et al. 2011). Genetic 
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contributions to nodal organization are however not the only contributions to nodal health. 
Nodes are also destroyed through acquired disease states like multiple sclerosis. In MS, 
sodium channels clusters fail to maintain stability at nodes (Craner, Newcombe et al. 2004, 
Coman, Aigrot et al. 2006). This disruption is thought to contribute to axonal degeneration 
pathology and loss of neuronal function in MS patients (Craner, Newcombe et al. 2004). 
Given the difficulty in obtaining and analyzing human MS tissue, the exact mechanisms 
responsible for disruption of nodal sodium channels remain a mystery. One possible 
mechanism is auto-immunity to nodal proteins. Reports have shown auto-antibodies have 
been discovered to Neurofascin protein in MS patients (Mathey, Derfuss et al. 2007). Further 
investigation in in vitro co-cultures of DRGs and Schwann cells that found addition of 
antibodies that block the function of CAMs resulted in loss of voltage-gated sodium channels 
and AnkG accumulation at the nodes (Lustig, Zanazzi et al. 2001). One hypothesis is that in 
MS patients with auto-antibodies these antibodies prevent NF186 from functioning properly 
at the node. Functionally, these antibodies somehow result in destabilization of voltage-gated 
sodium channels from this domain. This immune-mediated mechanism of molecular 
interference was also found in acute motor axonal neuropathy (AMAN) where nodes are 
specifically altered with resulting interference in action potential propagation (Susuki, 
Rasband et al. 2007, Lonigro and Devaux 2009). In addition, an independent study took auto-
antibodies found in humans diagnosed with AMAN and injected them into rats and found 
subsequent nodal and paranodal proteins disruption (Susuki, Raphael et al. 2011). This study 
also found that injected rats had severely altered axonal conductance relative to control rats 
(Susuki, Raphael et al. 2011). Ultimately, the auto-antibodies led to axonal degeneration. 
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Nodal organization and maintenance represent an important area of research so human 
therapies can be expanded and elucidated for these devastating disorders. 
 Turning to the next axonal domain, our understanding the organization and 
maintenance of the paranode have significant implications in human disease and injury. 
There are already numerous complex interactions necessary between neurons and glial cells 
for proper paranodal maturation which suggests more potential mechanisms to interfere and 
cause pathology. Myelinopathies like Charcot-Marie Tooth and multiple sclerosis disease 
ultimately progress to axonal degeneration in affected neurons. Such disorders result from 
various causes. For example, genetic mutations in a Connexin isoform lead to CMT disease 
while autoimmune antibodies target tissue in MS. The final result in both cases was axonal 
domain disorganization (Lubetzki, Williams et al. 2005, Oguievetskaia, Cifuentes-Diaz et al. 
2005, Berger, Niemann et al. 2006, Shy 2006, Nave, Sereda et al. 2007, Trapp and Nave 
2008). Not only are nodes disrupted, but MS patients also present with disrupted paranodes. 
While human mutations in NF155, Caspr, or Cont have not been directly associated with 
disease predisposition and onset, they have been linked to significant disruption in disease 
pathology (Wolswijk and Balesar 2003, Coman, Aigrot et al. 2006, Howell, Palser et al. 
2006, Mathey, Derfuss et al. 2007). These studies revealed loss of Caspr enrichment at the 
paranode and disrupted juxtaparanodal potassium channel localization (Wolswijk and 
Balesar 2003, Coman, Aigrot et al. 2006, Howell, Palser et al. 2006). Initially, it was 
identified that NF155 expression was reduced in the paranodes of MS patients and 
considered an early marker for the ensuing demyelination of the nerve (Howell, Palser et al. 
2006, Maier, van der Heide et al. 2006). Notably, NF155 and lipid-raft association levels are 
also diminished at the paranodes of MS patients (Maier, van der Heide et al. 2005, Maier, 
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Baron et al. 2007). As previously mentioned, antibodies against Neurofascin are found in MS 
patients and likely contribute to disruption of this protein at the node (NF186) and paranode 
(NF155) (Mathey, Derfuss et al. 2007). Curiously, increasing titers of auto-antibodies were 
found in patients with chronic progressive MS relative to those with relapsing MS. Such 
findings suggest that as the disease progresses in severity it continually targets these critical 
proteins, preventing the regeneration of the paranodes and nodes. Due to the targeted 
degradation of both Neurofascins, the oligodendrocytes likely lack the ability to remyelinate 
affected lesions and reorganize axonal domains, thereby promoting the axonal degeneration 
observed in chromic MS patients. The fact that loss of Caspr expression precedes 
demyelination in MS patients offers additional support for degeneration of paranodes in MS 
lesions (Wolswijk and Balesar 2003). Destabilization of these paranodal proteins and 
structures resulted in AGSJ disruption of barrier function as shown by the movement of 
potassium channels into the paranodal region (Howell, Palser et al. 2006). In addition, axonal 
swellings that result from disorganization of axonal domains are commonly found in 
neurodegenerative disease like amyotrophic lateral sclerosis (ALS), CMT, Alzeheimer’s 
disease, Wallerian degeneration, and cerebrospinal ataxia (Collard, Cote et al. 1995, 
Brownlees, Ackerley et al. 2002, Stokin, Lillo et al. 2005). In the early stages of ALS, the 
AIS diameter of associated neurons was increased (Sasaki and Maruyama 1992), so this may 
be a conserved mechanism of a diseased axon. These authors suggest that such swellings 
found in disease and seen at paranodes of AGSJ mutant mice may represent a conserved 
response to axonal distress, demyelination, and an early sign of axonal degeneration. Finally, 
we mention a few reports concerning juxtaparanodal proteins and human neurological 
disorders. Tag-1 and Caspr2 have been implicated in language impairment, autism, as well as 
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broad learning and cognition disorders which suggest CAMs have significant roles in the 
human nervous system function (Alarcon, Abrahams et al. 2008, Bakkaloglu, O'Roak et al. 
2008, Savvaki, Panagiotaropoulos et al. 2008, Vernes, Newbury et al. 2008). To date, genetic 
ablation in mice of axonal domain proteins has not been linked to a particular disease 
manifestation, but it is clear from the literature that these domain proteins are critical in 
precluding the progression of demyelinating neuropathies. In order to generate a full 
repertoire of human therapies for these degenerative diseases, future studies should continue 
to examine and investigate the molecular involvement and function of various axonal 
domains.  
  
38 
 
 
 
 
 
 
CHAPTER 2 
 
CUPRIZONE AND CASPR-CRE MODEL MOUSE SYSTEMS 
 
 
2.1 Introduction 
2.1.1 Mus musculus, an animal model for human biomedical research 
 The laboratory mouse (Mus musculus) represents a powerful system for mammalian 
genetic and biomedical research. The shared anatomy, physiology, and genetics between 
mice and humans make the mouse an ideal model for complex human diseases and testing 
drug effectiveness. Among the advantages to using the mouse as a model organism, the most 
important is their 95% genetic homology to humans. The use of mice for biomedical research 
has grown exponentially in the past decade. Mice have become effective models for diseases 
and conditions such as atherosclerosis (Mukhopadhyay 2013), cancer (van der Weyden and 
Adams 2013), diabetes (Scroyen, Hemmeryckx et al. 2013), glaucoma (Wong and Brown 
2012), hypertension (Ellison 2013), osteoporosis (Wasserman, Webster et al. 2013), 
neurological (Figiel, Szlachcic et al. 2012) and neuromuscular disorders (Michaud, Arnoux et 
al. 2010), as well as many rare diseases. 
 The mouse has become the dominant animal model in biomedical research for 
numerous reasons. From an economic perspective, mice are an efficient and cost-effective 
research tool. Mice are physically small, have a short generation time (20 day gestation), 
produce large litters, and have an accelerated lifespan (one mouse year equals about 30 
human years), keeping the costs, space, and time required to perform biomedical research 
39 
 
manageable and efficient. Additionally, natural variation among inbred mouse strains 
provides a means to study complex diseases involving the interaction of multiple genes, such 
as hypertension and atherosclerosis, allowing for identification of genetic risk factors in the 
human population. Spontaneous, naturally occurring mutations have often caused afflictions 
in mice that mimic similar human genetic diseases. Finally, our technical ability to quickly 
and reproducibly manipulate the mouse genome has provided an incredibly powerful tool to 
control gene expression and chronicle the resulting physiological outcomes. This 
recombinant technical knowledge has steadily grown and been routinely utilized in 
understanding complex neurological processes such as axonal domain organization. 
 
2.1.2 Mouse utilization in neuroscience and contributions to axonal domain 
organization research 
 At the anatomical, cellular, and molecular levels, study of the mouse brain has 
contributed greatly to our understanding of the human brain and neuroscience in general. By 
the numbers, the mouse brain contains 70 million neurons compared to human’s 86 billion 
neurons, although both animals retain 20% of those neurons within their cortexes 
(Herculano-Houzel, Collins et al. 2007). Interestingly rodent brains scale hypermetrically in 
size with their numbers of neurons while primate brain size increases approximately 
isometrically as a function of neuron number (Herculano-Houzel, Collins et al. 2007). Major 
anatomical regions with associated cellular organization as well as in situ hybridization and 
expression data of both mouse and human brains are preserved, cataloged, and compared in 
publically-available brain atlases (Lein, Hawrylycz et al. 2007). Cellular biologists and 
electrophysiologists have submitted and accepted thousands of neuroscience-related papers 
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highlighting preserved cellular structures and functions between mice and humans. And in 
examining molecular similarities, the mouse has arisen as the dominant animal model for 
human research given its ease with genetic manipulation and iteration.  
 While other animal models such as C. elegans and Drosophila have yielded insights 
into molecular axon-glial interactions, the mouse model has been broadly utilized in 
characterizing the organization of myelinated axonal domains. As described in detail in 
Chapter 1, the myelinated neuron can be subdivided into several segments: axon initial 
segment, node of Ranvier, paranode, juxtaparanode, and internode. Common to all 
myelinated neurons, specific molecules, both membrane-bound and cytoskeletal, are enriched 
within these neuronal subdivisions (Fig. 1.2). Researchers have consistently utilized 
recombinant mouse genomic techniques to control and manipulate the time, amount, and 
presence of these molecular domain constituents to define their relative effects on neuronal 
and behavioral function. Alternatively, researchers have used pharmacological methods to 
selectively target and perturb neuronal or glial populations within the mouse nervous system 
in order mimic human outcomes in such tissues. Overall, there are numerous practical and 
historical reasons why the mouse represents the best neuroscience animal model for studying 
the organization of myelinated neuronal domains. 
  
2.1.3 The cuprizone mouse model  
Young adult mice fed cuprizone (bis–cyclohexanone-oxaldihydrazone), a copper 
chelator, induces a synchronous, consistent demyelination in nervous system tissues. While 
the exact mechanism of action remains unclear, the demyelination pathophysiology is best 
explained by the chelation of copper in the brain or related support tissues resulting in 
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selective toxicity and death of mature oligodendroglia. Demyelination occurs in lesion sites 
with significant size to allow detection of relevant cellular, molecular, and biochemical 
properties. Additionally, remyelination can take place once cuprizone is removed from the 
diet of mice. However, demyelination and remyelination are not mutually exclusive in the 
cuprizone model, and remyelination can occur simultaneously with demyelination at certain 
periods of cuprizone treatment. 
A significant cascade of biochemical and cellular events take place during cuprizone-
induced demyelination and refractory cuprizone-removed remyelination. Myelin gene 
expression quickly declines to a minimum at 3 weeks and quickly reverses to a 5 week 
maximum. Reduction in myelinated fibers and mature oligodendrocytes follow a slow steady 
decline until their nadir at 5 weeks and gradual increase to original levels at 9 weeks. Mature 
oligodendroglia apoptosis peaks at 3 weeks; astrocytes, microglia and macrophage 
accumulation peak between 4-5 weeks. Interestingly, oligodendroglia progenitor 
accumulation peaks at 4-5 weeks but does not fall to original baseline levels even after 
twelve weeks post-cuprizone treatment.  
Most cuprizone studies have utilized traditional immunohistochemistry techniques in 
order to assess the histological changes in cell types and markers in neurological tissues. 
Surprisingly, the vast majority of these studies use chromogenic rather than fluorescent 
reporters thereby limiting the potential information gathered from such cuprizone-treated 
tissues. With this pilot collaboration between the Matsushima and Bhat labs, we sought to 
answer five basic questions: (1) Do we see differences in MBP levels comparing untreated to 
cuprizone-treated mice using immunofluorescent staining and confocal microscopy? (2) Are 
such MBP findings consistent with previously published chromogenic microscopy results? 
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(3) Do we see differences in Caspr levels comparing untreated to cuprizone-treated mice 
using immunostaining? (4) Are the effects of cuprizone comparable in cerebellar white 
matter tracts to cerebral white matter tracts? (5) How does progressive cuprizone toxicity 
from 3-6 weeks affect paranodal organization (as seen with Caspr)?  
 
2.1.4 Mouse recombinant technology, site-specific recombination, and establishment 
of conditional (Cre-LoxP) knockout mouse lines  
Modern genetic techniques and models continue to improve our ability to isolate and 
test particular genes and their function. Perhaps the most important advantage to using the 
mouse for biomedical research is the ability to experimentally manipulate the mouse genome. 
Genes can be injected directly into the fertilized egg of a mouse creating what is known as a 
transgenic animal. Some of the most useful non-native mouse genes introduced into the 
mouse genome have been site-specific recombinases (SSRs), including the two most utilized: 
Cre (Causes recombination) and Flp (Flippase). Used in combination with their respective 
34bp target loxP (locus of crossover in phage P1) or FRT DNA sequences, these 
recombinases have enabled the systematic generation of transgenic cell lines as well as 
embryonic stem (ES) cells. In particular, conditional mouse knockouts utilizing the Cre-Lox 
system have been used extensively when conventional knockout mouse models lead to early 
death before observation of an associated phenotype or phenomena. The spatiotemporal 
ablation of genetic regions with flanking loxP sites depends wholly upon the concurrent 
specificity of Cre expression. In turn, Cre expression specificity is subsequently dependent 
upon both the promoter/enhancer elements associated with the Cre sequence as well as the 
chromosomal site and environment (eu- vs. hetero-chromatin). The development and 
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expansion of such Cre-Lox mouse models has received significant NIH funding and 
development (NIH Neuroscience Blueprint Cre Driver Network) with several centers (Baylor 
College of Medicine, Cold Spring Harbor Lab, and Scripps Research Institute) contributing 
resources and mouse lines (Table 2.1). 
Particular to our studies, the gold-standard pan-neuronal Cre expression line was Cre 
utilizing neuron-specific promoter neurofilament light chain (Nefl-Cre) promoter (Leconte, 
Semonin et al. 1994, Schweizer, Gunnersen et al. 2002, Thaxton, Pillai et al. 2011). While 
early recombination events were observed as early as post-natal day one (Thaxton, Pillai et 
al. 2011), Cre expression was temporally and dynamically regulated differently in central and 
peripheral neurons. Ultimately, this neuron-specific but tepid promoter for Cre expression 
was suitable to be replaced by a more robust pan-neuronal Cre expression line. Initial 
inception of a Cre expression line under the control of the Caspr locus began in late 2008 
between Manzoor Bhat PhD and JrGang Cheng. Here I describe the process of confirming 
the pCaspr-Cre construct and identification of recombinant embryonic stem cell lines by both 
PCR and Southern blot techniques. 
 
2.2 Materials and Methods  
2.2.1 Cuprizone Treatment in Animals 
Mice (C57B/6, JAX# 000664) were bred in a pathogen-free facility at University of 
North Carolina-Chapel Hill (UNC-CH) in accordance with the guidelines established by 
UNC-CH Institutional Animal Care and Use Committee. To induce demyelination, mice that 
were 8–10 weeks of age were exposed to 0.2%cuprizone (Sigma, St. Louis, MO). Ground  
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Cre Strain Name Promoter Source Stock 
Number 
B6(129S4)-Et(cre/ERT2)119Rdav/J Unknown Baylor JAX-
009575 
B6(129S4)-
Et(cre/ERT2)1382Rdav/J 
Unknown Baylor JAX-
009580 
B6(129S4)-
Et(cre/ERT2)13866Rdav/J 
Pcdhb4, protocadherin beta 
4/5 
Baylor JAX-
012688 
B6(129S4)-
Et(cre/ERT2)1642Rdav/J 
Unknown Baylor JAX-
009581 
B6(129S4)-
Et(cre/ERT2)1645Rdav/J 
Unknown Baylor JAX-
009582 
B6(129S4)-
Et(cre/ERT2)1957Rdav/J 
Unknown Baylor JAX-
009583 
B6(129S4)-
Et(cre/ERT2)2007Rdav/J 
Unknown Baylor JAX-
009584 
B6(129S4)-
Et(cre/ERT2)2047Rdav/J 
Unknown Baylor JAX-
009585 
B6(129S4)-Et(cre/ERT2)21Rdav/J Unknown Baylor JAX-
009574 
B6(129S4)-Et(cre/ERT2)296Rdav/J Unknown Baylor JAX-
009577 
B6(129S4)-Et(cre/ERT2)398Rdav/J Unknown Baylor JAX-
009578 
B6(129S4)-Et(cre/ERT2)4Rdav/J Unknown Baylor JAX-
009573 
B6(129S4)-
Et(cre/ERT2)6691Rdav/J 
Unknown Baylor JAX-
010688 
B6(129S4)-
Et(cre/ERT2)6959Rdav/J 
Unknown Baylor JAX-
010689 
B6(129S4)-
Et(cre/ERT2)7089Rdav/J 
Unknown Baylor JAX-
010690 
B6(129S4)-
Et(cre/ERT2)7149Rdav/J 
Unknown Baylor JAX-
010691 
B6(129S4)-
Et(cre/ERT2)7381Rdav/J 
Unknown Baylor JAX-
010692 
B6(129S4)-
Et(cre/ERT2)8120Rdav/J 
Unknown Baylor JAX-
010693 
B6(129S4)-
Et(cre/ERT2)8131Rdav/J 
Unknown Baylor JAX-
010694 
B6(129S4)-Et(cre/ERT2)837Rdav/J Unknown Baylor JAX-
009579 
B6(129S4)-
Et(cre/ERT2)9699Rdav/J 
Unknown Baylor JAX-
010695 
B6(129S4)-Et(icre)1402Rdav/J Unknown Baylor JAX-
009587 
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Cre Strain Name Promoter Source Stock 
Number 
B6(129S4)-Et(icre)1470Rdav/J Unknown Baylor JAX-
009588 
B6(129S4)-Et(icre)1555Rdav/J Unknown Baylor JAX-
009589 
B6(129S4)-Et(icre)754Rdav/J Unknown Baylor JAX-
009586 
B6(129S4)-
Et(icre/ERT2)10596Rdav/J 
resistance to inhibitors of 
cholinesterase 8 homolog B 
(C. elegans) 
Baylor JAX-
010696 
B6(129S4)-
Et(icre/ERT2)10727Rdav/J 
resistance to inhibitors of 
cholinesterase 8 homolog B 
(C. elegans) 
Baylor JAX-
010697 
B6(129S4)-
Et(icre/ERT2)14208Rdav/J 
apolipoprotein M (mouse) Baylor JAX-
012690 
B6(129S4)-
Et(icre/ERT2)14915Rdav/J 
GTPase activating protein and 
VPS9 domains 1 (mouse) 
Baylor JAX-
012694 
B6(129S4)-Tg(SYN1-
icre/mRFP1)9934Rdav/J 
SYN1, synapsin I (human); 
ransient receptor potential 
cation channel, subfamily C, 
member 4 associated protein 
(mouse) 
Baylor JAX-
012687 
B6;129S4-Et(cre/ERT2)278Rdav/J Unknown Baylor JAX-
009576 
STOCK Et(icre/ERT2)14374Rdav/J expressed sequence tag 
BU936969 (mouse) 
Baylor JAX-
012691 
STOCK Et(icre/ERT2)14602Rdav/J resistance to inhibitors of 
cholinesterase 8 homolog B 
(C. elegans) (human) 
Baylor JAX-
012692 
STOCK Et(icre/ERT2)14624Rdav/J resistance to inhibitors of 
cholinesterase 8 homolog B 
(C. elegans) (human) 
Baylor JAX-
012693 
B6(Cg)-Calb2tm1(cre)Zjh/J calbindin 2 (mouse) CSHL JAX-
010774 
B6(Cg)-Calb2tm2.1(cre/ERT2)Zjh/J calbindin 2 (mouse) CSHL JAX-
013730 
STOCK Ccktm1.1(cre)Zjh/J cholecystokinin (mouse) CSHL JAX-
012706 
B6(Cg)-Ccktm2.1(cre/ERT2)Zjh/J cholecystokinin (mouse) CSHL JAX-
012710 
STOCK Corttm1(cre)Zjh/J cortistatin (mouse) CSHL JAX-
010910 
B6(Cg)-Crhtm1(cre)Zjh/J corticotropin releasing 
hormone (mouse) 
CSHL JAX-
012704 
B6;129S4-Dlx1tm1(cre/ERT2)Zjh/J distal-less homeobox 1 CSHL JAX-
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(mouse) 014551 
Cre Strain Name Promoter Source Stock 
Number 
B6(Cg)-Dlx5tm1(cre/ERT2)Zjh/J distal-less homeobox 5 
(mouse) 
CSHL JAX-
010705 
B6(Cg)-Etv1tm1.1(cre/ERT2)Zjh/J ets variant gene 1 (mouse) CSHL JAX-
013048 
STOCK Gad2tm1(cre/ERT2)Zjh/J glutamic acid decarboxylase 2 
(mouse) 
CSHL JAX-
010702 
STOCK Gad2tm2(cre)Zjh/J glutamic acid decarboxylase 2 
(mouse) 
CSHL JAX-
010802 
B6(Cg)-Lhx6tm1(cre/ERT2)Zjh/J LIM homeobox protein 6 
(mouse) 
CSHL JAX-
010776 
STOCK Nkx2-
1tm1.1(cre/ERT2)Zjh/J 
NK2 homeobox 1 (mouse) CSHL JAX-
014552 
B6;129S-
Nos1tm1.1(cre/ERT2)Zjh/J 
nitric oxide synthase 1, 
neuronal (mouse) 
CSHL JAX-
014541 
B6(Cg)-Pvalbtm1(cre/ERT2)Zjh/J parvalbumin (mouse) CSHL JAX-
010777 
B6(Cg)-Ssttm1(cre/ERT2)Zjh/J somatostatin (mouse) CSHL JAX-
010708 
STOCK Ssttm2.1(cre)Zjh/J somatostatin (mouse) CSHL JAX-
013044 
STOCK Viptm1(cre)Zjh/J vasoactive intestinal 
polypeptide (mouse) 
CSHL JAX-
010908 
B6(129S)-
Et(cre/ERT2)25175Rdav/Mmmh 
Unknown MMRRC 036018-
MU 
B6(129S)-
Et(cre/ERT2)25279Rdav/Mmmh 
Unknown MMRRC 036019-
MU 
B6(129S)-
Et(cre/ERT2)25378Rdav/Mmmh 
Unknown MMRRC 036020-
MU 
B6(129S)-
Et(cre/ERT2)25422Rdav/Mmmh 
Unknown MMRRC 036021-
MU 
B6(129S)-
Et(cre/ERT2)25463Rdav/Mmmh 
Unknown MMRRC 036022-
MU 
B6(129S)-
Et(EGFP/cre)16053Rdav/Mmmh 
Unknown MMRRC 034568-
MU 
B6(129S)-
Et(EGFP/cre)16055Rdav/Mmmh 
Unknown MMRRC 034569-
MU 
B6(129S)-
Et(EGFP/cre)16059Rdav/Mmmh 
Unknown MMRRC 034570-
MU 
B6(129S)-
Et(EGFP/cre)16102Rdav/Mmmh 
Unknown MMRRC 034571-
MU 
B6(129S)-
Et(EGFP/cre)16218Rdav/Mmmh 
Unknown MMRRC 034572-
MU 
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Cre Strain Name Promoter Source Stock 
Number 
B6(129S)-
Et(EGFP/cre)16250Rdav/Mmmh 
Unknown MMRRC 034573-
MU 
B6(129S)-
Et(EGFP/cre)16255Rdav/Mmmh 
Unknown MMRRC 034574-
MU 
B6(129S)-
Et(EGFP/cre)16261Rdav/Mmmh 
Unknown MMRRC 034575-
MU 
B6(129S)-
Et(EGFP/cre)16279Rdav/Mmmh 
Unknown MMRRC 034576-
MU 
B6(129S)-
Et(icre)21468Rdav/Mmmh 
Unknown MMRRC 034577-
MU 
B6(129S)-
Et(icre)21603Rdav/Mmmh 
Unknown MMRRC 034578-
MU 
B6(129S)-
Et(icre)21605Rdav/Mmmh 
Unknown MMRRC 034579-
MU 
B6(129S)-
Et(icre)21614Rdav/Mmmh 
Unknown MMRRC 034580-
MU 
B6(129S)-
Et(icre)21733Rdav/Mmmh 
Unknown MMRRC 034581-
MU 
B6(129S)-
Et(icre)22787Rdav/Mmmh 
Unknown MMRRC 034582-
MU 
B6(129S)-
Et(icre)23031Rdav/Mmmh 
Unknown MMRRC 034583-
MU 
B6(129S)-
Et(icre)23033Rdav/Mmmh 
Unknown MMRRC 034584-
MU 
B6(Cg)-
Cux2tm1.1(cre)Mull/Mmmh 
cut-like homeobox 2 MMRRC 031778-
MU 
B6(Cg)-
Cux2tm2.1(cre)Mull/Mmmh 
cut-like homeobox 2 MMRRC 032778-
MU 
B6(Cg)-
Cux2tm3.1(cre/ERT2)Mull/Mmmh 
cut-like homeobox 2 MMRRC 032779-
MU 
B6(Cg)-
Dbx1tm1.1(cre)Mull/Mmmh 
developing brain homeobox 1 MMRRC 031751-
MU 
B6(Cg)-Otoftm1.1(cre)Mull/Mmmh otoferlin MMRRC 032781-
MU 
B6(Cg)-
Otoftm2.1(cre/ERT2)Mull/Mmmh 
otoferlin MMRRC 032782-
MU 
B6(Cg)-
Wnt3atm1.1(cre)Mull/Mmmh 
wingless-related MMTV 
integration site 3A 
MMRRC 031748-
MU 
B6.Cg-Tg(Camk2a-
tTA)1Mmay/MullMmmh 
calcium-calmodulin-
dependent kinase II 
MMRRC 031781-
MU 
B6.Cg-Tg(Klk8-
tTA)QMmay/MullMmmh 
kallikrein related-peptidase 8 MMRRC 031780-
MU 
B6.Cg-Tg(Klk8-
tTA)SMmay/MullMmmh 
kallikrein related-peptidase 8 MMRRC 031779-
MU 
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Cre Strain Name Promoter Source Stock 
Number 
B6.Cg-Tg(Nes-
cre)1Kln/MullMmmh 
nestin MMRRC 031750-
MU 
C57BL/6J-Tg(DCX-
cre)35MullMmmh 
Doublecortin (human) MMRRC 031752-
MU 
C57BL/6J-Tg(DCX-
cre)38Mull/JMmmh 
Doublecortin (human) MMRRC 031753-
MU 
C57BL/6J-Tg(DCX-
cre/ERT2)1Mull/Mmmh 
Doublecortin (human) MMRRC 032780-
MU 
C57BL/6J-Tg(Fos-
tTA)1Mmay/MullMmmh 
FBJ osteosarcoma oncogene MMRRC 031756-
MU 
C57BL/6J-Tg(tetO-cre,-
EGFP)2MullMmmh 
Unknown MMRRC 031754-
MU 
C57BL/6J-Tg(tetO-cre,-
EGFP)3MullMmmh 
Unknown MMRRC 031755-
MU 
 
Table 2.1 – Mouse Cre lines established by NIH Neuroscience Blueprint Cre Project 
A partial list of the 100+ Cre lines established by NIH-funded Neuroscience Blueprint 
project outlined by strain name (column 1), expression promoter used (if known, column 2), 
original location of creation (column 3), and stock number (column 4). As evident by the 
numerous lines with ‘unknown’ promoters, many of these Cre lines have yet to be fully 
characterized in determining which subset of cell types and ages they produce Cre 
recombinase.  
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Purina 2000 mouse chow (Purina, Richmond, IN) was mixed with powdered cuprizone by 
weight and fed daily ad libitum. Groups of four to five mice were fed for 3, 5, or 6 weeks 
with the mouse chow containing cuprizone. Age-matched untreated controls were fed a diet 
of ground Purina mouse chow throughout the entire experiment. Mice of appropriate age 
were anesthetized, sacrificed, and tissues processed as noted below.  
 
2.2.2 Generation of Caspr-Cre mutant animals 
The Cntnap1 (Caspr) locus spans ~16 kb of genomic DNA on mouse chromosome 11 
(NCBI Gene ID: 53321). To knock-in Cre recombinase under the control of the Caspr 
promoter, a targeting construct (pGEM-DT-CNTN-Cre-FpNF or pCaspr-Cre, 15503bp) was 
generated in which Cre recombinanse and Neomycin (neo) sites were targeted to insert in 
exon 1 of Caspr. Generation of pCaspr-Cre was performed by the UNC BAC Core. Starting 
with a pBluescript vector, the Cre recombinase sequence was inserted upstream of a neo 
cassette flanked by upstream PGK and downstream bGHpA sites. A ~1.7kb genomic 
sequence of the Caspr promoter and first portion of exon 1 was cloned upstream to Cre. A 
second ~6kb genomic sequence with the second portion of Caspr exon 1 through exon 12 
was cloned downstream to bGHpA sequence. Prior to embryonic stem (ES) cell 
microinjections, the expected restriction enzyme digestion patterns in the targeting vector 
were confirmed. 50 g of targeting construct was linearized with ScaI followed by 
electroporation into ES cells by UNC Animal Models Core Facility.  
Two sets of 98 well plates (rows A-H, columns 1-12 or (dot) dA-dH, 1-12) were 
received with ES cells containing potentially recombined Caspr chromosomes. ES cells were 
lysed and chromosomal DNA isolated. PCR primers were designed to identify recombinant 
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Caspr-Cre chromosomes. Briefly, a forward primer (5’CAAGACTAGGCCATTGCCAG) 
called Caspr-5'genomic FP was designed to sit upstream of the 5’ recombination sequence 
while a reverse primer (5’ ATCTCACGTACTGACGGTGGGAGA) called All-Cre RP sits in 
the Cre recombinase sequence. PCR was performed using this set of primers to identify a 
2.4kb band. Those ES cell lines containing positive 2.4kb bands were then tested a second 
time for positive identification of the 2.4kb band.  
Double positive ES cell lines were then tested using Southern blot for secondary 
confirmation of Caspr-Cre recombination. Three different (BamHI, SalI, or XhoI) restriction 
endonuclease digestions were performed overnight on one microgram of DNA isolated from 
ES cell lines A9, E10, dB1, dD2, or recombinant negative (-ES). Two liters of 1xTBE was 
prepared from 10x stock (108g Tris base, 55g Boric acid, 40 mL 0.5M EDTA (pH 8.0) in 1 L 
H2O), and 300 mL of 0.8% agarose gel (2.4g agarose) in 1x TBE was prepared and cast into 
a 20x15cm gel. 5 μL of 5x DNA running buffer was added to digested samples. Genomic (25 
μL) and standard (15 μL) DNA ladder was loaded into the wells and ran at 150V for 4-5 
hours. After using a UV lamp to mark on a blank film the gel edges, well lanes, and various 
ladder bands, a picture was taken to assess quality of genomic digestion. One liter of 0.25 N 
HCl (20.8 mL 12N HCl in 979.2 mL H2O) and two liters of 0.4 N NaOH (32g NaOH in 
2000 mL H2O) was prepared. The agarose gel was transferred to a 13x9 inch glass dish and 
gently washed in 250 mL of 0.25 N HCl for 5 minutes. After using a pipet to safely remove 
the first HCl wash, a second HCl wash was performed for 10 minutes after which the gel was 
rinsed with deionized-H2O for 15 or more minutes. Water was discarded and gel washed 
with 250 mL of 0.4 NaOH for 20 minutes. A nylon membrane (Bio-rad Zeta-Probe GT 
Genomic, #162-0197) was cut into two equally sized filter paper rectangles. Nylon 
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membrane was marked in a corner and rinsed in water for 15 or more minutes. Two 3M filter 
papers were cut large enough to slightly overhang sponge used (about 28x38cm). After 
placing a tray and sponge in a large reservoir basin, 1500 mLs of 0.4 NaOH was poured onto 
the sponge. A sandwich of the following materials was layered onto the wet sponge while 
using a 10 mL pipette to push out bubbles: 1)Sponge (soaked with 0.4 NaOH), 2) two layers 
of filter paper, 3) 0.8% gel with digested and separated genomic DNA, 4) nylon membrane, 
5) two layers of filter paper, 6) parafilm strips to isolate paper towels from contacting 
reservoir, 7)paper towels with additional weight (25 pound book) to keep the layers 
compressed. Allowed transfer overnight and exchanged wet paper towels for dry paper 
towels in morning and transfer through the afternoon. After afternoon transfer, nylon 
membrane with DNA was rinsed for 15 minutes in 2xSSC (300mM NaCl, 30mM Sodium 
Citrate [Na3C6H5O7], pH=7.0) and dried overnight.  
While membrane was drying, Caspr-Cre southern probe primers were designed (FP = 
AAGAAAGGCGGAGTCGACG, RP = CAAGACTAGGCCATTGCCAGCCAGAC) to 
produce a 900bp PCR product band. 25-100ng of purified probe DNA was prepared in 42μL 
H2O with Strategene Prime-IT RmT Random Primer Labeling Kit (#300392-1). Samples 
were quickly boiled for five minutes and transferred to ice to produce single stranded DNA. 
42 μL sample was transferred to a 1.5mL tube with 5 μL of radioactive P-32 and 3 μL 
Magenta Polymerase and incubated for 20-30 minutes on 37°C hot block. While incubating, 
tubes were prepared for probe purification using components from Qiagen PCR Purification 
Kit (#28104). 250 μL PBI buffer was prepped and added to one 1.5mL tube, 750 μL PE 
buffer to another tube, and 50 μL H2O to another tube. One empty tube was labeled to hold 
the eluted probe, one pick column and round-bottom collection tube. Once labeling 
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polymerase incubation was finished, added 2 μL of stop mix to 45 μL reaction. Mouse COT 
DNA was thawed while a rotating incubator was pre-warmed to 65°C. All P32 radioactive 
was separated into liquid or solid components and disposed of according to UNC 
Environmental Health and Safety requirements. PBI buffer (250 μL) was combined with P32 
labeled probe (47 μL) volume and transferred to a pink column. Sample was spun 1 minute 
and flowthrough discarded. Column was rinsed with PE buffer (750 μL), spun 1 minute, 
flowthrough discarded, spun an additional 2 minutes, and any remaining flowthrough 
discarded. The pink column was removed, placed in an empty round-bottom tube, and 
allowed 5 minutes for residual ethanol to evaporate. Purified P32 labeled probe DNA was 
eluted using 50 μL H2O to dried column and spun 1 minute. 2.5 μL 20x SSPE (3.6M NaCl, 
0.2M NaH2PO4, 0.02M EDTA, pH=7.7) and 5 μL COT-1 DNA was added for every 50 μL 
of eluted probe. Probe tube was spun down and kept at room temperature until needed while 
preparing hybridization tubes and membrane. 
The previously dried nylon membrane with restriction digested genomic DNA was 
placed DNA-side-up in a hybridization tube and briefly wetted with 6X SSC (0.9M NaCl, 
90mM trisodium citrate, pH=7.0). Aqueous prehybridization/hybridization (APH) solution 
[APH=5x SSC; 5x Denhardt’s solution (0.1% Ficoll (type 400), 0.1% polyvinylpyrrolidone, 
and 0.1% bovine serum albumin); 1% (w/v) SDS; 100 µg/ml denatured salmon sperm DNA 
(added just before use)] was prepared by adding Mouse COT DNA to base solution and 
warmed 15 minutes at 65°C in incubator. Once warmed, APH solution with DNA (1mL per 
10cm
2
 of membrane) was added to the membrane inside pre-warmed hybridization tube and 
rotated in incubator for 3 hours. P32 labeled DNA probe tube was mixed by gentle flick and 
boiled at 100°C via hot block for 10 minutes then on ice. APH solution with DNA was 
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exchanged for an equal volume pre-warmed APH solution with both COT DNA and probe 
solution. Membrane was incubated with P32 probe in rotating hybridization incubator at 
65°C overnight. After hybridization, membrane was washed with three times 15 minutes at 
45°C in the following solutions: 1)2x SSC, 2) 2x SSC, 0.1% SDS, and 3) 0.1x SSC, 0.1% 
SDS. Finally, membrane was rinsed with 2x SSC at room temperature and excess liquid 
blotted off. Membrane was wrapped in plastic wrap, taped down to autoradiography film 
inside developing box, and put at -20°C to develop overnight. Film was developed on a 
Kodak developer and bands aligned to previously marked blank film with DNA ladder 
separation to estimate kilobase size of detected P32 positive bands.  
 
2.2.3 Tissue preparation, antibodies and immunostaining 
For spinal cord sections and cerebellar sections, mice were deeply anesthetized and 
intra-cardially perfused with PBS followed by ice-cold 4% paraformaldehyde in PBS. The 
spinal cord or cerebellum was dissected out and post-fixed in 4% paraformaldehyde 
overnight at 4°C. The tissues were rinsed with PBS and sectioned to 30 um using a 
Vibratome (Leica). The sections were then immediately immunostained as previously 
described (Garcia-Fresco, Sousa et al. 2006, Pillai, Thaxton et al. 2009). Primary antibodies 
for immunostaining were used at the following concentrations overnight at 4°C: RbCaspr 
@1:500 (Bhat, Rios et al. 2001, Pillai, Thaxton et al. 2009, Thaxton, Pillai et al. 2010) and 
MsIgG1-MBP @1:200 (Abcam, SMI-94). Secondary antibodies used for 
immunofluorescence were Alexa Fluor-488 anti-mouse and -568 anti-rabbit conjugated 
antibodies (Invitrogen).  
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2.2.4 Image Analysis and Software 
Confocal images were captured with a Bio-Rad Radiance 2000 laser scanning system 
attached to a Zeiss Axioplan2 microscope. The immunofluorescence images shown are Z 
stacks of five to eight sections with a scan step of 0.25 m. All scanning parameters were 
optimized for the wild-type tissues, and the mutant tissues were scanned at identical settings. 
Quantitative measurements were performed on at least three independent tissue samples for 
immunofluorescence analysis. Using ImageJ, three or more randomly selected areas from 
white matter tracts (40-60k square pixels in size) were used to determine the mean signal 
intensity for Caspr and MBP of each section in both untreated and cuprizone-treated mice. 
These data were summarized and graphed as the mean percentage of cuprizone-treated signal 
to untreated signal. Software used for assembling figures included Zeiss LSM Image 
Browser (v4.2), ImageJ (v1.47d), GIMP (v2.82), and OpenOffice (v3.4.1). 
 
2.3 Results 
2.3.1 Cuprizone-treated mice reveal significant losses of paranodal Caspr and glial 
Myelin Basic Protein in cerebral and cerebellar white matter tracts 
The cuprizone mouse model is an experimental model in which massive 
demyelination can be reproducibly induced in large areas of mouse brain once exposed to 
this copper chelator chemical in their diet. Cuprizone targets mature olidgodendroglia, 
inhibits their ability to fulfill the metabolic demand in maintaining vast amounts of myelin, 
and ultimately promotes apoptosis in these glia. If the cuprizone chemical is withdrawn, this 
model displays a reproducible phase of oligodendroglia proliferation, maturation, and 
remyelination. Previous literature using the cuprizone mouse model relied on colorimetric 
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histology and transmission electron microscopy scoring to demonstrate extensive 
demyelination occurs at week 4 and complete demyelination by week 5 with continuous 
exposure. More recent findings have shown that even feeding with 0.2% cuprizone for 2 
weeks results in a similarly deleterious oligodendroglia toxicity and demyelination 
phenotype. For our study, our collaborator’s exposed three sets of mice with 0.2% cuprizone 
in their feed for 3, 5, or 6 weeks at which point untreated and treated mice were sacrificed, 
fixed and tissue stained for paranodal Caspr and glial Myelin Basic Protein (MBP). Our 
hypothesis proposed immunostaining would reveal greater cellular detail as to cuprizone’s 
effect on axonal domain organization in treated mice.  
We began our studies examining the most studied region in the cuprizone mouse 
model, the corpus callosum or white matter tracts connecting the left and right hemispheres 
of the cerebrum. We summarized our findings for the corpus callosum in Figure 2.1. 
Beginning with the 3 week time point, low magnification images showed a generalized 
decrease in both paranodal Caspr (Fig. 2.1Ba vs. 2.1Aa) and glial MBP (Fig. 2.1Bb vs. 
2.1Ab) in the corpus callosum of cuprizone-treated mice. Typical paranodal domain 
organization appeared present in about half as many axons stained with Caspr in higher 
magnification images of mice treated with cuprizone for 3 weeks (Fig. 2.1Bd) compared to 
untreated (Fig. 2.1Ad). Higher magnification images of MBP showed a diffuse stain but 
generally lower signal intensity in mice treated with cuprizone for 3 weeks (Fig. 2.1Be) 
compared to untreated (Fig. 2.1Ae). After random selection of rectangular panels within the 
WMTs of untreated and cuprizone-treated mice, mean signal intensity and standard deviation 
was generated and graphed as the relative percentage of cuprizone-treated to untreated 
(100%) signal at 3 weeks (Fig. 2.1C). Our results yielded a mean intensity and standard  
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Figure 2.1. Corpus callosum white matter tracts reveal generally decreased levels of 
Caspr and Myelin Basic Protein in animals treated for 3, 5 and 6 weeks with 0.2% 
cuprizone compared to untreated animals.  
A–I. 3, 5, or 6 week untreated or cuprizone-treated mice with immunostaining of cerebral 
corpus callosum white matter tracts (WMT) for paranodal Caspr (Aa,d–Ha,d, white, Ac,f–
Hc,f, red) and glial Myelin Basic Protein (MBP) (Ab,e–Hb,e, white, Ac,f–Hc,f, green) with 
associated signal quantitation; Cuprizone’s selective neurotoxicity for oligodendroglia is 
apparent in low magnification images as untreated WMT’s (Aa-c, Da-c, Ga-c) show greater 
expression levels of Caspr and MBP at 3 (Aa-c vs. Ba-c), 5 (Da-c vs. Ea-c), and 6 weeks 
(Ga-c vs. Ha-c) compared to cuprizone-treated (+C) animals. Mean signal intensity for Caspr 
(red) and MBP (green) in WMT is quantified in both untreated and cuprizone treated mice at 
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3 (C), 5 (F), and 6 weeks (I). Higher magnification images (Ad,e,f-Hd,e,f) are taken from 
respective white rectangular samples of low magnification merged panels (Ac-Hc). These 
images show significant decrease in overall MBP signal as well as disruption of Caspr 
localization at the paranode in cuprizone-treated mice compared to untreated mice at 3 
(Bd,e,f vs. Ad,e,f), 5 (Ed,e,f vs. Dd,e,f), and 6 weeks (Hd,e,f vs. Gd,e,f). Note no 
statistically significant difference was observed in overall MBP signal intensity at 6 weeks 
(Hd vs. Gd) but clearly MBP signal was less uniform suggesting oligodendroglia are 
repopulating and/or remyelinating previously MBP-deficient regions. Scale bars =10μm (Ac-
Hc) or 5μm (Af-Hf). 
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deviation of 56.1±6.6% for Caspr signal in 3 week cuprizone-treated relative to untreated 
mice and 58.2±4.3% for MBP signal.  
Moving to the 5 week time point, low magnification images revealed a dramatic 
decrease in both paranodal Caspr (Fig. 2.1Ea vs. 2.1Da) and glial MBP (Fig. 2.1Eb vs. 
2.1Db) in the corpus callosum of cuprizone-treated mice. Typical paranodal domain 
organization appeared nearly absent in axons stained with Caspr in both low and high 
magnification images of mice treated with cuprizone for 5 weeks (Fig. 2.1Ed) compared to 
untreated (Fig. 2.1Dd). Higher magnification images of MBP showed a diffuse stain and 
significantly diminished signal in mice treated with cuprizone for 5 weeks (Fig. 2.1Ee) 
compared to untreated (Fig. 2.1De). While not directly stained, a notable increase in nuclei 
(indicated by the circular/oval structures absent of Caspr or MBP signal) was observed in the 
corpus callosum of mice treated with cuprizone for 5 weeks compared to untreated mice. As 
done for 3 week data, mean signal intensity and standard deviation was generated and 
graphed as the relative percentage of cuprizone-treated to untreated at 5 weeks (Fig. 2.1F). 
Our results yielded a mean intensity and standard deviation of 77.3±15.6% for Caspr signal 
in 5 week cuprizone-treated relative to untreated mice and 62.8±8.4% for MBP signal. 
 Finally coming to the 6 week time point, low magnification images displayed a 
moderate decrease in paranodal Caspr (Fig. 2.1Ha vs. 2.1Ga) signal but not glial MBP (Fig. 
2.1Hb vs. 2.1Gb) in the corpus callosum of cuprizone-treated mice. Like at 5 weeks, 
paranodal domain organization appeared nearly absent in axons stained with Caspr at both 
low and higher magnification sections of mice treated with cuprizone for 6 weeks (Fig. 
2.1Hd) compared to untreated (Fig. 2.1Gd). Interestingly, higher magnification MBP images 
revealed both diminished diffuse staining but also enriched projections of likely 
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remyelinating oligodendroglia of mice treated with cuprizone for 6 weeks (Fig. 2.1He) 
compared to untreated (Fig. 2.1Ge). As performed for previous signal data, mean signal 
intensity and standard deviation was generated and graphed as the relative percentage of 
cuprizone-treated to untreated at 6 weeks (Fig. 2.1I). Our results produced a mean intensity 
and standard deviation of 53.9±8.1% for Caspr signal in 6 week cuprizone-treated relative to 
untreated mice and 99.5±13.3% for MBP signal. This similar MBP signal intensity (Fig. 2.1I) 
between untreated and cuprizone treated mice can be most easily explained as 
oligodendroglia in the corpus callosum are repopulating and regenerating their myelin sheath 
projections to begin remyelination of white matter tracts. The relatively large standard 
deviation (Fig. 2.1I) in MBP signal as well as low magnification image in 6 week cuprizone-
treated mice (Fig. 2.1Hb) suggests this remyelination process is heterogeneous and regional 
in nature. 
We continue our paranodal domain organization studies examining a less studied 
region in the cuprizone mouse model, the cerebellar white matter tracts (WMT) where 
oligodendroglia myelinate the axons descending through the granular layer (GL) from 
Purkinje neurons. We summarized our findings in the cerebellum in Figure 2.2. Starting with 
the 3 week time point, low magnification images displayed a generalized decrease in both 
paranodal Caspr (Fig. 2.2Ba vs. 2.2Aa) and glial MBP (Fig. 2.2Bb vs. 2.2Ab) signal in the 
cerebellum of cuprizone-treated relative to untreated mice. Paranodal domain organization 
was conserved in most axons stained with Caspr but Caspr signal appeared less intense in 
higher magnification images of 3 week cuprizone-treated mice (Fig. 2.2Bd) compared to 
untreated (Fig. 2.2Ad). Higher magnification MBP images exhibited a diffuse and generally 
lower signal in cerebellar WMTs of mice treated with cuprizone for 3 weeks (Fig. 2.2Be)  
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Figure 2.2. Cerebellar white matter tracts show generally decreased levels of Caspr and 
Myelin Basic Protein signal in 3, 5 and 6 week cuprizone-treated animals compared to 
untreated animals.  
A–I. 3, 5, or 6 week untreated or cuprizone-treated mice with immunostaining of cerebellar 
white matter tracts for paranodal Caspr (Aa,d–Ha,d, white, Ac,f–Hc,f, red) and glial Myelin 
Basic Protein (MBP) (Ab,e–Hb,e, white, Ac,f–Hc,f, green) with associated signal 
quantitation; Low magnification images (Aa,b,c–Ha,b,c) show the typical cellular 
arrangement of the granular layer (GL) surrounding myelinated white matter tracts (WMT) 
of Purkinje axons (Ac). Cuprizone’s selective neurotoxicity for oligodendroglia is apparent 
as untreated WMT’s (Aa-f, Da-f, Ga-f) show greater levels of Caspr and MBP at 3 (Aa-f vs. 
Ba-f), 5 (Da-f vs. Ea-f), and 6 weeks (Ga-f vs. Ha-f) compared to cuprizone-treated (+C) 
animals. Mean signal intensity for Caspr (red bar) and MBP (green bar) in WMT is 
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quantified in cuprizone-treated relative to untreated mice at 3 (C), 5 (F), and 6 weeks (I). 
Higher magnification images (Ad,e,f-Hd,e,f) are taken from respective white rectangular 
samples of low magnification merged panels (Ac-Hc). These images show significant 
decrease in overall MBP signal as well as disruption of Caspr localization at the paranode in 
cuprizone-treated mice compared to untreated mice at 3 (Bd,e,f vs. Ad,e,f), 5 (Ed,e,f vs. 
Dd,e,f), and 6 weeks (Hd,e,f vs. Gd,e,f). Note no statistically significant difference was 
observed in overall Caspr signal intensity at 6 weeks but Caspr localization was affected (Hd 
vs. Gd). Scale bars =10μm (Ac-Hc) or 5μm (Af-Hf). 
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compared to untreated (Fig. 2.2Ae). Using identical methods as in the corpus callosum, mean 
signal intensity and standard deviation was generated using a random selection of panels 
within the WMTs of untreated and cuprizone-treated mice and graphed as the relative 
percentage of cuprizone-treated to untreated (100%) signal. Our results (Fig. 2.2C) yielded a 
mean intensity and standard deviation of 50.7±9.7% for Caspr signal in 3 week cuprizone-
treated relative to untreated mice and 39.6±5.2% for MBP signal.  
At the 5 week time point, low magnification images revealed a significant decrease in 
both paranodal Caspr (Fig. 2.2Ea vs. 2.2Da) and glial MBP (Fig. 2.2Eb vs. 2.2Db) in the 
cerebellum white matter tracts of cuprizone-treated mice. Typical concentrated paranodal 
domain organization was replaced with diffuse axonal localization of Caspr in both low and 
higher magnification images of mice treated with cuprizone for 5 weeks (Fig. 2.2Ed) 
compared to untreated (Fig. 2.2Dd). Higher magnification images of MBP presented a 
significantly diminished and diffuse stain in mice treated with cuprizone for 5 weeks (Fig. 
2.2Ee) compared to untreated (Fig. 2.2De). Mean signal intensity and associated standard 
deviation was determined and graphed as the relative percentage of cuprizone-treated to 
untreated at 5 weeks (Fig. 2.2F). Values found were 50.8±5.8% for Caspr and 72.7±2.8% for 
MBP in 5 week cuprizone-treated immunostaining signal relative to untreated signal. 
 Interestingly, low magnification images displayed a decrease in glial MBP (Fig. 
2.2Hb vs. 2.2Gb) signal but no similar decrease in paranodal Caspr (Fig. 2.2Ha vs. 2.2Ga) 
signal in the cerebellar white matter tracts of 6 week cuprizone-treated mice. In contrast to 
corpus callosum, some recovery of compact paranodal domain organization (stained with 
Caspr) was observed in both low (Fig. 2.2Ha vs. 2.2Ga) and high (Fig. 2.2Hd vs. 2.2Gd) 
magnification sections of mice treated with cuprizone for 6 weeks compared to untreated. 
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Curiously, higher magnification MBP images of the cerebellar WMTs showed diminished 
diffuse staining but not the MBP-enriched projections (Fig. 2.1He) as seen in the corpus 
callosum of mice treated with cuprizone for 6 weeks (Fig. 2.2He) compared to untreated 
(Fig. 2.2Ge). As with previous signal data, mean signal intensity and standard deviation was 
generated and graphed as the relative percentage of cuprizone-treated to untreated at 6 weeks 
(Fig. 2.2I). Our results produced a mean intensity and standard deviation of 98.1±3.4% for 
Caspr and 69.2±5.9% for MBP signal in 6 week cuprizone-treated relative to untreated mice. 
Similar Caspr signal intensity (Fig. 2.2I) between untreated and cuprizone-treated mice 
suggests that oligodendroglia in the cerebellum versus the corpus callosum recover from 
cuprizone toxicity more quickly to reform and organize paranodes. Taken together, the 
cuprizone mouse model combined with immunohistochemistry represent a useful tool in 
understanding how oligodendroglia toxicity, demyelination, glial recovery, and 
remyelination affect axonal domain organization in the central nervous system. 
 
2.3.2 Identification of three Caspr-Cre recombinant lines (A9, E10, dB1) 
 Design and generation of a Cre expression line under the control of the Caspr locus 
began in late 2008 between Manzoor Bhat PhD and JrGang Cheng (UNC BAC Engineering 
Core Facility). This second inception and plan of the Caspr-Cre recombinant mouse came 
after a first generation, random-insertion Caspr-Cre mouse failed to produce Cre in a robust 
or in a neuron-specific manner. Early initial data suggested the first generation, Caspr 
promoter sequence length used was too short and random insertion insufficient to gather 
required pro-transcriptional elements to generate the necessary robust expression of Cre. 
Instead, this second generation of Caspr-Cre would be a targeted knock-of the Cre 
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recombinase enzyme sequence in-frame with exon 1 of the wild-type Caspr locus located on 
mouse chromosome 11 (Fig. 2.3A). Obtained from JrGang Cheng, a plasmid called pGEM-
DT-CNTN-Cre-FpNF or pCaspr-Cre (15503bp) was midi-prepped and digested with the 
restriction enzymes EcoRI, NotI, SalI, and ScaI to confirm the predicted plasmid map using 
the observed DNA fragments. Having confirmed the plasmid, 50ug of pCaspr-Cre was 
linearized using ScaI and sent to the UNC Animal Models Core Facility for male pro-nuclear 
microinjections into mouse embryos.  
 Several iterations of PCR primer design and testing were conducted while waiting for 
microinjections to be performed. Initial sets of primers for PCR were also used as a 
secondary confirmation to complement the restriction digests. Up to a dozen sets of PCR 
primers were tested against both genomic DNA and pCaspr-Cre plasmid DNA. After 
narrowing the selection criteria for primers which reliably produced bands with minimal off-
target products, a final set of one forward and reverse primer was found (Fig. 2.3A). The 
forward primer was located within the neighboring CCR10 gene while the reverse primer 
was located within the introduced Cre recombinase sequence. Only in the case of a 
recombined chromosome 11 would these primers result in a 2.4kb fragment. DNA was 
isolated and purified from the first two sets of 98 well plates containing injected embryonic 
stem (ES) cell lines. Using the previously described PCR primer set, 4 out of 186 ES cell 
lines produced a 2.4kb band (Fig. 2.3B). These recombinant lines were named according to 
their relative grid location on the plates with a ‘dot’ or ‘d’ surname if found on the second 
plate. Initially confirmed lines A9, E10, dB1, dD2 as well as recombinant-negative lines E11 
and dD3 were put through a second round of PCR (Fig. 2.3B). A9, E10, and dD2 lines   
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Figure 2.3. Generation of Caspr-Cre recombinant mouse. 
A-D. Multi-step confirmation from plasmid construct to Southern blots of Caspr-Cre 
recombinant mouse embryonic stem (ES) cells. A. Three DNA segments are highlighted: top 
segment shows the knockin pCaspr-Cre construct with Caspr’s split exon 1 (blue boxes) 
containing the Cre recombinanse (yellow box) and neomycin (magenta box) sequences, 
middle segment shows a partial genomic map of the Caspr locus showing two exons of 
upstream CCR10 gene (grey boxes) and fourteen exons of Caspr (blue boxes), and bottom 
segment showing the recombinant chromosome resulting from homologous recombination of 
pCaspr-Cre and wild-type mouse chromosome 11. Note hooked arrows indicate differing 
transcriptional direction of CCR10 and Caspr genes within the Caspr locus. Forward primer 
1 (black arrow) sits on the CCR10 sequence (grey box) while reverse primer 2 (red arrow) 
sits on the Cre recombinanse (yellow box). Note a 2.4kb PCR product can only occur in the 
resulting recombinant chromosome. B. Screening two sets of 98 well plates containing 
microinjected ES cell lines reveal positive Caspr-Cre recombinant chromosomes. The left 
four images show the initially identified four positive ES cell lines A9, E10, dot-BI, and dot-
D2. A second PCR on right confirmed these lines while negative controls E11 and dot-D3 
failed to generate a 2.4kb band. C. Relative size and location of Southern blot DNA probe 
(yellow rounded rectangle) to recombinant (red line) and wild-type chromosomes (black line) 
digested with BamHI, SalI, and XhoI restriction enzymes. Note the predicted knockin of the 
Cre-Neo cassette increases the SalI and XhoI digested chromosome by 3.3kb, while an 
introduced BamHI site in the recombinant Cre should result in a 0.9kb smaller chromosome. 
D. Southern blot analysis confirms the targeted recombinant Caspr locus in ES lines A9, 
E10, and dot-B1 but not dot-D2 or an ES cell negative control (-ES). 
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produced a clear 2.4kb band while dB1 produced a weak 2.4kb band and E11 and dD3 
produced no 2.4kb band (Fig. 2.3B).  
 Southern blot was considered as a second method to confirming these recombinant 
Caspr-Cre lines. After performing in silico comparisons of several potential restriction 
enzyme digests, three enzymes were chosen for use in the Southern blot: BamHI, SalI, and 
XhoI. These sites locations are marked on the wild-type and recombinant chromosomes in 
Figure 2.3C. In addition, the region and size for the subsequent Southern probe was 
determined (Fig. 2.3C) Initial testing of Southern blot conditions was performed on wild-type 
ES cells (ES-) (data not shown) to confirm specificity of the DNA probe for this 
chromosomal locus as well as expected restriction banding patterns of probed chromosomal 
DNA. After confirmation of probe specificity and banding patterns, genomic DNA from ES 
lines A9, E10, dB1, dD2, and wild-type (ES-) was restriction digested overnight with 
BamHI, ran on a gel, transferred and fixed to a nylon membrane, exposed to the P32 
radioactive DNA probe, and then stringently washed. The probed nylon membrane was 
exposed to radiographic film overnight in the freezer. Once developed, the film revealed two 
autoradiographic-positive bands of sizes 3.6kb and 4.5kb from BamHI-digested ES lines A9, 
E10, and dB1 (Fig. 2.3D) which correspond to one Caspr-Cre recombinant (Fig. 2.3C, red 
line) and one wild-type chromosome respectively (Fig. 2.3C, black line). Curiously, the 
Southern blot of ES cell line dD2 digested with BamHI had only one 4.5kb band present 
suggesting no Caspr-Cre recombinant chromosome but only two wild-type chromosomes 
(Fig. 2.3D). As expected, the wild-type ES cell line (ES-) digested with BamHI produced a 
single 4.5kb band and revealed no 3.6kb recombinant band (Fig. 2.3D). Given the 
unexpected Southern blot results for ES cell line dD2, only ES cell lines A9, E10, and E11 
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were carried forward for testing with SalI and XhoI digests (Fig. 2.3D, right blot). The 
Southern blot using SalI revealed two autoradiographic-positive bands of sizes 9.6kb and 
6.3kb from ES lines A9, E10, and dB1 (Fig. 2.3D, right blot), confirming one Caspr-Cre 
recombinant (Fig. 2.3C, red line) and one wild-type chromosome respectively (Fig. 2.3C, 
black line). As expected, the wild-type ES cell line (ES-) digested with SalI produced a 
single 6.3kb band and revealed no 9.6kb recombinant band (Fig. 2.3D, right blot). Likewise, 
Southern blot using XhoI revealed two bands of sizes 11kb and 7.7kb from ES lines A9, E10, 
and dB1 (Fig. 2.3D, right blot), confirming one Caspr-Cre recombinant (Fig. 2.3C, red line) 
and one wild-type chromosome respectively (Fig. 2.3C, black line). As expected, the wild-
type ES cell line (ES-) digested with XhoI produced a single 7.7kb band and revealed no 
11kb recombinant band (Fig. 2.3D, right blot). Taken together, PCR and Southern blot data 
confirmed the targeted recombination of Cre recombinase within exon 1 of the Caspr locus 
in ES cell lines A9, E10, and dB1. These ES lines were subsequently sent out for injections 
into blastocysts and derivation of chimeric breeder mice.  
 
2.4 Discussion 
2.4.1 The cuprizone mouse model establishes a reproducible 
demyelination/remyelination model for the study of myelinated axonal domain 
disorganization and reformation 
The cuprizone mouse model is a reproducible myelination/remyelination model by 
killing mature oligodendroglia in the central nervous system by exploiting their selective 
toxicity to the copper chelator cuprizone. Once concurrent demyelination occurs with the 
death of oligodendroglia, the cuprizone chemical can subsequently be withdrawn to produce 
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a phase of oligodendroglia proliferation, maturation, and remyelination. Recent findings have 
shown that even short 2 week feedings with 0.2% cuprizone result in a similarly deleterious 
demyelination/remyelination cycle. Importantly, the cuprizone model represents a 
reproducible model for novel insights into the cellular mechanisms of axonal domain 
destruction and formation. For our study, our collaborator’s exposed three sets of mice with 
0.2% cuprizone in their feed for 3, 5, or 6 weeks at which point untreated and treated mice 
were sacrificed, fixed and tissue stained for paranodal Caspr and glial Myelin Basic Protein 
(MBP). Our hypothesis proposed immunostaining using fluorescent reporters relative to 
colorimetric reporters would reveal greater cellular detail as to cuprizone’s effect on axonal 
domain organization in treated mice. 
The majority of literature with the cuprizone mouse model favors 
immunohistochemical methods with colormetric reports rather than immunofluorescent 
reporters. While this historical trend was initially a surprise, we found it to be an opportunity 
to apply our lab’s experience and success with immunofluroescent reporters on such 
cuprizone-treated tissues. Additionally, it allowed us the opportunity to use a highly 
reproducible model to determine the short-term effects of demyelination/remyelination on 
paranodal organization in myelinated axons. Here we seek to answer our originally proposed 
questions: (1)Do we see differences in MBP levels comparing untreated to cuprizone-treated 
mice using immunostaining and confocal microscopy? Are these MBP findings consistent 
with previously published light microscopy results? Yes and yes. In both the cerebral corpus 
callosum (Figure 2.1) and cerebellar white matter tracts (Figure 2.2), we see a generalized 
decrease in MBP levels at 3 and 5 weeks of cuprizone-treatment compared to untreated mice. 
An exception to this trend was in the corpus callosum of 6 week cuprizone-treated mice 
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where we see highly variable but overall similar levels of MBP signal to untreated mice. 
Previous literature has reported an average 50% increase in MBP levels in the corpus 
callosum at 6 weeks cuprizone-treatment relative to starting MBP levels; our result suggests 
a similar finding to this trend, but since our coronal slice selection criteria wasn’t as specific 
to particular brain region, our tissue slice may represent a region of slightly more active 
oligodendrocyte repopulation and myelination. Interestingly, our 6 week cuprizone-treated 
cerebellar white matter tracts did not show a similar increase in MBP signal as the corpus 
callosum. Even more puzzling, our results reveal more extreme loss of MBP signal using 
fluorescent reporters compared to published cerebellum light microscopy. In light of this 
data, it could suggest that standardization of the 0.2% cuprizone chow preparation is critical 
for proper dosing. Alternatively, it could suggest the oligodendroglia in the cerebellum are 
even more sensitive to our cuprizone regimen relative to the published data, and that once 
mature oligodendroglia are killed, there are fewer immature oligodendroglia relative to the 
corpus callosum to repopulate and remyelinate the white matter tracts.  
Moving on the myelinated axonal domain questions: Do we see differences in Caspr 
levels comparing untreated to cuprizone-treated mice using immunostaining? Are the effects 
of cuprizone similar in cerebellar white matter tracts as well-studied cerebral white matter 
tracts? How does progressive cuprizone toxicity from 3-6 weeks affect paranodal 
organization (as seen with Caspr)? Similar to MBP, we do see statistically significant 
differences between untreated and cuprizone-treated mice. In both 3 and 5 weeks, we 
observed a significant decrease in the overall Caspr levels in the corpus callosum and 
cerebellar white matter tracts in cuprizone-treated mice relative to untreated mice. This was 
also the finding in 6 week cuprizone-treated corpus callosum slices but not in cerebellar 
71 
 
white matter tracts. Instead, we observed no statistical difference in Caspr signal levels of 
cerebellar white matter tracts between 6 week cuprizone-treated and untreated mice. Despite 
the overall similar levels, paranodal Caspr localization appeared less concentrated and more 
diffuse in the cerebellar white matter tracts of 6 week cuprizone-treated compared to 
untreated mice. Such data reinforces the hypothesis that the cellular context and/or 
susceptibility to cuprizone toxicity were different in corpus callosum and cerebellar white 
matter tracts. It also may reflect that oligodendrocytes regenerate myelin components such as 
MBP disproportionally to other components like NF155 required to reform and establish 
myelinated domain organization as indirectly observed by Caspr signal localization in axons. 
Higher magnification images clearly demonstrated a problem with proper paranodal Caspr 
localization at any age of the mice treated with cuprizone. Here we report that established 
immunohistochemical techniques using colorometric detection fail to give the cellular and 
molecular resolution that modern immunofluorescent reporters can offer. We also report for 
the first time a distinct difference in corpus callosum and cerebellar outcomes relative to 
MBP and Caspr intensity levels.  
 
2.4.2 Identification and application of three Caspr-Cre recombinant lines 
 In order to establish a more robust, early developmental neuronal Cre line, we utilized 
a targeted knock-in approach to place a Cre recombinase under the control of the Caspr 
locus. We showed that our recombined Caspr-Cre construct was identified in 4 of the 184 
injected ES cell lines using a single set of PCR primers. Those positively identified lines 
were A9, E10, dot-B1, and dot-D1. As described by the UNC Mouse Genome Core (personal 
correspondence), this recombination frequency rate (4/184 or 2.2%) was above their average 
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one percent recombination (personal communications). This better than average frequency in 
recombination may reflect the relatively small ratio of foreign Neo+Cre DNA sequence (2kb) 
relative to the long chromosomal 5’ and 3’ DNA arms (1.7kb and 6kb, respectively). All four 
of these lines were subjected to a Southern blot scheme using BamHI-restricted chromosomal 
DNA. These results confirmed three (A9, E11, and dB1) of the lines after yielding two 
different bands, one representing the wild-type chromosome and the other recombinant 
chromosome. Curiously, the dD2 ES cell line only showed a single Southern blot band for 
the wild-type chromosome and not the recombinant chromosome. The most likely 
explanation for this result is that dD2 ES cell line represents a false positive and was 
contaminated with recombinant chromosomal DNA from a different sample. Since PCR is a 
highly sensitive moleculer technique, false positives are common if any such contaminants 
are present. The Southern blot doesn’t have the sensitivity of PCR. Instead, the Southern blot 
signifies a highly specific technique since the radioactive probe product under stringent 
conditions only binds in a one-to-one ratio to the chromosomal DNA. Supplementary 
Southern blots using SalI- and Xho-digested DNA confirmed the three lines A9, E10, and 
dB1 contained the Caspr-Cre recombined chromosomes. Once these three lines were 
confirmed, ES cell lines were injected into blastocytes to make chimeric mice. 
 We designed a mouse mating scheme in order to confirm functional levels of Cre 
recombinase in the expected neuronal populations. Once Caspr-Cre chimeric mice were 
obtained, they were mated with the Cre reporter line R26R-LacZ (JAX Stock #009427). 
When crossed with a Cre transgenic strain, lacZ is expressed in all cells/tissue where Cre is 
expressed (Soriano 1999), thus we expected to see early robust LacZ expression and 
subsequent blue color change in all neuronal-lineage cell types once stained with LacZ 
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solution. To our surprise, tissues stained with LacZ staining solution failed to reveal 
significant differences in blue color changes (data not shown). At first, the initial hypothesis 
was an isolated problem with the R26R-LacZ reporter mouse, but control Nefl-Cre lines did 
produce blue neuronal cells after crossing and tissue staining. Subsequent lack of color 
change in any cells of several mouse founder lines derived from A9, E10, and dB1 suggested 
the nature of the problem was conserved between all Caspr-Cre constructs. After purifying 
and designing primers to sequence the Caspr-Cre locus, an unexpected insertion of 11bp 
sequence was found just prior to the Cre recombinase sequence. This 11bp sequence likely 
disrupts reading frame of the Cre crecombinase and results in a truncated and non-functional 
protein product rather than the Cre enzyme necessary to catalyze the appropriate LoxP sites 
in the R26R-LacZ mouse line.  
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CHAPTER 3 
 
WHIRLIN, A CYTOSKELETAL SCAFFOLDING PROTEIN, STABILIZES THE 
PARANODAL REGION AND AXONAL CYTOSKELETON IN MYELINATED AXONS 
 
3.1 Introduction 
Nervous system function depends on proper molecular organization between neurons 
and glial cells. In myelinated neurons, the segregation and enrichment of proteins in the 
defined domains, the Node of Ranvier, paranode, and juxtaparanode, is critical for saltatory 
action potential propagation (Bhat 2003, Salzer 2003, Thaxton and Bhat 2009, Thaxton, 
Pillai et al. 2011). Without proper organization, electrical nerve conduction is delayed and 
can result in significant motor and sensory deficits. The paranodal domain is a region of 
direct interaction between the glial myelin membrane loops and neuronal plasma membrane. 
Axo-glial septate junctions (AGSJ) link these glial membrane loops to the axonal membrane 
and establish the paranodal ionic barrier separating sodium (Na
+
) channel-enriched node 
from the potassium (K
+
) channel-enriched juxtaparanode (Rosenbluth 1988). AGSJ’s are 
composed of three transmembrane proteins: Contactin (Cont) (Boyle, Berglund et al. 2001), 
Contactin-associated protein (Caspr) (Bhat, Rios et al. 2001), and Neurofascin155 (glial-
derived 155kDa isoform) (Tait, Gunn-Moore et al. 2000). Genetic ablation in any of the three 
molecules disrupts the paranodal barrier function and results in degraded action potential 
propagation (Tait, Gunn-Moore et al. 2000, Bhat, Rios et al. 2001, Boyle, Berglund et al. 
2001, Garcia-Fresco, Sousa et al. 2006, Zonta, Tait et al. 2008, Pillai, Thaxton et al. 2009). 
While much research has focused on these three proteins, other molecules contribute to 
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domain formation and stabilization. For example, Caspr2 and TAG-1 are required for 
organization of the juxtaparanodal domain and localization of potassium (K+) channels 
(Poliak, Salomon et al. 2003). For long-term stability, Caspr and Caspr2 are thought to rely 
on cytoskeletal scaffold proteins to link their associated complexes with the axonal 
cytoskeleton. Loss of Caspr results in significant cytoskeletal disorder (Garcia-Fresco, Sousa 
et al. 2006), and since its extracellular partner Cont lacks an intracellular c-terminus, the c-
terminus of Caspr is likely a critical region of interaction between AGSJ’s and the axonal 
cytoskeleton. Previous studies using 4.1B mutant mice revealed that this cytoskeletal protein 
contributes to paranodal and juxtaparanodal stability (Horresh, Bar et al. 2010, Buttermore, 
Dupree et al. 2011). A recent report also highlights 4.1G as an organizer of internodes in the 
peripheral nervous system (Ivanovic, Horresh et al. 2012). The neuron is abundant with 
cytoskeletal scaffolds however, and such findings do not exclude the possibility that other 
cytoskeletal elements may contribute to paranodal maintenance and long-term stability. 
Whirlin (Whrn) is a cytoskeletal scaffold protein that plays an important role in vision 
and hearing (Mburu, Mustapha et al. 2003, Yang, Kaeser-Woo et al. 2010). In humans, 
WHRN (DFNB31) mutations have been linked to Usher syndrome Type II (USH2), an 
autosomal recessive vision-hearing impairment disorder (van Wijk, van der Zwaag et al. 
2006, Friedman, Schultz et al. 2011). In mice, the Whrn coding sequence consists of 12 total 
exons with two dominant splice variants, a full length and short (exon 5-12) isoform. Both 
variants contain a Proline-rich domain and PDZ-domain(s) which have been shown to link 
submembranous cytoskeletal elements to transmembrane complexes, as well as self-
oligomerize (Delprat, Michel et al. 2005). In the eye, Whrn interacts with the transmembrane 
proteins Usherin (USH2) and Very Large G protein-coupled Receptor-1 (VLGR1/GPR98) 
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within the periciliary membrane complex of photoreceptors. Likewise in the inner ear, Whrn 
interacts with Usherin and VLGR1/GPR98 which form the stereociliary ankle-links. 
Additionally, Whrn interacts indirectly with 4.1B (Okumura, Mochizuki et al. 2010) and 
4.1R through Mpp1/p55 (Mburu, Kikkawa et al. 2006), and directly with Myosin XVa 
(Belyantseva, Boger et al. 2005). Finally, Whrn is implicated with Esp8 in stereocilia-length 
regulation (Manor, Disanza et al. 2011). While the function of Whrn in the ear and the eye 
has received significant attention, very little is known about its function in the central and/or 
peripheral nervous system. There are reports of Whrn protein expression in the cerebrum, 
cerebellum, and brainstem in wild-type mice and the protein is absent in Whrn knockout 
(Whrn
-/-
) and whirler (Whrn
wi/wi
) mutant mice. In Drosophila, the closest homolog to Whrn is 
dysc (Jepson, Shahidullah et al. 2012). In dysc mutants there is arrhythmic locomotor 
behavior but the eclosion circadian rhythms and clock protein cycling is unaffected (Jepson, 
Shahidullah et al. 2012). Here we report that Whrn is involved in proper compaction of the 
paranodal region in myelinated axons and for proper stabilization of the axonal cytoskeleton. 
 
3.2 Materials and Methods 
3.2.1 Animals 
Whrn exon 1 homozygous mutants used were obtained from Dr. Jun Yang’s lab 
(University of Utah, Salt Lake City, Utah, 84132). The mice were backcrossed to C57BL6 
mice (JAX Laboratories #000664, Bar Harbor, Maine) for two generations and maintained as 
heterozygous Whrn
+/-
 breeding stocks. All animal experiments were performed according to 
Institutional Animal Care and Use Committee approved guidelines for ethical treatment of 
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laboratory animals at the University of North Carolina at Chapel Hill and the University of 
Texas Health Science Center at San Antonio. 
 
3.2.2 Genotyping 
Genomic DNA from mouse tails and/or toe snips was extracted using a kit according 
to manufacturer’s instructions (Sigma-Aldrich Extract-N-Amp™ Tissue PCR Kit (XNAT2)). 
Cycling conditions used were: 95°C for 5min, 35 cycles of (95°C for 30sec, 68°C for 
1.5min), and 68°C for 3min. Primer sequences for PCR were obtained from Dr. Jun Yang’s 
lab as follows: common WhrnRP (Pdzg5r) CAGGGAAGTTGAGGCACACGG, wild-type 
Whrn+FP (pdzg1) GGGTGAGTGAATGCCAGCCAG, and mutant Whrn-FP (PNT3A) 
GAGATCAGCAGCCTCTGTTCCAC. The Whrn+ product size is 894bp; the Whrn- product 
size is 700bp. 
 
3.2.3 Generation of Whrn Antibody 
We generated rabbit, guinea pig, and rat polyclonal anti-Whrn antibodies similar to 
previous literature (Belyantseva, Boger et al. 2005). A full length Whrn mouse cDNA 
construct in pcDNA3.1 was obtained from Dr. Jun Yang’s lab. Regions encoding amino-acid 
residues 220–326 and 699–804 of mouse whirlin (Genbank: NP_001008791.1) were 
subcloned individually into pGEX4T1 and expressed in Escherichia coli (BL21; Stratagene, 
La Jolla, CA). Fusion proteins were isolated by incubating with Glutathione Sepharose 4 Fast 
Flow (GE Healthcare, Sweden). Each fusion protein was used to immunize a rabbit, guinea 
pig, or rat (Cocalico Biologicals Inc, Reamstown, PA). cDNAs encoding amino acids 220–
326 or 699–804 of mouse Whrn were also introduced into pMAL-c2x (New England 
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Biolabs, Beverely, MA), transformed into E. coli (DE3 BL21; Stratagene) and induced to 
express the corresponding maltose binding (MBP) fusion protein. The expressed MBP-fusion 
proteins were purified using amylose resin (New England Biolabs, Beverely, MA) and then 
linked to a NHS-activated Sepharose 4 Fast Flow (GE Healthcare, Sweden). Only antisera 
from the immunized rabbit #349 (RbWhrn349) was affinity purified using the corresponding 
MBP–Whrn fusion protein. 
 
3.2.4 RNA Preparation and RT-PCR 
Sciatic nerves, dorsal root ganglia, and spinal cord sections were removed from p21 
Whrn mutant and wild-type mice. Tissue was stored and processed in RNAlater Stabilization 
Reagent (QIAGEN). Total RNA was isolated using QIAshredder columns (QIAGEN) and 
RNeasy Mini Kit (QIAGEN). RNA concentration was estimated and approx. 5ng RNA was 
used for reverse transcription followed by PCR amplification using the MyTaq One-Step RT-
PCR kit (Bioline). RT-PCR analysis was performed on three separate sets of animals. 
Cycling conditions used were: 45°C for 20min, 95°C for 1min, 35 cycles of (95°C for 10sec, 
62°C for 10sec, 72°C for 30sec), and 72°C for 5min. Primers used for PCR were as follows: 
Actin (Ex2) FP : GCTCCGGCATGTGCAA, Actin (Ex4) RP: 
AGGATCTTCATGAGGTAGT. Whrn (Ex1) FP: ACCAGATTCTGCGCGTCAAC, Whrn 
(SalI-Ex4) RP: tccgGTCGACcacctccagaatctggtctc; Whrn (EcoRI-Ex9) FP: 
CCCAgaattcGGGGCCTGCCTTCCACC, Whrn (SalI-Ex10) RP: 
cgggGTCGACgttggcaccctccgcgg 
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3.2.5 Other Antibodies and Immunostaining Reagents 
The following antisera were previously described: guinea pig and rabbit anti-Caspr 
(Bhat, Rios et al. 2001, Pillai, Thaxton et al. 2009, Thaxton, Pillai et al. 2010), guinea pig 
anti-NF186 and guinea pig anti-pan Neurofascin (Pillai, Thaxton et al. 2009, Thaxton, Pillai 
et al. 2010), guinea pig anti-4.1B antibodies (Buttermore, Dupree et al. 2011), and mouse 
anti-Calbindin (Buttermore, Piochon et al. 2012). Other primary antibodies used include the 
following: mouse anti- Kv1.2 (University of California Davis/NIH NeuroMab Facility; 
K14/16), mouse anti-CASK (University of California Davis/NIH NeuroMab Facility; 
K56A/50), mouse anti-Ankyrin G (University of California Davis/NIH NeuroMab Facility; 
N106/36), mouse anti-Neurofilament H (Chemicon, MAB1623), rabbit anti-alpha-Tubulin 
(Cell Signaling #2144) and anti-Myelin Basic Protein (Abcam, SMI-94). Secondary 
antibodies used for immunofluorescence were Alexa Fluor-488, -568, and -647 conjugated 
(Invitrogen). HRP-conjugated secondary antibodies were purchased from Jackson 
ImmunoResearch for immunoblotting.  
 
3.2.6 Immunostaining 
Briefly, sciatic nerves were removed from anesthetized littermate wild-type and Whrn 
mutants of either sex and fixed in 4% paraformaldehyde in PBS for 15-30 min. The nerves 
were washed with PBS three times (10min each) and stored at 4°C until teased. The nerves 
were teased into individual fibers in PBS, mounted on glass slides, and dried overnight at 
room temperature. Fibers were either immediately used for immunostaining or stored at -
80°C until needed. Teased nerve slides were submerged in acetone (methanol instead for 
anti-MBP staining) at -20°C for 20 min then washed with PBS, followed by immunostaining 
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(Thaxton, Pillai et al. 2011). For spinal cord sections and cerebellar sections, wild-type and 
mutants were deeply anesthetized and intra-cardially perfused with PBS followed by ice-cold 
4% paraformaldehyde in PBS. The spinal cord or cerebellum was dissected out and post-
fixed in 4% paraformaldehyde overnight at 4°C. The tissues were rinsed with PBS and 
sectioned to 30 um using a Vibratome (Leica). The sections were then immediately 
immunostained as previously described (Garcia-Fresco, Sousa et al. 2006, Pillai, Thaxton et 
al. 2009). Primary antibodies for immunostaining were used at the following concentrations 
overnight at 4°C: RbCaspr @1:500, GPNF186 @1:400, MsIgG2b- Kv1.2 @1:200, GPNFCt 
@1:400, GP-beta-IVspectrin @1:1000, GP4.1B @1:10000, and MsIgG-Nfl-H @1:1000, 
MsIgG1-Calb @1:1000, and MsIgG1-MBP @1:200. 
 
3.2.7 Immunoblotting 
Sciatic nerves and dorsal root ganglia from littermate wild-type and mutants of either 
sex were excised and processed using a glass homogenizer in ice-cold lysis buffer (50mM 
Tris-HCl, pH 7.5, 150 mM NaCl, 10 mM EDTA, 1% Triton X-100, 1% SDS, and a protease 
mixture tablet). The lysate was incubated for 30 min on ice and then centrifuged at 16,000xg 
for 20 min at 4°C. The sciatic nerve or dorsal root ganglia supernatant was saved for further 
processing. Spinal cords from littermate wild-type and mutants of either sex were excised 
and either directly processed or frozen at -80°C. Spinal cords were homogenized using a 
glass mortar and pestle on ice with lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 10 
mM EDTA, 1% Triton X-100, and a protease inhibitor mixture tablet) and incubated for 30 
min on ice with occasional trituration. The homogenate was centrifuged at 1000xg for 10 min 
at 4°C. The supernatant was collected and subjected to an additional centrifugation at 
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100,000xg for 30 min at 4°C. The resulting second supernatant was collected and saved for 
further processing. Protein concentrations of final lysates were determined using the Lowry 
assay (BC assay; Bio-Rad). Lysates were resolved by SDS-PAGE and transferred onto 
nitrocellulose membranes, followed by immunoblotting procedures described previously 
(Thaxton, Pillai et al. 2011). Primary antibodies for immunoblotting were used at the 
following concentrations for 1 hr at room temperature: Affinity-purified RbWhrn349 @ 
1:1000 (overnight at 4°C), GPCaspr @ 1:2000, GPNFCt @ 1:2000, Rb4.1B @ 1:50000, 
MsIgG1-CASK @ 1:50000, RbCaspr2 @ 1:50000, RbTubulin @ 1:2000 (overnight at 4°C). 
 
3.2.8 Electrophysiology 
The conduction velocity measurements of sciatic nerves were carried out on three 
separate wild-type (+/+) and Whrn
-/-
 mice as described previously (Pillai, Thaxton et al. 
2009, Thaxton, Pillai et al. 2010). 
 
3.2.9 Image Analysis and Software 
Confocal images were captured with a Zeiss LSM510 microscope. Scanning 
parameters were optimized for wild-type tissues and maintained for scanning the mutant 
tissues. Immunofluorescence images for sciatic nerves and spinal cords are composite 
projections from Z stacks of three to six sections (0.6um scan step) or stacks of ten to twenty 
sections (0.6um scan step) for cerebellar slices. Software used for assembling figures 
included Zeiss LSM Image Browser (v4.2), ImageJ (v1.47d), GIMP (v2.82), and OpenOffice 
(v3.4.1).  
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3.2.10 Quantification of Phenotype and Statistics 
For the initial quantification, we utilized a blinded counting strategy to best estimate 
the spring-like phenotype. Teased sciatic nerves were prepared from 7 week-old wild-type or 
Whrn
-/-
 mice. One individual prepared all teased slides and randomly assigned a number to 
each slide. Once completed, the individual compiled a table of genotypes matched to 
assigned numbers. Blinded to that table, a second individual immunostained the numbered 
slides and counted wild-type and Whrn
-/-
 Caspr-stained paranodes. Immunostained paranodes 
were counted under a fluorescent microscope at 40X magnification. Any paranode with 3 or 
more spring-like, loops were considered phenotype-positive. Data was compiled as the 
percentage of phenotype-positive paranodes out of total paranodes. Phenotype percentages 
per slide were matched to genotype and then a final average phenotype percent for 7 week-
old wild-type or Whrn
-/-
 fibers was calculated as well the standard error of the mean (SEM). 
A standard t-test was used to calculate the statistical significance (p-value) between the 
percent for 7 week-old wild-type or Whrn
-/-
 fibers.  All measured data was tabulated in 
Microsoft Excel. A p-value of 0.05 was considered to indicate a significant difference 
between groups. 
For secondary quantitation of paranodal parameters in 4-8 week-old animals, Caspr-
stained paranodes were imaged using a confocal LSM510 microscope and accompanying 
Zeiss Image software. A composite projection of Z-stacks was performed for each image. 
Large-caliber sciatic nerve images (~10um total diameter glial-edge to glial edge) were 
analyzed given the initial observation of more phenotype-positive paranodes in large vs. 
small caliber axons. Twenty wild-type and twenty Whrn
-/-
 paranode images were selected for 
each time point (60 total images). Using Zeiss software tools, each paranode was measured in 
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microns for nodal gap (distance between nodal-paranodal boundaries in white), paranodal 
diameter (distance across axon caliber in blue), paranodal width (distance from nodal-
paranodal boundary to paranodal-juxtaparanodal boundary in red), and phenotype percentage 
(a paranode was considered phenotype-positive if the purple line from the paranodal-
juxtaparanodal boundary crossed a Caspr AGSJ line three times (i.e. 1.5 circular myelin 
wrapping loops) and phenotype-negative if less than three times). All measured data was 
tabulated in Microsoft Excel. The average and standard deviation of each age and genotype 
was graphed for nodal gap, paranodal diameter, and paranodal width. Phenotype percentage 
was reported as a percent of phenotype-positive paranodes out of twenty total counted for 
that age and genotype. 
 
3.2.11 Transmission electron microscopy 
Animal tissues were fixed using 4% Formaldehyde/1% Glutaraldehyde (4CF1G) via 
intra-cardiac perfusion for 30minutes. Tissues were dissected out and placed in 4CF1G to 
post-fix overnight at 4°C. Tissues were then processed by UTHSCSA Electron Microscopy 
core. Core processing steps as follows: (1)buffer rinse in 0.1M phosphate buffer for 5 
minutes to overnight, (2)post-fixation in 1% Zetterqvist’s buffered Osmium Tetroxide for 30 
minutes, (3)buffer rinse in Zetterqvist’s buffer for 3 minutes, (4)en bloc staining in 2% 
aqueous uranyl acetate for 20 minutes, (5)dehydration in 70% alcohol for 10 minutes, then 
95% alcohol for 10 minutes, then 100% alcohol twice for 10 minutes, then propylene oxide 
twice for 10 minutes, (5)resin infiltration in 1:1 propylene oxide:resin for 30 minutes then 
100% resin for 30 minutes under 25psi vacuum. Once embedded, the tissue in sliced in 90nm 
sections and placed on copper grids. Grids were stained with uranyl acetate for 30sec in the 
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microwave and then with Reynold’s lead citrate for 20s. Samples were imaged at 80 kV on a 
JEOL 1230 electron microscope using AMT (advanced microscopy techniques) software. 
 
3.3 Results 
3.3.1 Whrn is Expressed in Central and Peripheral Nervous System Tissues 
Throughout Development 
Whrn is a cytoskeletal scaffolding protein which functions to link membrane protein 
complexes to the cytoskeleton within hair cell stereocilia of the ear and photoreceptors in the 
eye. To begin assessing its function in myelinated neurons, we obtained Whirlin exon 1 
knockout mice (Yang, Liu et al. 2010). As reported previously, the murine Whrn locus 
consists of 12 exons with two dominant splice variants, a full length (~4kb) isoform and a 
short (~2.5kb) isoform (Fig. 3.1A). Both variants contain PDZ-domains (Fig. 3.1A, yellow 
box) and a Proline-rich domain (Fig. 3.1A, blue box). After initial back crossing to C57BL6 
mouse strain, we identified and confirmed the Whrn genotype using PCR methods. To begin 
characterizing mRNA expression of Whrn in the central (CNS) and peripheral nervous 
systems (PNS), we examined the relative expression of Whrn by reverse transcriptase 
polymerase chain reaction (RT-PCR) in dorsal root ganglia (DRG), sciatic nerves (SN), and 
spinal cord (SC) tissues (Fig. 3.1B) in postnatal 21 day-old mice. With this subset of tissues 
we could delineate the origin of Whrn expression as SC tissue is a combination of glial and 
neuronal nuclei, DRG is predominantly neuronal, and SN is principally glial cytoplasm and 
nuclei. Since Whrn has two major isoforms, we designed specific primers to distinguish the 
full length isoform (Exons 1-4) alone and those common to the full length and short isoforms 
(Exons 9-10). No expression of Whrn isoforms was observed in Whrn
-/-
 mice (Fig. 3.1B).  
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Figure 3.1. Whirlin (Whrn) is a PDZ-containing protein expressed throughout the 
central and peripheral nervous system.  
A. Schematic showing the twelve exons which make up the Whrn full-length sequence 
including untranslated exon regions (white boxes) and coding sequence (alternating grey 
boxes). Whrn’s second, shorter isoform begins with an alternative transcriptional start site. 
Both variants contain PDZ-domains (yellow boxes) and a Proline-rich domain (blue box). A 
red, rounded rectangle highlights the region used for antibody creation (RbWhrn349). B. RT-
PCR analysis shows absence of any Whrn transcripts in homozygous Whrn exon 1 knockout 
mice from dorsal root ganglia (DRG, peripheral neuronal nuclei), sciatic nerves (SN, 
peripheral glial nuclei), and spinal cords (SC, combination neuronal/glial nuclei). mRNA 
transcripts were reverse transcribed and amplified using primers located on Whrn exon 1 and 
4 (top panel), Whrn exon 9 and 10 (middle panel), or actin (bottom panel). C. Relative 
quantification of Whrn mRNA from Fig. 3.1B expressed as a ratio of Whrn to actin band 
intensity. D. Immunoblots of 110kDa Whrn protein band in wild-type and Whrn mutant 
DRG, SN, SC, and whole eye using affinity-purified RbWhrn349 antibody. αTubulin served 
as a loading control. E. Immunoblots of wild-type and Whrn knockout mutant 4, 6, 8, and 16-
week-old spinal cord lysates. The expression profile using various myelinated axonal domain 
markers includes Caspr, Neurofascin (186 and 155), 4.1B, Caspr2, as well as CASK. 
αTubulin served as a loading control. F. Immunofluorescence of teased sciatic nerve fibers 
from wild-type (upper panel) and Whrn knockout mice (lower panel) mice. Neurofascin (red) 
and paranodal Caspr (green) reveal paranodal compaction is disrupted in Whrn knockout 
fibers. Note Neurofascin (red) detects both paranodal NF155 and nodal NF186 isoforms.  
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Robust expression of Whrn (Exons 1-4) mRNA was observed in DRG and SC tissue while 
weak expression was observed in SN tissue. Interestingly, weak expression of Whrn (Exons 
9-10) mRNA was observed in DRG and SC tissue but no significant expression was observed 
in SN tissue. Actin (Exons 2-4) mRNA expression was used as a control for total RNA 
present. Relative expression is quantified as a ratio of Whrn to Actin mRNA (Fig. 3.1C) 
between three total RT-PCR analyses. After finding Whrn mRNA expression in the wild-type 
CNS and PNS neuronal tissues, we next sought to determine its protein expression in P30 
Whrn
+/+
 versus Whrn
-/-
 mice by immunoblotting. In order to pursue these experiments, we 
generated several antibodies and affinity-purified one to the non-domain encoding, c-
terminal region (aa699-804) of Whrn (Fig. 3.1A, red bar). After affinity-purification, we 
immunoblotted wild-type (+) and Whrn knockout (-) lysates derived from DRG, SN, SC, and 
whole eye (Fig. 3.1D, upper blots). Whole eye lysates were used as a positive control for 
protein expression based on previous reports (Yang, Liu et al. 2010). A 110kDa Whrn band 
representing the full length protein was present in DRG, SC, and whole eye lysates. No 
110kDa Whrn band was observed in Whrn
-/-
 lysates or in wild-type SN lysate. Each tissue 
type showed similar total protein levels between genotypes based on total Tubulin on 
immunoblots (Fig. 3.1D, lower blots). Having confirmed Whrn
-/-
 tissues were deficient in 
Whrn mRNA and protein, we next sought to determine if loss of Whrn resulted in altered 
protein expression of known nodal, paranodal, and juxtaparanodal proteins. We prepared 
spinal cord lysates from 4, 6, 8, and 16 week-old wild-type (+/+) and Whrn knockout (-/-) 
mice and immunoblotted for Whrn (110kDa) (Fig. 3.1E). Whrn protein expression levels 
were similar from 4 to 16 weeks in wild-type mice while no expression was observed in the 
Whrn
-/-
 at any time point. Next, we immunoblotted for the paranodal protein Caspr (190kDa) 
87 
 
and found similar expression levels between 4-16 week-old in both Whrn
+/+
 and Whrn
-/-
 
mice. Using a pan-Neurofascin-c-terminal (NFct) antibody, we observed similar levels of 
nodal Neurofascin186 and paranodal Neurofascin155 protein expression in wild-type and 
Whrn knockout mice across 4-16 weeks of age. Examination of neuronal cytoskeletal protein 
4.1B and juxtaparanodal protein Caspr2 shows steady protein expression levels in wild-type 
and Whrn knockout mice from 4-16 weeks of age. Finally, previous reports showed in vivo 
interaction between rat Whrn/CIP98 and calmodulin-dependent serine kinase (CASK) (Yap, 
Liang et al. 2003), a synaptic organization protein. After immunoblotting for CASK, no 
difference in its protein level was observed across Whrn genotype or ages from 4-16 weeks. 
Total protein levels in spinal cord lysates were consistent across the ages and genotypes 
based on Tubulin levels (Fig. 3.1E). In summary, these developmental expression profiles 
suggest that loss of Whrn expression does not affect the overall expression of other axonal 
domain markers. 
 
3.3.2 Whrn Knockout Mice Reveal a Quantifiable Paranodal Compaction Phenotype 
in Peripheral Myelinated Axons 
To determine the effects of Whrn loss on axonal domain organization, we examined 
well-characterized nodal, paranodal, and juxtaparanodal markers by immunofluorescence in 
wild-type and Whrn
-/-
 mice. Extensive and repeated immunostaining with our Whrn antibody 
revealed no consistent localization or differences in Whrn localization between wild-type to 
Whrn
-/-
 fibers (data not shown). Compared to wild-type, the most striking observation in 
teased Whrn
-/-
 sciatic nerve fibers was the spring-like separation (Fig. 3.1F) of the paranodal 
axo-glial septate junction (AGSJ) loops beginning along the paranodal-juxtaparanodal border 
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as observed by Caspr and NF155 immunostaining. Irregular paranodal compaction is rarely 
observed in wild-type fibers, so we sought to quantify the overall observation of this 
phenotype in Whrn
+/+ 
and Whrn
-/- 
fibers. We utilized a blinded counting strategy to best 
estimate the spring-like phenotype in wild-type
 
and Whrn
-/- 
fibers. One individual prepared 
and numbered slides while a second individual immunostained slides and counted any 
spring-like phenotypes from wild-type (N=4676) or Whrn
-/- 
(N=2798) Caspr-stained 
paranodes. A statistically significant difference (student t-test p=0.02) was observed in the 
percentage of irregular paranodal compaction at 0.3% (SEM=0.07%) in wild-type fibers 
compared to 1.8% (SEM=0.45%) in Whrn knockout mice. Having confirmed the significance 
of this spring-like paranodal phenotype in 7 week-old Whrn knockout fibers, we expanded 
our analysis to 4-8 week-old time points.  
Sciatic nerves from Whrn
+/+
 or Whrn
-/-
 littermate mice at 4, 6, and 8 weeks, were 
immunostained with antibodies against nodal, paranodal, and juxtaparanodal markers (Fig. 
3.2). In the 4 week-old wild-type sciatic nerve (Fig. 3.2Aa-d), juxtaparanodal Kv1.2 (Fig. 
3.2Aa) was separated from nodal NF186 (Fig. 3.2Ac) by paranodal Caspr (Fig. 3.2Ab). This 
demarcation of domains (Fig. 3.2Ad) in myelinated fibers is also observed in 4 week-old 
Whrn
-/-
 fibers (Fig. 3.2Bd). Myelin loops of AGSJs in 4 week-old Whrn
-/-
 sciatic nerve fibers 
(Fig. 3.2Bb) were already separating away from the paranode compared to 4 week-old wild-
type sciatic nerve fibers (Fig. 3.2Ab). Breaks in Kv1.2 localization (Fig. 3.2Ba) were 
observed even where Caspr staining (Fig. 3.2Bb) was limited to a single myelin loop, 
suggesting AGSJ’s barrier function was conserved. Juxtaparanodal localization was diffuse 
and asymmetric in Whrn
-/-
 fibers compared to wild-type (Fig. 3.2Aa vs. 3.2Ba). When   
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Figure 3.2. Loss of Whirlin in the peripheral nervous system results in disrupted 
paranodal compaction.  
A–H. 4, 6, 8-week-old teased sciatic nerve fibers either wild-type (Aa–Ad, Ca–Cd, Fa–Fd) 
or Whrn knockout (Ba–Bd, Da–Dd, Ea–Ed, Ga–Gd, Ha–Hd) immunostained against Kv1.2 
(Aa-Da, Fa, Ga, red), NFCt (Ea, Ha, red), Caspr (Ab–Hb, green), NF186 (Ac-Dc, Fc, Gc, 
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blue), AnkG (Ec, Hc, blue), and merged images (Ad–Hd). In all Whrn mutant panels, Caspr 
(Bb, Bd; Db, Dd; Eb, Ed; Gb, Gd; Hb, Hd, green) and paranodal NF155 (NFCt) (Ea, Ed; 
Ha, Hd, red) fail to compact properly at the paranodes. Nodal NF186 or AnkG are not 
affected (Ac,d–Hc,d, blue). Scale bars (Ad-Hd) = 5μm. I. Sample image shows parameters 
of various domain measurements in (nodal gap in white, paranodal diameter in blue, 
paranodal width in red, and counting of spring-like phenotype in purple) using ~10 micron 
caliber, Caspr-immunostained wild-type and Whrn
-/-
 fibers. J-L. No statistically significant 
differences were observed comparing 4, 6, and 8-week-old wild-type and mutant fibers with 
concern to nodal gap (J), paranodal diameter (K), or paranodal width (L) (N=20 for each 
genotype/age combination). Note the greater percentage of paranodes with compaction issues 
in mutant fibers (M, light purple bars) likely contributes to the increased deviation in 
paranodal widths (L, light red bars). 
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comparing wild-type to Whrn knockout mice, we observed no obvious differences in 
intensity levels of juxtaparanodal (Fig. 3.2Aa vs. 3.2Ba) or nodal (Fig. 3.2Ac vs. 3.2Bc) 
markers. At 6 weeks, teased sciatic nerves of wild-type (Fig. 3.2Ca-d) showed typical Kv1.2 
juxtaparanodal (Fig. 3.2Ca), Caspr paranodal (Fig. 3.2Cb), and NF186 nodal (Fig. 3.2Cc) 
organization. 6 week-old Whrn null sciatic nerves have typical NF186 (Fig. 3.2Dc) nodal 
domain organization while Caspr paranodal compaction (Fig. 3.2Db) and Kv1.2 
juxtaparanodal (Fig. 3.2Da) localization were disrupted. Additional immunostaining in 6 
week-old Whrn null sciatic nerves with a pan-Neurofascin-C-terminal (NFct) antibody (Fig. 
3.2Ea) detected both nodal NF186 and paranodal NF155. Paranodal NF155 (Fig. 3.2Ea, non-
nodal signal) and Caspr (Fig. 3.2Eb) immunostaining overlapped (Fig. 3.2Ed) in Whrn
-/-
 
sciatic nerve fibers and revealed similar problems with paranodal compaction. AnkyrinG 
(AnkG) nodal (Fig. 3.2Ec) domain organization in 6 week-old Whrn
-/-
 sciatic nerve fibers 
appeared similar to wild-type (Fig. 3.2Cc). Finally, immunostained 8 week-old sciatic nerves 
of wild-type (Fig. 3.2Fa-d) and Whrn
-/-
 (Fig. 3.2Ga-d, 3.2Ha-d) mice revealed similar NF186 
nodal (Fig. 3.2Fc vs. 3.2Gc) and AnkG nodal organization (Fig. 3.2Hc). Like 4 and 6 week-
old sciatic nerves, Caspr (Fig. 3.2Gb, Hb) and NFct (Fig. 3.2Ha) immunostaining 
consistently revealed paranodal compaction defects as well as Kv1.2 juxtaparanodal (Fig. 
3.2Fa vs. 3.2Ga) diffusion in Whrn knockout mice when compared with wild-type (Fig. 
3.2Fb).  In summary, the nodal domain of myelinated sciatic nerves were organized similarly 
between 4, 6, and 8 week-old mice in both wild-type and Whrn
-/-
 nerves, but the paranodal 
and juxtaparanodal regions displayed phenotypes that suggest that normal compaction of the 
paranodal loops fails to occur in Whrn knockout mice at all ages examined.  
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To follow-up on an observation made during initial quantification that larger diameter 
myelinated fibers had proportionally more paranode compaction issues compared to thinner 
myelinated fibers, we imaged and assembled twenty Caspr-stained confocal images for each 
genotype and time point (4, 6, and 8 week-old) to assess any subtle, sub-micron paranodal 
changes due to Whrn loss. Next, we measured various dimensions of the paranode (Fig. 3.2I). 
Note images collected were from ~10 micron caliber myelinated neurons. Using Zeiss 
software, micron measurements were recorded, tabulated, and reported as averages with 
standard deviations for the nodal gap (Fig. 3.2J), the paranodal diameter (Fig. 3.2K), 
paranodal width (Fig. 3.2L), as well as the percentage of paranodes which display paranodal 
compaction abnormalities (Fig. 3.2M). The nodal gap (Fig. 3.2J) for wild-type and Whrn
-/-
 
sciatic nerves was 0.77±0.16μm and 0.92±0.24μm at 4 weeks, 1.01±0.16μm and 
0.91±0.31μm at 6 weeks, and 1.06±0.21μm and 1.00±0.12 at 8 weeks respectively. No 
statistically significant difference was noted between ages or genotypes with respect to nodal 
gap. The paranodal diameter (Fig. 3.2K) for wild-type and Whrn
-/-
 sciatic nerves was 
2.20±0.42μm and 2.19±0.41μm at 4 weeks, 2.33±0.45μm and 2.43±0.45μm at 6 weeks, and 
2.14±0.35μm and 2.71±0.55 at 8 weeks respectively. With respect to paranodal diameter, no 
statistically significant difference was noted between ages or genotypes. The paranodal width 
(Fig. 3.2L) for wild-type and Whrn
-/-
 sciatic nerves was 3.45±0.58μm and 3.52±0.91μm at 4 
weeks, 3.41±0.57μm and 3.64±1.01μm at 6 weeks, and 3.58±0.48μm and 3.56±0.53 at 8 
weeks respectively. No statistically significant difference was found between ages or 
genotypes with respect to paranodal width. The paranodal compaction phenotype percentage 
(Fig. 3.2M) for wild-type and Whrn
-/-
 sciatic nerves was 15% (3/20) and 55% (11/20) at 4 
weeks, 15% (3/20) and 50% (10/20) at 6 weeks, and 15% (3/20) and 55% (11/20) 
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respectively. As a reminder, the increase in Whrn null phenotype percentage represents the 
shift in selection of larger-caliber myelinated fibers (50%) in contrast to all fibers (1.8%). 
Note the greater percentage of paranodes with compaction issues in Whrn
-/-
 sciatic nerves 
(Fig. 3.2M, light purple bars) likely contributes to the increased deviation in paranodal 
widths (Fig. 3.2L, light red bars). Additionally, comparisons between 8 week-old wild-type 
and Whrn
-/-
 sciatic nerve fibers demonstrated no significant difference in the conduction 
velocity (average ~30m/s) or waveforms (data not shown) of measured compound action 
potentials in two separate trials. 
 
3.3.3 Whrn Knockout Mouse Sciatic Nerve and Spinal Cord Myelinated Fibers 
Display Paranodal Compaction Abnormalities Throughout Development 
To expand on the characterization of Whrn loss with respect to myelinated domain 
organization, we examined a larger developmental window from postnatal ages 2 weeks to 1 
year old. Similar to the 4-8 week studies (Fig. 3.2), we immunostained fibers with well-
characterized nodal, paranodal, and juxtaparanodal markers, and the axonal cytoskeletal 
protein markers 4.1B and heavy chain Neurofilament (Nfl-H) given Whrn’s known 
cytoskeletal scaffolding role in the ear and eye. After immunostaining 2 week-old teased 
sciatic nerves from wild-type and Whrn knockout mice, we observed no striking differences 
in nodal formation using NF186 (Fig. 3.3Ac, Bc). Abnormalities in paranodal formation and 
compaction were observed in Caspr-stained Whrn
-/-
 fibers (Fig. 3.3Bb, Bf) compared to wild-
type (Fig. 3.3Ab, Af). Kv1.2 juxtaparanodal total signal appeared similar between 2 week-old 
wild-type (Fig. 3.3Aa) and Whrn
-/-
 fibers (Fig. 3.3Ba) but accumulation and enrichment of 
Kv1.2 channels (Fig. 3.3Bd) neighboring Caspr within the internodal region was observed.   
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Figure 3.3. Loss of Whirlin contributes to abnormal paranodal compaction and 
cytoskeleton instability throughout sciatic nerve age.  
A–I. 2-week, 10, 20, 30, 40-week, and 1-yr-old teased sciatic nerve fibers either wild-type 
(Aa–Ah, Ca–Ch, Ha–Hh) or Whrn knockout (Ba–Bh, Da–Dh, Ea–Eh, Fa–Fh, Ga–Gh, Ia–
Ih) immunostained against Kv1.2 (Aa-Ia, red), Caspr (Ab,f–Ib,f, green), NF186 (Ac-Ic, 
blue), heavy chain Neurofilament/Nfl-H (Ae-Ie, red), Protein 4.1 band/4.1B (Ag-Ig, blue), 
and merged images (Ad,h–Hd,h). In all Whrn mutant panels, Caspr (Bb,d,f,h; Db,d,f,h; 
Eb,d,f,h; Fb,d,f,h; Gb,d,f,h, Ib,d,f,h, green) fail to compact properly at the paranodes while 
juxtaparanodal marker Kv1.2 (Ba,Bd; Da,Dd; Ea,Ed; Fa,Fd; Ga,Gd; Ia,d, red) appears 
diffuse and disorganized. Nodal NF186 (Ac-Ic, blue) appear unaffected by genotype or age. 
Cytoskeletal markers like Nfl-H (De-Ge vs. Ce, Ie vs. He, red) and 4.1B (Dg-Gg vs. Cg, Ig 
vs. Hg, blue) show more diffusion and irregularities in intensity, particularly older animals, 
in Whrn mutant nerves compared to wild-type nerves, suggesting Whrn contributes to 
paranodal cytoskeletal stability. Scale bars (Ad-Id, Ah-Ih) = 5μm. 
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No obvious difference in intensity or localization of Nfl-H (Fig. 3.3Ae, Be) or 4.1B (Fig. 
3.3Ag, Bg) was found in 2 week-old sciatic nerve fibers comparing Whrn genotypes. 
Looking at 10 week-old sciatic nerve fibers, we observe no differences in nodal domains 
between wild-types or Whrn
-/-
 using NF186 (Fig. 3.3Cc, Dc). Similar to 8 week-old fibers 
(Fig. 3.2F-H), we observed 10 week-old Whrn
-/-
 fibers with abnormal paranodal compaction 
(Fig. 3.3Db, Df), when compared to wild-type fibers (Fig. 3.3Cb, Cf). Juxtaparanodal 
domains stained with Kv1.2 (Fig. 3.3Da vs. 3.3Ca) appear more diffuse but similar in overall 
intensity in 10 week-old Whrn
-/-
 fibers when compared to wild-type. We observed slight 
enrichment of Nfl-H (Fig. 3.3Ce vs. 3.3De) and 4.1B (Fig. 3.3Cg vs. 3.3Dg) within the 
paranodal region of 10 week-old wild-type sciatic nerves compared to Whrn knockout mice, 
but the overall intensity of Nfl-H and 4.1B along the remaining axon appeared similar. 
Immunostaining of 20, 30, and 40 week-old wild-type sciatic nerve fibers were performed 
and domain organization was identical to 10 week-old wild-type fibers (Fig. 3.3Ca-k). 
Looking at 20, 30, and 40 week-old Whrn
-/-
 peripheral nerve fibers, we observed no 
differences in nodal domains between Whrn wild-types (Fig. 3.3Cc) or knockout mice using 
NF186 (Fig. 3.3Ec-Gc). Similar to 10 week-old fibers (Fig. 3.3Db, Df), we observed 
numerous 20, 30, and 40 week-old Whrn null fibers stained with Caspr (Fig. 3.3Eb,d-Gb,d) 
with abnormal paranodal compaction when compared to wild-type fibers (Fig. 3.3Cb,d). In 
20, 30, and 40-week old Whrn
-/-
 fibers, juxtaparanodal domains stained with Kv1.2 (Fig. 
3.3Ea-Ga) showed numerous breaks at sites of Caspr signal, appeared less symmetrical, but 
displayed similar overall signal when compared to wild-type (Fig. 3.3Ca). Cytoskeletal 
marker Nfl-H staining (Fig. 3.3Ee-Ge) was generally uniform within the axon, and 4.1B (Fig. 
3.3Eg-Gg) was present in all axonal domains except the node in 20, 30, and 40 week-old 
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Whrn
-/-
 sciatic nerves. One year-old sciatic nerves showed no difference in nodal 
organization between wild-type and Whrn null mice using NF186 (Fig. 3.3Hc vs. 3.3Ic). One 
year-old Whrn
-/-
 sciatic nerves revealed abnormal paranodal compaction when stained with 
Caspr (Fig. 3.3Ib,d) compared to wild-type fibers (Fig. 3.3Hb,d). Notably, we observed 
paranodal compaction defects in older Whrn
-/-
 sciatic nerve fibers (40 week-old and 1 year-
old) that were loosened blocks and bulges of Caspr signal in addition to the spring-like 
phenotype of detached thin myelin loops observed in younger fibers (4-30 week-old). As 
seen previously, the juxtaparanodal domains of Whrn
-/-
 peripheral nerves stained with Kv1.2 
(Fig. 3.3Ia) showed significant asymmetric enrichment and periodic breaks as well as overlap 
with Caspr signal when compared with one year-old wild-type fibers (Fig. 3.3Ha). In 
relation, patchy, cytoskeletal-deficient staining was observed in older Whrn
-/-
 fibers (Fig. 
3.3Gh, 3.3Ih) near the paranode. Cytoskeletal marker Nfl-H staining was weakly enriched 
within the paranode of the wild-type axon (Fig. 3.3Hh) and less uniform within Whrn
-/-
 fibers 
with paranodal compaction problems (Fig. 3.3Ih). Likewise, 4.1B showed disrupted 
juxtaparanodal cytoskeletal staining in one year-old Whrn
-/-
 fibers (Fig. 3.3Ig) which was not 
observed in the wild-type fibers (Fig. 3.3Hg). 
We also sought to examine the effects of Whrn loss on axonal domain organization in 
the central nervous system (CNS). Utilizing white matter tracts in the spinal cord, we were 
able to identify by immunostaining subtle but consistent differences in paranodal 
compaction. As in the PNS (Fig. 3.3), we stained longitudinal spinal cord sections with 
nodal, paranodal, and juxtaparanodal markers (Fig. 3.4). No differences in nodal organization 
were observed between wild-type and Whrn
-/-
 mice using NF186 (Fig. 3.4Ac vs. 3.4Bc) in 2 
week-old spinal cord sections. At 10, 20, 30, 40 week-old, nodal organization appeared   
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Figure 3.4. Loss of Whirlin contributes to abnormal paranodal compaction throughout 
development in the spinal cord. 
A–G. 2-week, 10, 20, 30, 40-week teased sciatic nerve fibers either wild-type (Aa–Ad, Ca–
Cd, Ea–Ed, Ga–Gd, Ia–Id) or Whrn knockout (Ba–Bd, Da–Dd, Fa–Fd, Ha–Hd, Ja–Jd) 
immunostained against Caspr (Ac–Jc, green), Kv1.2 (Aa–Ja, red), NF186 (Ac–Jc, blue), and 
merged images (Ad–Jd). Nodal NF186 (Ac–Jc, blue) appear unaffected by age or genotype. 
In Whrn mutant spinal cords, Caspr (Bb,d; b,d; Fb,d; Hb,d; Jb,d; green) does not compact 
properly at the paranodes compared to wild-type Caspr (Ab,d; Cb,d; Eb,d; Gb,d; Ib,d; 
green).  In addition, juxtaparanodal marker Kv1.2 (Ba,d; Da,d; Fa,d; Ha,d; Ja,d; red) in 
Whrn mutant spinal cords shows similar signal intensity and occasional colocalization with 
Caspr-stained myelin loops. Scale bars (Ad–Jd) = 5μm. 
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similar between wild-type and Whrn
-/-
 spinal cord fibers using NF186 (Fig. 3.4Cc vs. 3.4Dc, 
3.4Ec vs. 3.4Fc, 3.4Gc vs. 3.4Hc, 3.4Ic vs. 3.4Jc). Immunostaining with paranodal Caspr 
revealed subtle and infrequent paranodal abnormalities in 2 week-old Whrn null spinal cord 
fibers (Fig. 3.4Bb) compared to wild-type (Fig. 3.4Ab). In contrast, obvious and regular 
paranodal compaction defects were observed in 10 (Fig. 3.4Cb vs. 3.4Db), 20 (Fig. 3.4Eb vs. 
3.4Fb), 30 (3.4Gb vs. 3.4Hb), and 40 week-old (Fig. 3.4Ib vs. 3.4Jb) Whrn
-/-
 spinal cords 
compared to their wild-type controls. Finally, juxtaparanodal Kv1.2 immunostaining of 10 
(Fig. 3.4Ca vs. 3.4Da), 20 (Fig. 3.4Ea vs. 3.4Fa), 30 (Fig. 3.4Ga vs. 3.4Ha), and 40 week-old 
(Fig. 3.4Ia vs. 3.4Ja) wild-type spinal cord myelinated axons showed similar overall 
expression as Whrn knockout axons, but consistent juxtaparanodal disorganization and 
colocalization with loosened Caspr-stained myelin loops was observed most often in Whrn
-/-
 
fibers. In summary, there is significant evidence that loss of Whrn disrupts normal paranodal 
compaction in 10-40 week-old myelinated spinal cord axons with subsequent effects on 
juxtaparanodal organization. Taken together, both the peripheral and central nervous systems 
likely utilize the cytoskeletal properties of Whrn to help stabilize the cellular organization 
between myelinating glial cells and neurons around the paranodal region throughout 
development.  
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Figure 3.5. Whirlin alone and combination 4.1B/Whirlin knockout mice have cerebellar 
Purkinje cells with bead-like, axonal swellings.  
A–D. 6-week sagittal sections of mouse cerebellum in either wild-type (Aa–Af), Whrn 
knockout (Ba–Bf), or double Whrn knockout and 4.1B null (Ca–Cf, Da–Df) immunostained 
against Protein 4.1B band/4.1B (Aa–Da, Ad–Dd, red), Calbindin (Ab–Db, green), myelin 
basic protein/MBP (Ae–De, green), and merged images (Ac,f–Dc,f). No striking difference 
was observed between wild-type and Whrn knockout slices in 4.1B staining (Aa,d vs. Ba,d) 
and only non-specific staining was present in 4.1B null animals (Ca–Da, Cd–Dd).  In Whrn 
mutant cerebellum sections (Ba–Bf), Purkinje axonal swellings appear bead-like using both 
Calb (Bb,c vs. Ab,c) and MBP (Be,f vs. Ae,f) in comparison to a uniform, thin caliber axon 
in wild-type fibers (Aa–f). Additionally, secondary ablation of 4.1B protein resulted in a 
greater number of swellings observed with Calb (Cb,c–Db,c vs. Bb,c) and MBP (Ce,f–De,f 
vs. Be,f) when compared with Whrn knockouts alone suggesting these cytoskeletal elements 
help prevent cytoskeletal disorganization in Purkinje cell axons. Scale bars (Ac–Dc, Af–Df) 
= 10μm. 
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3.3.4 Whirlin knockout mice have cerebellar Purkinje cells with bead-like, axonal 
swellings  
To determine the effects of Whrn loss on cerebellar Purkinje cell morphology, we 
immunostained cerebellar slices from 6 week-old wild-type, Whrn knockout, and double 
Whrn and 4.1B (Buttermore, Dupree et al. 2011) null animals (Fig. 3.5). Given that Caspr 
(Garcia-Fresco, Sousa et al. 2006) and CGT (Dupree, Girault et al. 1999, Marcus, Dupree et 
al. 2002), two genes critical for formation of a proper paranode, display Purkinje axonal 
swellings and cytoskeletal disorganization, we were curious as to the effects of the combined 
loss of Whrn and 4.1B. While no obvious differences in localization was observed using our 
Whrn antibody (data not shown) in any of these genotypes, we immunostained against 4.1B 
(Fig. 3.5Aa,d–Da, d; red), Purkinje-specific Calbindin (Fig. 3.5Ab–Db, green), and glial-
specific myelin basic protein/MBP (Fig. 3.5Ae–De, green). There was no difference in 4.1B 
staining intensity (Fig. 3.5Aa,d vs. 3.5Ba,d) between wild-type and Whrn knockout slices. 
Upon examining Whrn
-/-
 cerebellum sections (Fig. 3.5Ba–Bf), Purkinje axons appeared to 
contain bead-like, swellings along their extensions through the granular layer using both Calb 
(Fig. 3.5Bb,c vs. 3.5Ab,c, white arrowheads) and MBP (Fig. 3.5Be,f vs. 3.5Ae,f, white 
arrowheads) in comparison to a uniform caliber axon in wild-type fibers (Fig. 3.5Ab,c,e,f). 
The secondary loss of 4.1B protein resulted in more swellings observed with Calb (Fig. 
3.5Cb,c–3.5Db,c vs. 3.5Bb,c, white arrowheads) and MBP (Fig. 3.5Ce,f–3.5De,f vs. 3.5Be,f, 
white arrowheads) when compared with Whrn null animals alone. In summary, the 
cytoskeletal elements Whrn and 4.1B likely have an assistive role in preventing cytoskeletal 
accumulation and disorganization within cerebellar Purkinje cell axons in a similar 
phenotypic manner to Caspr null mice (Garcia-Fresco, Sousa et al. 2006). 
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3.3.5 Ultrastructural Abnormalities in Whrn Knockout Sciatic Nerve, Spinal Cord 
Fibers, and Cerebellar Purkinje Axons 
To further understand Whrn’s role in myelinated axons, transmission electron microscopy 
was performed in order to examine the ultrastructural architecture in myelinated axons in the 
PNS (Fig. 3.6) and CNS (Fig. 3.7) of three month-old wild-type and Whrn
-/-
 mice. Low-
magnification, cross-section electron micrographs of wild-type (Fig. 3.6A) and Whrn 
knockout (Fig. 3.6B) myelinated sciatic nerve fibers showed the typical organization of 
tightly bound, electron-dense myelin wraps around the internodal region of the axonal 
membrane. Accumulation of mitochondria and lipid vesicles in the internodal regions was 
seen more often in Whrn knockout compared to wild-type sciatic nerve fibers (Fig. 3.6B,C 
vs. 3.6A,D, black arrowheads). Consistent with our immunostaining data, no obvious 
differences in nodal organization was observed in either genotype (data not shown). Higher 
magnification along the wild-type paranodal region (Fig. 3.6E, small black arrowheads) 
revealed the hallmark electron-dense AGSJs formed between the glial paranodal loops and 
axolemma and accompanying parallel arrays of cytoskeletal elements in the axon. In contrast 
the Whrn knockout paranodal region (Fig. 3.6F, small black arrowheads) displayed poorly 
defined but present AGSJs, less organized neurofilaments and microtubules, and consistent 
accumulation of mitochondria and lipid vesicles (Fig. 3.6F, large black arrowheads) in the 
paranodal region. Similarly, the paranodal-juxtaparanodal transition region of the myelinated 
axons showed further accumulation of mitochondria and lipid vesicles and cytoskeletal 
disorganization in Whrn
-/-
 tissue (Fig. 3.6H, black arrowheads) compared to  
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Figure 3.6. Ultrastructural examination of three month-old Whirlin knockout sciatic 
nerves reveals organelle accumulation and cytoskeletal disruption. 
A–B, Low magnification electron micrographs through the internodal regions of sciatic 
nerves in three month-old wild-type and Whrn knockout mice in cross section (A vs. B) and 
longitudinal orientations (C vs. D). Overall cellular organization between Whrn knockout 
and wild-type sciatic nerve fibers is conserved with tightly compacted myelin around each 
axon. At a higher magnification, the wild-type paranodal loops (E, small arrowheads) have 
clearly defined characteristic transverse, electron-dense septa and parallel arrays of 
cytoskeletal elements. In contrast, Whrn mutant paranodal septa (F, small arrowheads) are 
less definitive and fuzzy with associated accumulation of organelles. Similarly, the 
paranodal-juxtaparanodal axonal region shows similar accumulation of organelles, 
particularly mitochondria and transport vesicles, in Whrn knockout animals (H, large 
arrowheads) compared to wild-type (G). Scale bars: A-B: 2μm, C-D: 1μm; E-H, 200nm. 
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wild-type (Fig. 3.6G). These results suggest that Whrn is important for proper long-term 
maintenance of the overall structure of the myelinated axons. 
 Turning to the central nervous system, low-magnification, cross-section electron 
micrographs of three month-old wild-type (Fig. 3.7A) and Whrn knockout (Fig. 3.7B) fibers 
showed slight differences in spinal cord myelinated fibers. Like the peripheral nerves, the 
overall organization between glial cell and neuron remained similar between wild-type and 
Whrn
-/-
 fibers. However, mitochondria were slightly more abundant in Whrn knockout fibers. 
This observation was more consistent looking at the nodal-paranodal longitudinal sections 
(Fig. 3.7C-D) of spinal cord sections. No obvious ultrastructural differences were observed in 
node of either genotype, but longitudinal electron micrographs of paranodal and 
juxtaparanodal regions showed greater accumulation of mitochondria and lipid vesicles as 
well as microtubule and neurofilament disorganization in Whrn
-/-
 spinal cords (Fig. 3.7D, 
black arrowheads) compared to wild-type fibers (Fig. 3.7C). Examining the cerebellum, we 
observed and confirmed Purkinje axon swellings in Whrn knockout fibers (Fig. 3.7F-H). 
Low-magnification electron micrographs of three month-old wild-type (Fig. 3.7E) and Whrn 
knockout (Fig. 3.7F-H) cerebellum granular layer showed striking differences in Purkinje 
axon myelinated fibers. This region shows axonal swellings filled with densely-packed 
organelles, particularly mitochondria and vesicles, in Whrn knockout animals (Fig. 3.7F-H, 
black arrowheads) compared to wild-type (Fig. 3.7E). Taken together, the ultrastructural 
analyses of Whrn knockout mice demonstrate that Whrn is critical for the stability of 
paranodal organization, proper axonal cytoskeletal arrangements, and prevention of sub-
cellular organelle accumulation in myelinated axons. 
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Figure 3.7. Ultrastructural examination of Whirlin knockout central nervous system 
tissues reveals organelle accumulation in myelinated axons. 
Electron micrographs of internodal cross sections (A-B) and nodal-paranodal longitudinal 
(C-D) regions in three month-old spinal cords from wild-type (A, C) and Whrn knockout 
mice (B, D). Overall cellular organization is conserved between wild-type and Whrn
-/-
 and 
sciatic nerve fibers with tightly compacted myelin around each axon. Enrichment of 
mitochondria and occasional myelin ruffling is observed in Whrn knockout mice compared to 
wild-type. E-H: Electron micrographs of cerebellar Purkinje myelinated axons running 
through the granular layer of three-month old mice. This region shows axonal swellings filled 
with densely-packed organelles, particularly mitochondria and vesicles, in Whrn knockout 
animals (F-H, black arrowheads) compared to wild-type (E, black arrowhead). Scale bars: 
A-F: 1μm. 
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3.4 Discussion 
Cellular and molecular interactions between neurons and glia establish and stratify 
the numerous tasks of the nervous system. In particular, linkage of cellular membranes with 
the underlying cytoskeleton via cytoskeletal linker proteins helps maintain the specialized 
cellular arrangements necessary to glial and neuronal function. The potential of Whrn to link 
plasma membrane proteins with multiple cytoskeletal protein partners has been well 
established (Mburu, Mustapha et al. 2003, Belyantseva, Boger et al. 2005, Delprat, Michel et 
al. 2005, Mburu, Kikkawa et al. 2006, van Wijk, van der Zwaag et al. 2006, Okumura, 
Mochizuki et al. 2010, Yang, Liu et al. 2010, Manor, Disanza et al. 2011), yet a precise role 
for Whrn in the central or peripheral nervous system or even more specifically in myelinated 
neurons has not been examined. In myelinated axons, axonal membrane proteins like Caspr 
and Caspr2 help stabilize domain organization through linkage of 4.1B to the underlying 
cytoskeleton. This loss of organization at both the light and electron microscopy level is 
readily apparent in mutant mice lacking Caspr (Bhat, Rios et al. 2001), Caspr2 (Poliak, 
Salomon et al. 2003), and 4.1B (Buttermore, Dupree et al. 2011). Here we report a milder but 
similar phenotype with loss of cytoskeletal organization and accumulation of organelles in 
the myelinated fibers of Whrn knockout animals. Comprehensive phenotypic analyses of 
Whrn knockout mice demonstrate that loss of Whrn disrupts proper paranodal compaction 
and long-term stability of the myelinated axons throughout development. 
 
3.4.1 Whrn Alternative Splicing and Phenotypes  
To understand the function of Whrn in the nervous system, one must be considerate 
of Whrn mRNA splice variants and rule out confounding mouse genetic strain differences. 
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Currently, two mutant mouse strains exist for Whirlin: the whirler (Whrn
wi/wi
) mouse has a 
spontaneous genomic deletion of exons 6-9 while the Whrn (Whrn
-/-
) knockout mouse (Yang, 
Liu et al. 2010) has a targeted exon 1 deletion. We examined the localization of several 
myelinated axon markers (Caspr, 4.1B, Kv1.2, and NF186) in Whrn wild-type mice from 
each background strain and observed no disruptions in the localization of these proteins or 
the morphology of the paranodes (data not shown). Our initial studies comparing Whrn
-/-
 to 
Whrn
wi/wi 
mouse strains suggested myelinated domain organization, early paranodal 
disorganization, and nerve conduction (~30m/s) was indistinguishable between each mutant 
mouse line. Given the novelty of the phenotype, we additionally substantiated no mouse 
strain effects after back-crossing to isogenic C57BL6 mice for two generations. Given the 
consistency of the mutant phenotype regardless of background mouse genetics, we were 
assured the phenotype was attributed to loss of Whrn function and not alternative Whrn splice 
variants or mouse genetic background variation.  
 
3.4.2 Whrn Localization in Myelinated Axons 
A key question that remains unresolved is Whrn’s subcellular localization in 
myelinated axons. Initial characterization of polyclonal antibody sera suggested numerous 
non-specific targets, which triggered our subsequent affinity-chromatography purification of 
the generated Whrn antibodies. Despite our repeated efforts, we were unable to resolve the 
specific subcellular localization of Whrn in myelinated fibers with either our affinity-purified 
Whrn antibody, commercial Whrn antibodies, or other published Whrn antibodies (Yang, Liu 
et al. 2010). A recent report detected proper Whrn localization in ear stereocilia using Whrn 
antibodies that our lab generated (Grati, Shin et al. 2012). Several plausible explanations can 
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be presented to explain our current results: 1) the levels of Whrn expression are below the 
threshold of detection by immunofluorescence as suggested by Whrn tissue immunoblots, or 
2) Whrn antibodies retain cross-reactivity with other non-Whrn target proteins even after 
affinity-purification. Given these technical limitations, future studies of Whirlin subcellular 
localization and function in the PNS and CNS should consider genetically-modified Whrn 
mouse models that include Whrn-specific epitope tags. 
 
3.4.3 Scaffolding by Whrn and Previously Established Protein Networks May 
Underlie Paranodal Compaction and Stabilization 
Whrn has several established roles derived from its complex and numerous 
interactions with other protein partners within the ear and eye. This complexity comes from 
identifying and comparing the human and mouse Whrn mutants and splice variants. The 
significant bulk of Whrn research has been performed in the ear and eye since human WHRN 
mutations contribution to a subset of Usher syndromes. In the eye, full-length Whrn 
colocalizes with the transmembrane proteins Usherin and VLGR1 at the periciliary 
membrane complex in photoreceptors (Yang, Liu et al. 2010).  Studies demonstrate the two 
N-terminal PDZ domains of the full-length Whrn isoform are responsible for this interaction. 
In the ear, the shorter Whrn isoform has a more significant role since mutation and/or loss of 
Whrn’s C-terminus correlates to poorer hearing deficits compared to Whrn’s N-terminus. 
The Whrn short isoform interacts through its Proline-rich domain and last PDZ domain with 
Myosin XVa and Mpp1/p55. Additional reports demonstrate Whrn protein expression in the 
mouse cerebrum, cerebellum, and brainstem (Wang, Zou et al. 2012), rat cerebellum (Yap, 
Liang et al. 2003), and in the Drosophila central nervous system (Jepson, Shahidullah et al. 
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2012). Taken together, Whrn has a well-documented history of shared protein-protein 
interaction across multiple model systems and cells. 
We propose that Whrn as a cytoskeletal scaffold crosslinks a subcellular axonal 
meshwork to stabilize the paranode, juxtaparanode, or both, and that in Whrn’s absence, 
subcellular compaction of the paranode and organization of underlying microtubules, 
neurofilaments, cause cytoskeletal disorganization leading to an accumulation of 
mitochondria, and lipid vesicles along myelinated axons. However, given the lack of 
conclusive Whrn immunostaining in these subcellular regions, we acknowledge the 
possibility that this spatiotemporal relationship of Whrn protein expression and resulting null 
phenotype may be indirectly linked. Here we propose the potential sites of interaction for 
Whrn within these regions given its established protein-protein interactions in vivo. Within 
the paranode, Caspr’s intracellular c-terminus contains a SH3 domain, a potential site of 
interaction with Whrn’s Proline-rich domain. The paranode and juxtaparanode are also 
enriched for 4.1B, a known protein partner in the ear stereocilia for Mpp1/p55 which 
interacts with Whrn (Mburu, Kikkawa et al. 2006). Caspr2 also contains a PDZ-binding 
motif which could potentially interact with one of Whrn’s PDZ domains (Poliak, Salomon et 
al. 2003). Finally, Whrn’s c-terminus has the potential for self-oligomerization (Delprat, 
Michel et al. 2005), allowing for even more complex networks of protein-protein interaction 
within the myelinated axon. 
Domain organization in myelinated axons is a complicated developmental process, 
culminating from intrinsic and extrinsic cellular factors. Here we demonstrate that Whrn 
expression is important for proper axonal domain organization and expand the role of Whrn 
outside the ear and eye. Our phenotype also highlights that the paranodal-juxtaparanodal 
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interface may represent a substantial region for insight into paranodal stabilization and 
potential interaction with the cytoskeleton. Whrn’s protein domains have the potential to 
stabilize the paranodal myelin loops and associated cytoskeleton through direct or indirect 
interactions with Caspr, 4.1B, or other unidentified cytoskeletal proteins. These observations 
are correlated using several techniques including biochemistry, light and electron 
microscopy. Our observed paranodal phenotypes are consistent throughout development 
(2wk-1yr) and similar between central and peripheral nervous systems. One important 
consideration about cytoskeletal linker proteins, both Whrn and 4.1B null mice have no 
statistical difference in conduction velocities in sciatic nerves compared to wild-type mice, 
despite having clear paranodal instability in Caspr-stained myelinated fibers. Such data 
suggest cytoskeletal linker proteins may be functionally redundant with respect to  myelinated 
domain organization and may require secondary or tertiary genetic ablations to achieve 
downstream functional effects. Such evidence is observed with the increase in Purkinje 
axonal swellings in the double Whrn; 4.1B null mouse cerebellum compared to the single 
Whrn knockout or wild-type mouse cerebellum. In conclusion, our observations indicate 
Whrn acts as a cytoskeletal scaffolding protein that is essential for proper paranodal 
compaction and stabilization of the axonal cytoskeleton for long-term health of myelinated 
axons. 
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CHAPTER 4 
 
LOCALIZATION OF PDZD7 TO THE STEREOCILIA ANKLE-LINK ASSOCIATES 
THIS SCAFFOLDING PROTEIN WITH THE USHER SYNDROME PROTEIN 
NETWORK 
 
 
4.1 Introduction 
Usher syndrome type 1 (USH1) and 2 (USH2) proteins are essential for hair cell 
stereocilia development and mechanotransduction (MET) (Schwander, Kachar et al. 2010, 
Pan and Zhang 2012, Yang, Wang et al. 2012). The MET complex is built around both ends 
of the tip-link. USH1 proteins form a very distinctive functional and structural network that 
is part of the MET complex. Cadherin-23 (CDH23) and protocadherin-15 form the tip-link 
(Kazmierczak, Sakaguchi et al. 2007), while harmonin, sans, and myosin VIIa (MYO7A) are 
clustered at the upper tip-link insertion density (UTLD) (Grati and Kachar 2011). Harmonin 
is presumed to control the UTLD slippage during MET adaptation via its dual ability to 
simultaneously bind stereocilia actin and CDH23 (Michalski, Michel et al. 2007, Grillet, 
Xiong et al. 2009), and MYO7A likely controls tip-link tension (Kros, Marcotti et al. 2002, 
Grati and Kachar 2011).  
Three USH2 proteins have been so far identified: usherin and GPR98 (also known as 
VLGR1) are plasma membrane proteins that form the ankle-links, and whirlin is thought to 
be a scaffold for protein interactions with these links (Michalski, Michel et al. 2007). Whirlin 
is also implicated in stereocilia-length regulation (Manor, Disanza et al. 2011).  
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Molecular genetic diagnosis in many USH patient cohorts on known USH genes 
failed to reveal mutations in a number of patients, suggesting more USH genes remain to be 
identified (Bonnet, Grati et al. 2011). PDZD7, a three-PDZ domain protein with a central 
proline-rich region, has similar domain composition to harmonin and whirlin. A monoallelic 
mutation in PDZD7 acts as modifier of homozygous USH2A (encoding usherin) mutations 
(Ebermann, Phillips et al. 2010), resulting in retinitis pigmentosa with accelerated onset and 
increased severity. Moreover, monoallelic deleterious mutations in PDZD7 and GPR98 were 
found to cause a digenic case of USH2 (Ebermann, Phillips et al. 2010). Originally, a 
homozygous reciprocal chromosomal translocation was found to disrupt the PDZD7 gene 
implicated in a nonsyndromic congenital hearing impairment (Schneider, Marker et al. 2009).  
Biochemical investigations demonstrated that the PDZ2 domain of PDZD7 binds the 
PDZ-domain interacting motif (aspartate- threonine-histidine-leucine)— containing 
intracellular tails of both GPR98 and usherin. In the retina, PDZD7 has been localized to the 
base of the connecting cilia of photoreceptors (Ebermann, Phillips et al. 2010). Moreover, 
morpholino-induced reduction of PDZD7 in zebrafish embryos led to photoreceptor death 
and hair cell stereocilia disorganization, mimicking the USH phenotype (Ebermann, Phillips 
et al. 2010). These findings implicate PDZD7 in assembly/scaffolding of USH2 complex in 
photoreceptors and likely hair cells. In addition, since USH2 proteins play a role in 
development of the stereocilia hair bundle, it follows that PDZD7 might also contribute to 
their morphogenesis. PDZD7 was found to coimmunoprecipitate with sans and harmonin 
(Schneider, Marker et al. 2009); however, its subcellular localization and function in 
mammalian hair cells remain unknown. Here we use mass spectrometry and fluorescence 
microscopy to investigate subcellular localization of PDZD7 in hair cells in order to 
114 
 
understand its potential role in the development and function of their mechanosensory 
stereocilia. 
 
4.2 Materials and Methods 
4.2.1  Mass spectrometry 
 Purified E20–E21 chick hair bundles were analyzed by mass spectrometry as 
described previously (Shin, Longo-Guess et al. 2010). Label-free protein quantitation used 
MS2 intensities (Spinelli, Klimek et al. 2012) divided by molecular mass, normalized to the 
sum of all intensity/molecular mass; these normalized molar intensities (im) are proportional 
to the mole fraction of each protein (J.-B. Shin and P. G. Gillespie, unpublished 
observations). Peptide data analyzed here were from an X! Tandem analysis (Craig and 
Beavis 2004) of 13 samples, each of 100 ears’ worth of bundles (Shin, Longo-Guess et al. 
2010). 
 
4.2.2  Antibodies 
 Affinity-purified rabbit antibodies PB960/961 (Covance) were generated against 
peptide REAWTLDSRSPTKVRPRLDLE corresponding to mouse PDZD7 isoform-1 amino 
acids 486–506 (GenBank: NP_001182194.1). A mouse polyclonal anti-PDZD7 antibody 
(YFPA20973) directed against human PDZD7 amino acids 1–511 (AAH29054) was 
purchased from AbFrontier. Specificity of both PDZD7 antibodies was validated by 
immunocytochemistry on COS7 cells expressing mCherry-PDZD7. Guinea pig whirlin 
antibodies GP66 and GP68 were generated against recombinant proteins corresponding 
respectively to amino acids 1–234 and 718–907 of human whirlin (Gen- Bank: 
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NP_056219.3) and were validated by immunocytochemistry on COS7 cells expressing GFP-
Whirlin, and by absence of immunofluorescence on inner ear tissue from mutant mice from 
mouse strain B6.Cg-Whrn
wi
 Tyrp1
b
/++J. Immunopurified rabbit GPR98 antibody was 
generated against a recombinant protein corresponding to amino acids 6152–6298 of mouse 
GPR98 (GenBank: AAL30812.1); the same rabbit antiserum was used in McGee et al. 
(McGee, Goodyear et al. 2006). Rabbit immunopurified antibody against TPRN(NBP1-
70732) was purchased from Novus Biologicals. PB206 anti-MYO7A antibody was described 
by Grati and Kachar (Grati and Kachar 2011). 
 
4.2.3  Inner ear tissue 
 All procedures followed the Oregon Health and Sciences University or National 
Institutes of Health (protocol 1215-11) approved animal care protocols and guidelines. 
Animals from either sex were used. The Whirler mice (B6.Cg-Whrn
wi
 Tyrp1
b
/++J) carrying a 
large genomic deletion in Ush2d were obtained from The Jackson Laboratory (stock no. 
000571). 
 
4.2.4  Immunocytochemistry 
 Immunofluorescence staining of PDZD7, whirlin, GPR98, taperin, and MYO7A was 
performed on whole-mount preparations of finely dissected organ of Corti and vestibular 
organs as previously described (Schneider, Dose et al. 2006). Mander’s fluorescence overlap 
coefficient (r) and Pearson’s correlation coefficient (Rr) calculations (Zinchuk and Zinchuk 
2008) were performed with the NIH ImageJ software (Grati and Kachar 2011). 
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4.2.5 Complementary DNA expression vectors 
 Full-length mouse PDZD7 cDNA (NM_001195265) was amplified on randomly 
reverse-transcribed mRNA preparation from inner ear neuroepithelia using primers 5- 
AGTCtccggaGCACGTGGTTTCACGGTAGGCTTTGAC-3and 5- 
AGTCctcgagCTAGGAAGGGTCATGGGGATCCTTAAG-3, cloned into pmCherry-C1 
vector (Clontech) within BspEI and XhoI restriction sites. Constructs encoding plasma 
membrane interleukin-2 receptor -chain— which is 200 amino-acids-long, has a single 
transmembrane domain, and a cytosolic COOH terminus (GenBank CAH73597)—the 
COOH terminus of which was fused to the cytosolic 75 COOH-terminal amino acids of 
mouse usherin (GenBank NP_067383.3; called IL2-ush2a) and to the cytosolic 140 COOH-
terminal amino acids of mouse GPR98 (GenBank AAL30812.1; called IL2 -GPR98)—were 
generated in a pCDNA3 expression vector (Invitrogen) using standard RT-PCR and cloning 
methods. All the final constructs were fully sequenced. EGFP-tagged full-length whirlin 
(AY739114) was a gift from Dr. Thomas Friedman (NIH, Bethesda, MD). Sans and 
harmonin constructs were previously described (Grati and Kachar 2011). 
 
4.2.6 Culture and transfection of rat inner ear tissue 
 Inner ear explants were transfected using Helios gene gun as previously described 
(Rzadzinska, Schneider et al. 2004) and incubated for 24 h. The efficiency of transfection 
ranged from zero to four hair cells per tissue explant, and at least three transfected cells were 
examined for each condition. 
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4.2.7 Culture and transfection of LLC-PK1 and COS7 cells 
 LLC-PK1-CL4 cells were cultured and transfected as described (Grati, Aggarwal et 
al. 2006). COS7 cells were plated on coverslips and maintained at 37°C in DMEM 
supplemented with 10% FBS. Cultures were transfected using GeneJuice (Novagen). Cells 
were fixed 24 h after transfection in 4% PFA in PBS, permeabilized for 10 min in 0.5% 
Triton X-100, and processed for immunocytochemistry. Fluorescence colocalization 
evaluation was performed on at least 10 transfected cells per experiment, as described (Grati 
and Kachar 2011). 
 
4.2.8 Scanning electron microscopy 
 Freshly dissected cochleae were processed for scanning electron microscopy by the 
OTOTO (osmiumthiocarbohydrazide- osmium-thiocarbohydrazide-osmium) method, as 
previously described (Manor, Disanza et al. 2011) and viewed on a Hitachi S-4800 operating 
at 5 kV. 
 
4.3 Results 
4.3.1 Detection of PDZD7 by mass spectrometry 
 Using shotgun mass spectrometry, we identified PDZD7 in hair bundles purified from 
E20–E21 chicken utricles (Fig. 4.1A,B). We detected 33 total peptides (14 unique) for 
PDZD7 across 13 bundle mass-spectrometry experiments. PDZD7 was not detected in eight 
experiments with whole chicken utricle, indicating that it is highly enriched in hair bundles. 
Using MS2 intensities (Spinelli, Klimek et al. 2012) to obtain a semiquantitative measure of 
protein concentration, PDZD7 was present at 30 molecules per stereocilium, with a 95%   
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Figure 4.1. Detection of PDZD7 in hair cells stereocilia.  
A–D, Mass spectrometry analysis. A, C, Representative MS2 spectra for PDZD7 and GPR98 
showing fragments that were either matched (colored) or unmatched (black) to hypothetical 
database spectra. The peptide sequence and statistical score indicating identification 
confidence are shown for each. B, D, Total peptide coverage of PDZD7 and GPR98. The 
width of each bar indicates the length of the identified peptide, the position of the bar along 
the x-axis corresponds to its position in the sequence, the height of the bar indicates the 
number of identical peptides identified, and the shading of the bar corresponds to log(e), the 
statistical significance for peptide identification, averaged over all identical peptides. The 
statistical score indicating identification confidence is shown for each protein. E–N, PDZD7 
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immunolocalization in developing rat hair cells. Confocal microscopy of inner (IHC; E, H, I, 
J, and N), outer (OHC; F, M), and vestibular (VHC; G, K, L) hair cells from postnatal (P) 
day 2 (E–I ), 7 (J–L), and 10 (M, N) rats immunostained with mouse polyclonal YF-
PA20973 (mAb) and rabbit polyclonal PB960 antibodies, showing localization of PDZD7 
(red) at the stereocilia ankle-link region; actin (green).H, High magnification of a long and a 
short stereocilium from a P2 inner hair cell revealing the PDZD7 fluorescence just above the 
tapered base. J, Horizontal cross-section through inner HC stereocilia showing that PDZD7 
immunofluorescence (red) is peripheral to the actin core (green); it is abundant between 
stereocilia of the same row and between stereocilia of longer and shorter rows, but excluded 
from the back of the tallest stereocilia. K, Oblique view of P7 vestibular stereocilia showing 
PDZD7 fluorescence (red, inset) at the ankle-link region. L, Absence of PDZD7 (red) at the 
upper tip-link insertion sites where MYO7A (blue) is clustered (arrowheads). O–Q, Maturing 
hair cells expressing mCherry-PDZD7 showing that PDZD7 targets the ankle-link region. 
Scale bars: E–G, I–Q, 5m; H, 300 nm. 
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confidence interval of 2–300 molecules per stereocilium. This concentration was similar to 
that of GPR98 (~20 molecules per stereocilium; Fig. 4.1C,D) but greater than that of usherin 
(1 molecule per stereocilium; data not shown). 
 
4.3.2 Localization of PDZD7 at the stereocilia base 
Affinity-purified rabbit polyclonal antibody PB960 and the commercially available mouse 
polyclonal antibody YF-PA20973 were highly specific to PDZD7 and showed no cross-
reactivity with either whirlin or harmonin in COS7 cells (data not shown). To investigate 
whether PDZD7 is part of the harmonin–sans complex at the UTLD, part of the ankle-link 
complex, or both, we examined its localization by whole-mount immunofluorescence on 
cochlea and vestibular sensory epithelia at several developmental stages. Although robust 
PDZD7 immunofluorescence reactivity was seen at stereocilia ankle-link region (Fig. 4.1E–
K,M,N), we could not detect it at the UTLD, where MYO7A clusters (Fig. 4.1L, arrowhead). 
This immunolocalization was corroborated by targeting of mCherry-tagged PDZD7, which 
predominantly localized to ankle-link regions of transfected organotypic organ of Corti and 
vestibular hair cells (Fig. 4.1O–Q). Using a commercial rabbit polyclonal antibody to taperin, 
which is restricted to the tapered base of the stereocilia (Rehman, Morell et al. 2010), we 
localized PDZD7 just above and adjacent to the tapered stereocilia base, coinciding with the 
presumed ankle-link region (Fig. 4.2A–C). 
 
4.3.3 PDZD7 colocalization with stereocilia ankle-link proteins 
Whirlin has been localized to the ankle-link area of stereocilia in developing organ of Corti 
and vestibular hair cells and disappears concomitantly from stereocilia of mature cochlear   
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Figure 4.2. PDZD7 colocalization with ankle-link proteins in maturing rat hair cells.  
A–C, Colocalization of PDZD7 and taperin in hair cells. A, B, Back (A) and orthogonal (B) 
views of stereocilia rows of P10 outer HCs colabeled for PDZD7 (blue) and taperin (green) 
showing the distribution of both PDZD7 (blue) and taperin (green) along the long and short 
stereocilia. Red, actin. C, A diagram summarizing PDZD7 (blue) and taperin (green) 
distribution along the stereocilia (red).D–H, PDZD7 and whirlin colocalization in developing 
hair cells. Whirlin is revealed with antibodies GP66 (D–F ) and GP68 (G, H). D, Oblique 
view of P8 outer HC bundle showing immunofluorescence distribution of PDZD7 (P, green) 
and whirlin (W, red). Blue, actin. E, H, Oblique view of P8 VHC stereocilia showing 
immunofluorescence distribution of PDZD7 (green) and whirlin (blue). Red, actin. F, A view 
of a P2 vestibular hair bundle showing partial colocalization of PDZD7 (green) and whirlin 
(blue); r = 0.64 and Rr = 0.60. Red, actin.G, Orthogonal view through P2 outer HC bundles 
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showing PDZD7 (green) and whirlin (blue) immunofluorescence at the ankle-link region. 
Red, actin. I–K, PDZD7 and GPR98 colocalization in P4 hair cells. I, Back view of P4 outer 
HC showing PDZD7 (green) and GPR98 (blue) colocalization at the ankle-link region. J, K, 
Oblique (K ) and surface (L) views of P4 VHCs showing PDZD7 (green) and GPR98 (blue) 
colocalization at the ankle-link region (r = 0.73; Rr = 0.81 in K ). L–N, Whirlin and GPR98 
colocalization in P4 hair cells. L, A view of P4 outer HC showing whirlin (green) and 
GPR98 (blue) colocalization at the ankle-link region. M, A view of P4 IHC showing whirlin 
(green) and GPR98 (blue) colocalization at the ankle-link region. N, Front lateral view of P4 
VHC showing whirlin (green) and GPR98 (blue) presence at the ankle-link region. In all 
three hair cell types, whirlin is also seen at the stereocilia tips (L–N ). Scale bars: A, B–H, J, 
K, N, 5m; I, L, M, 2.5m. 
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hair cells with the disappearance of the ankle-links (Michalski, Michel et al. 2007). Whirlin 
is presumed to scaffold the ankle-link proteins usherin and GPR98 since it interacts in vitro 
with their cytoplasmic tails (Adato, Lefevre et al. 2005, van Wijk, van der Zwaag et al. 
2006). Whirlin is also present at stereocilia tips at all developmental stages, where it is a 
component of the myosin XVa–Eps8 complex, which regulates stereocilia length (Manor, 
Disanza et al. 2011). Using immunocytochemistry-characterized antibodies specific to 
whirlin (see Materials and Methods, above; and data not shown), we studied its 
coimmunolocalization with PDZD7. Both proteins were found together at the ankle-link area 
of developing hair cells (Fig. 4.2D–H), but with limited fluorescence overlap, as indicated by 
the low Mander’s and Pearson’s coefficients (r=0.64, Rr=0.60; Fig. 4.2F). 
GPR98 associates heterotypically with usherin to form extracellular ankle-links 
(Michalski, Michel et al. 2007). Since PDZD7 has been reported to interact in vitro with 
cytosolic tails of GPR98 and usherin (Ebermann, Phillips et al. 2010), we investigated the 
colocalization of PDZD7 with GPR98 (Fig. 4.2I–K). Using a GPR98 antibody directed 
against its intracellular sequence, we found that GPR98 fluorescence strongly overlaps with 
that of PDZD7 along the ankle-link region (Mander’s and Pearson’s coefficients: r=0.73, 
Rr=0.81; Fig. 4.2I–K). In parallel, we investigated the colocalization of whirlin and GPR98 
in maturing hair cells (Fig. 4.2L–N) and observed overlap between these two molecules 
along the ankle-link region (Fig. 4.2L, inset). In adult hair cells, ankle link fluorescence 
corresponding to PDZD7 or GPR98 was not seen in mature outer or inner hair cells (HCs; 
Fig. 4.3A,B), but persisted in mature vestibular HCs (VHC; Fig. 4.3C,D). However, whirlin 
localized to the tips of stereocilia of all mature hair cell types (Fig. 4.3E–I) and to the ankle-  
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Figure 4.3. PDZD7 colocalization with stereocilia ankle-link proteins in mature rat hair 
cells. 
A–D, PDZD7 (P) and GPR98 (G) colocalization in P15 hair cells. Both GPR98 (green) and 
PDZD7 (blue) are absent from mature inner HCs (IHCs; A) and outer HCs (OHCs; B), 
following the disappearance of ankle-links. Red, actin (A). In mature VHCs where ankle-
links persist, GPR98 (green) and PDZD7 (blue) fluorescence strongly overlap, as seen 
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through longitudinal and oblique views of the stereocilia. E–I, PDZD7 (P) and whirlin (W) 
colocalization in P15 hair cells. In organ of Corti, PDZD7 (blue) is absent from mature inner 
(E, F ) and outer (G) HCs following the disappearance of ankle-links. Whirlin fluorescence 
(green) persists in stereocilia tips and some accumulation is visible around the ankle-link 
region (F, arrowhead). Longitudinal (H) and oblique (I ) views of mature VHCs shows that 
PDZD7 fluorescence (blue) covers the regions where whirlin fluorescence (green) is present 
around the ankle-link area. In mature VHCs, whirlin is also seen concentrated at the 
stereocilia tips (H, I ). J, Scanning electron micrograph of P10 whirler inner HC stereocilia 
showing short stereocilia that are interconnected with all sorts of links, including the ankle-
links (K, arrowheads). Scale bars: A–J, 5m; K, 1m. 
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link region of mature VHCs (Fig. 4.3H, I ). Moreover, a visible residual accumulation of 
whirlin was observed in organ of Corti mature HCs (Fig. 4.3F). 
 
4.3.4 PDZD7 interactions with Usher proteins in COS7 and LLC-PK1 cells 
In COS7 and LLC-PK1 cells, PDZD7 was predominantly cytosolic, but also colocalized with 
actin filament networks, particularly at cellular edges (Fig. 4.4A,B). PDZD7 colocalization 
with actin filaments likely depends on binding of PDZD7’s central proline–serine–threonine 
rich domain to actin, as do harmonin-b isoforms (Boeda, El-Amraoui et al. 2002). We also 
reexamined the interactions of PDZD7 with sans and harmonin (Schneider, Marker et al. 
2009) in COS7 cells (Fig. 4.4A,B). A fraction of PDZD7 colocalized with sans (Fig. 4.4A) 
independently of actin filaments, consistent with data from pulldown assays (Schneider, 
Marker et al. 2009). However, PDZD7 was not associated with the actin plaques generated 
by harmonin crosslinking (Fig. 4.4B), suggesting that reported coimmunoprecipitation of 
harmonin and PDZD7 (Schneider, Marker et al. 2009) likely depends on their common actin 
binding. We also investigated the interactions of PDZD7 and whirlin with usherin and 
GPR98 cytosolic COOH-terminal tails in polarized LLC-PK1 cells (Fig. 4.4). For this 
purpose, we fused these tails to the COOH terminus of the IL2 receptor -subunit (IL2), 
which targets to the plasma membrane; trafficking and targeting properties of these 
constructs can be influenced by exogenous cytosolic C-terminal sequences (Grati, Aggarwal 
et al. 2006). Both IL2 -ush2a (Fig. 4.4C,E) and IL2-GPR98 (Fig. 4.4D,F) fusion proteins 
were highly enriched at the apical plasma membrane of LLC-PK1 cells, and each recruited 
PDZD7 (Fig. 4.4C,D) or whirlin (Fig. 4.4E,F), demonstrating that the cytosolic COOH-
terminal tails of usherin and GPR98 can interact with both PDZD7 and whirlin.  
127 
 
 
Figure 4.4. A–F, PDZD7 interactions with Usher proteins in COS7 and LLC-PK1 cells.  
A, In the presence of EGFP-sans (green), mCherry-PDZD7 (red) is randomly spread in the 
COS7 cell cytosol, associated with actin filaments (blue), or also recruited to EGFP-sans 
clusters, as shown by the high values of Mander’s (r = 0.80) and Pearson’s (Rr = 0.81) 
coefficients. B, EGFPharmonin- b (green) forms plaques associated with actin (blue). The 
distribution of mCherry-PDZD7 (red) is unchanged in the presence of EGFP-harmonin-b, 
and its colocalization with EGFP-harmonin-b actin-bound plaques is nonsignificant based on 
the values of r = 0.80 and Rr = 0.10. C, F, Confocal cross-section scans of the apical plasma 
membrane of polarized LLC-PK1 cells coexpressing fusion proteins IL2-ush2a (green in C 
and red in E) and IL2-GPR98 (green in D and red in F ) together with either mCherry-
PDZD7 (red in C, D) or EGFP-Whirlin (green in E, F ), showing that both fusion proteins 
are enriched in the apical plasma membrane where they highly colocalize with both whirlin 
and PDZD7. Scale bars, 10m.  
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4.4 Discussion 
We show that PDZD7, a protein homologous to whirlin and harmonin, is exclusively located 
in the stereocilia ankle-link insertion sites at the site of the ankle-link complex and not found 
at the UTLD. This localization apparently conflicts with the reported in vitro interactions of 
PDZD7 with UTLD scaffolds harmonin and sans and our observation that sans is able to 
recruit PDZD7 in transfected COS7 cells. PDZD7 and sans in vitro interactions nevertheless 
suggests that these two molecules might associate in the hair cell cytosol to traffic to the 
apical pole. Moreover, PDZD7 localization to the ankle-link region, together with its binding 
in vitro (Ebermann, Phillips et al. 2010) and in LLC-PK1 cells to the cytoplasmic tails of 
usherin and GPR98, is consistent with its role as a USH2 phenotype modifier and structurally 
explains the cooperative effects of mutations in usherin and PDZD7, as well as that of 
GPR98 and PDZD7, causing a digenic USH2 phenotype (Ebermann, Phillips et al. 2010). 
Accordingly, PDZD7 localization in the ankle-link makes it a good candidate to cause 
USH2—but not USH1—in humans, and suggests its inclusion in molecular diagnosis testing 
of USH2 patients.  
In cross-sectional confocal views of hair bundle preparations, only a small fraction of 
PDZD7 fluorescence colocalized with that of whirlin at the ankle-link region. This implies 
that these two multi-PDZ domain-containing scaffolds could be playing a complementary 
role in the structure of the ankle-links and possibly in the molecular polarity of these 
structures. In the whirler mouse (B6.Cg-Whrn
wi
 Tyrp1
b
/++J), carrying a deleterious mutation 
in Ush2d, the gene that encodes whirlin, stereocilia are unusually short but GPR98 
immunofluorescence has been abundantly detected in maturing inner hair cells (Michalski, 
Michel et al. 2007). In these mutant hair cells, with well organized, cohesive, and staircase-
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shaped short stereocilia hair bundles, GPR98 likely forms interstereocilia links that can be 
seen by scanning electron microscopy (Fig. 4.3J,K). This result suggests that whirlin is not 
essential for scaffolding GPR98. However, usherin immunofluorescence was not detectable 
in innner HC bundles of the whirler mouse (Michalski, Michel et al. 2007), suggesting that 
whirlin is essential for scaffolding usherin at the ankle-link region. We propose that PDZD7 
positions and stabilizes GPR98 at the ankle-link region of vestibular and maturing organ of 
Corti hair cells. 
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